An evolutionarily conserved regulatory mechanism for endosomal membrane trafficking by Struthers, Marion Symington
 
 
 
 
 
Struthers, Marion Symington (2009) An evolutionarily conserved 
regulatory mechanism for endosomal membrane trafficking. PhD thesis. 
 
 
 
 
http://theses.gla.ac.uk/1350/
 
 
 
Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
 
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk  
 
 
 
AN EVOLUTIONARILY CONSERVED 
REGULATORY MECHANISM FOR 
ENDOSOMAL MEMBRANE TRAFFICKING 
 
 
 
 
 
 
 
A thesis submitted to the 
FACULTY OF BIOMEDICAL AND LIFE SCIENCES 
 
 
 
 
 
 
For the degree of 
DOCTOR OF PHILOSOPHY 
 
 
 
 
 
by 
Marion Symington Struthers 
 
 
 
 
 
 
Division of Molecular and Cellular Biology 
Faculty of Biomedical and Life Sciences 
University of Glasgow 
 
 
 
September 2009 
 
 
 
      2 
Abstract 
Membrane fusion in all eukaryotic cells is facilitated by the formation of SNARE (soluble 
N-ethylmaleimide-sensitive factor attachment protein receptor) complexes; a process that 
is regulated by Sec1p/Munc18 (SM) proteins.  Membrane fusion has been conserved 
through evolution and hence a lot or our knowledge about the molecular mechanism that 
regulates membrane traffic has come from experimentally tractable model organisms such 
as Saccharomyces cerevisiae.  The work presented in this thesis demonstrates that the 
mammalian SNARE protein, syntaxin 16 (Sx16), is a functional homologue of the yeast 
SNARE protein, Tlg2p, as expression of Sx16 in tlg2  cells, fully complements trafficking 
defects displayed by these cells.  This finding is supported by experiments demonstrating 
that Sx16 interacts both physically and functionally with the SM protein of Tlg2p, Vps45p, 
both in vivo and in vitro.  Vps45p regulates Sx16 in a manner similar to the way that it 
regulates Tlg2p; controlling entry into functional SNARE complexes and regulating 
cellular levels.  A model, in which Vps45p is required for regulating membrane fusion and 
regulating the cellular levels of Tlg2p, is also presented and discussed in this thesis.     3 
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1.1 Type 2 Diabetes 
Diabetes mellitus is characterised by hyperglycemia (high blood sugar) and is a result of 
defects in insulin secretion, action or both (Saltiel and Kahn, 2001, Zimmet et al., 2001).  
There are two main types of diabetes, Type 1 and Type 2 (Saltiel and Kahn, 2001, Zimmet 
et al., 2001).  Type 1 is caused by the autoimmune destruction of the pancreatic b-cell islet, 
resulting in a block in insulin secretion (Saltiel and Kahn, 2001, Zimmet et al., 2001).  
Type 2 diabetes is characterised by insulin resistance caused by a deregulation of insulin 
action (Saltiel and Kahn, 2001, Zimmet et al., 2001).   
Type 2 diabetes is by far the most prevalent type of diabetes, accounting for approximately 
90-95% of those individuals suffering from diabetes (Zimmet et al., 2001).  In 2008, the 
World Health Organisation (WHO) reported that more than 180 million people worldwide 
suffer from diabetes and have estimated that this number is likely to double by 2030.   
1.1.1 Insulin signaling 
Binding of insulin to its heterotetrameric receptor (a2β2) occurs via the extracellular alpha 
subunits of the receptor resulting in a conformational change which, in turn, activates the 
tyrosine-kinase domains present in the intracellular portion of the beta subunits of the 
receptor (reviewed in (Lee and Pilch, 1994)).  This results in the activation of two signal 
transduction pathways, the phosphatidylinositol 3-kinase (PI3K) pathway and the casitas b-
lineage lymphoma (c-Cbl) pathway, both of which result in the translocation of the glucose 
transporter 4 (GLUT4) receptor from its intracellular location to the plasma membrane, by 
a mechanism which is still unclear (Bryant et al., 2002, Leney and Tavare, 2009).   
1.1.1.1  PI3K pathway 
PI3K is recruited to the plasma membrane by tyrosine phosphorylation of the insulin 
receptor substrate (IRS 1/2) (Myers et al., 1993).  PI3K phosphorylates 
phosphatitidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate 
(PIP3) (Tengholm and Meyer, 2002).  This results in the recruitment of proteins containing 
the pleckstrin homology (PH) domain, in particular protein kinase B (PKB also known as 
Akt) and its upstream kinase phosphatidylinositol-dependent kinase 1 (PDK1) (Alessi et 
al., 1997, Stephens et al., 1998, Stokoe et al., 1997).  It is thought that PKB/Akt may 
stimulate GLUT4 translocation through the Rab GTPase Activating protein (RabGAP) Marion S. Struthers, 2009    Chapter 1, 16 
 
domain of the Akt Substrate of 160 kDa (AS160) (Eguez et al., 2005, Larance et al., 2005, 
Sano et al., 2003) and/or through PIKfyve (phophoinositide kinase, FYVE finger 
containing) (Ikonomov et al., 2007, Ikonomov et al., 2002).  Isoforms of protein kinase C 
(PKC), λ/ζ, have also been implicated in the translocation of GLUT4 to the plasma 
membrane however the mechanism of this is still unknown (Bandyopadhyay et al., 1997a, 
Bandyopadhyay et al., 1997b, Imamura et al., 2003, Liu et al., 2006, Lorenzo et al., 2002). 
1.1.1.2  c-Cbl pathway 
This pathway works independently of the PI3K pathway and involves the tyrosine 
phosphorylation of c-Cbl (Ribon and Saltiel, 1997).  c-Cbl is recruited to the plasma 
membrane by two adaptor proteins; c-Cbl associated protein (CAP) and adaptor molecule 
containing PH and Src homology-2 (SH2) domains (APS) (Ribon et al., 1998).  Tyrsoine-
phosphorylated c-Cbl recruits CrkII, an adaptor protein, and C3G, a guanine exchange 
factor for the Rho-like GTPase TC10, into lipid rafts (Chiang et al., 2001, Gupte and Mora, 
2006, Ribon et al., 1996, Ribon et al., 1998, Ribon and Saltiel, 1997).  The activation of 
this pathway by insulin is thought to regulate the translocation of GLUT4 to the plasma 
membrane, possibly acting through several different processes such as cortical actin 
rearrangement (Kanzaki and Pessin, 2001), phosphatidylinositol 3-phosphate (PI(3)P) 
formation (Maffucci et al., 2003), recruitment of the exocyst complex to the plasma 
membrane (Inoue et al., 2003, Inoue et al., 2006) and/or the inactivation of the Rab protein, 
Rab31 (Lodhi et al., 2007). 
1.1.2 GLUT4 
In the 1950s it was first demonstrated that the hormone, insulin, stimulated the uptake of 
glucose into muscle and adipose tissue (Levine and Goldstein, 1958, Park and Johnson, 
1955).  However it was not until 1989 that the facilitative glucose transporter, GLUT4, was 
cloned and identified as the major isoform responsible for the uptake of glucose into these 
tissues in response to insulin (Birnbaum, 1989, Charron et al., 1989, Fukumoto et al., 1989, 
James et al., 1989, Kaestner et al., 1989).  As discussed above, insulin stimulates the 
movement of GLUT4 from an intracellular membrane-bound pool to the plasma membrane 
(Bryant et al., 2002).  This was demonstrated using subcellular fractionation (Deems et al., 
1994, Marette et al., 1992, Pilch et al., 1993), electron and fluorescence microscopy 
(Voldstedlund et al., 1993), bis-mannose photolabelling of plasma membranes (Calderhead 
et al., 1990, Holman et al., 1990) and also epitope-tagged versions of GLUT4 (Bryant et Marion S. Struthers, 2009    Chapter 1, 17 
 
al., 2002, Czech et al., 1993, Dawson et al., 2001, Dobson et al., 1996, Kanai et al., 1993).  
At the surface of the cell, GLUT4 allows the transport of glucose out of the blood into the 
cell down a concentration gradient (Saltiel and Kahn, 2001).  Glucose can then be stored as 
glycogen in the liver and skeletal muscle or as fat in adipose tissue (Saltiel and Kahn, 
2001). 
A substantial amount of work has been carried out to investigate the location of GLUT4 in 
the absence of insulin (under basal conditions) (reviewed in (Bryant et al., 2002, Leney and 
Tavare, 2009)).  GLUT4 is associated with a variety of different intracellular 
compartments.  These include the Golgi complex, trans-Golgi network (TGN), late 
endosomes and recycling endosomes (Ralston and Ploug, 1996), with the majority of 
GLUT4 found in a subset of vesicles known as the GLUT4 storage vesicles (GSVs), which 
are also enriched in insulin-responsive aminopeptidase (IRAP) and vesicle associated 
membrane protein-2 (VAMP-2) (Malide et al., 1997).   
1.1.3 A model for GLUT4 trafficking 
Understanding the intracellular trafficking of GLUT4 has proven difficult due to the fact 
that under basal conditions GLUT4 is localized to many different intracellular membrane-
bound organelles (Bryant et al., 2002).  A model that has been proposed to explain the 
multiple intracellular locations of GLUT4 suggests that GLUT4 exists in two interrelated 
endosomal pathways; a fast cycling pathway which functions to control trafficking 
between the plasma membrane and the early endosomes returning GLUT4 to an 
intracellular location in the absence of insulin and a slow cycling pathway which functions 
by trafficking GLUT4 from the recycling endosomes to the TGN and on to the GSVs 
(Bryant et al., 2002).   According to this model, insulin binding to its receptor releases 
GLUT4 from these GSVs, by some unknown mechanism, which results in its trafficking to 
the plasma membrane (Bryant et al., 2002).  It is unlikely that in the absence of insulin 
GLUT4 remains in a static pool of GSVs, as this would result in the depletion of GLUT4 
from the other intracellular compartments in which it can be detected (Bryant et al., 2002).  
The GLUT4 trafficking model described here is summarised in the following diagram. Marion S. Struthers, 2009    Chapter 1, 18 
 
   
Figure 1.1 – A model for insulin-stimulated GLUT4 trafficking. 
The fast and slow cycling pathways are labelled Cycle 1 and 2, respectively.  This diagram is 
taken from (Bryant et al., 2002). 
 
In order to understand how insulin alters the trafficking itinerary of GLUT4 to bring about 
its delivery to the cell surface, it is important to understand how membrane traffic is 
regulated in eukaryotic cells. 
1.2 Trafficking and Transport in Eukaryotic cells 
All eukaryotic cells are compartmentalised into numerous membrane-bound compartments 
or organelles.  Exchange of materials between these organelles occurs by means of 
vesicular transport; a highly specific mechanism that ensures the correct delivery of 
molecules from one intracellular membrane bound compartment to another (Bonifacino 
and Glick, 2004, Palade, 1975).  Efficient trafficking of molecules between organelles is 
essential, as the incorrect localisation of proteins could have disastrous, even fatal, 
consequences for the cell. 
1.2.1 SNARE proteins  
Soluble N-ethylmalemide (NEM) sensitive factor (NSF) attachment protein (SNAP) 
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synapse by their ability to interact with NSF and its attachment protein a-SNAP during 
affinity purification (Sollner et al., 1993).  Since then, a large number of SNARE proteins 
have been identified in yeast, plants and animals (Bennett, 1995, Linial, 1997, Rothman, 
1994).  These C-terminally anchored proteins play a critical role in membrane trafficking 
in all eukaryotic cells (Jahn and Sudhof, 1999).  Members of the SNARE protein family 
share one feature in common, a weakly conserved 60-70 aa domain located in their           
C-terminal region, upstream of the transmembrane domain (Jahn and Sudhof, 1999).  This 
motif known as the SNARE motif/domain is largely unstructured and is characterised by a 
heptad repeat of hydrophobic residues (Jahn and Sudhof, 1999).  The association of four of 
these SNARE domains results in the formation of a highly structured and stable four helix 
bundle (Antonin et al., 2002, Poirier et al., 1998, Sutton et al., 1998) also known as the 
SNARE or core complex, formation of which is sufficient to catalyse the energetically 
unfavourable process of fusing two phosholipid bilayers (Jahn and Sudhof, 1999).  Surface 
force measurements have demonstrated that the energy provided during the formation of a 
single SNARE complex is sufficient to catalyse hemifusion; the fusion of one leaflet of a 
lipid bilayer (Li et al., 2007).  For complete lipid bilayer fusion (50-100kBT) it is thought 
that 3 or more SNARE complexes (each providing 35kBT of energy) are required (Cohen 
and Melikyan, 2004, Hua and Scheller, 2001, Li et al., 2007). 
1.2.2 The SNARE hypothesis 
In 1993, Rothman and colleagues proposed the SNARE hypothesis to explain the fidelity 
of membrane fusion (Sollner et al., 1993).  That is, how the cell ensures that a transport 
vesicle docks and fuses only with the appropriate target membrane.  According to the 
SNARE hypothesis transport vesicles carry v (vesicle) SNAREs bind, in a highly specific 
manner, to their cognate t (target) SNAREs located on the appropriate target membrane 
(Sollner et al., 1993).  Only when a complex is formed between the appropriate set of 
SNARE proteins will membrane fusion proceed and thus the specificity of t- and v-
SNARE interaction contributes to the specificity of membrane fusion (Sollner et al., 1993). 
More recently the definition of typical t-SNAREs and v-SNAREs has become less clear 
cut (Jahn and Sudhof, 1999) for example during the homotypic fusion events of vacuolar, 
endoplasmic reticulum (ER) and Golgi membranes following cell division (Fasshauer et 
al., 1998).  This along with the unexpected discovery of four hydrophilic (3 glutamine and 
1 arginine) residues conserved at the zero layer of SNARE complexes has led to the 
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functional SNARE complex containing three Q-SNAREs and one R-SNARE (Fasshauer et 
al., 1998).  Q-SNAREs can be further subdivided into Qa-SNAREs (also known as 
syntaxins or t-SNARE heavy chain), Qb-SNAREs and Qc-SNAREs (both of which are 
also known as the t-SNARE light chains) (Bock et al., 2001).  It should, however, be noted 
that the Q/R-SNARE classification does not encompass all SNARE proteins.  There are 
several SNAREs that cannot be classified as either Q- or R- SNAREs, for example the 
yeast ER-Golgi v-SNARE Bet1p, contributes a serine (S) residue instead of an arginine (R) 
residue at the zero layer of the SNARE complex (Fasshauer et al., 1998).  Similarly the 
mammalian t-SNARE, Vti1b, contributes an aspartate residue (D) at the zero layer of the 
SNARE complex in place of a glutamine (Q) (Zwilling et al., 2007). 
1.2.3 Syntaxins 
Syntaxins or Qa-SNAREs are a member of the superfamily of SNARE proteins.  They 
possess a SNARE and a transmembrane (TM) domain as well as an additional Habc 
domain (Fernandez et al., 1998) (Figure 1.2A).  The Habc domain is located in the N-
terminal half of the syntaxin and is composed of three anti-parallel alpha helices that fold 
back on each other (Figure 1.2B) (Fernandez et al., 1998). Marion S. Struthers, 2009    Chapter 1, 21 
 
          
Figure 1.2 – Schematic and graphical diagrams of Sx1a 
(A) A schematic diagram representing the key domains of syntaxins.  The residue numbers 
are specific for syntaxin 1a (Sx1a) (Fernandez et al., 1998).  (B) Graphical diagrams 
displaying the structure of the Habc domain as viewed in two different orientations. Those 
residues annotated are representative of Sx1a.  Taken from (Fernandez et al., 1998). 
 
Sequence alignment of the Habc domain from all syntaxins has shown a varying level of 
homology with the greatest number of similarities detected between syntaxins involved in 
neurotransmitter release (Fernandez et al., 1998). 
Identification of the Habc domain has greatly enhanced our understanding of how 
membrane fusion may be regulated by Sec1/Munc18 (SM) proteins (discussed in more 
detail in Section 1.3.2).  Structural and mutational studies have demonstrated that certain 
syntaxins, such as Sx1a and Sso1p, can exist in two different conformations, these are 
known as the closed and open conformations (Figure 1.3) (Dulubova et al., 1999, Misura et 
al., 2000, Munson et al., 2000). Marion S. Struthers, 2009    Chapter 1, 22 
 
 
Figure 1.3 – A representative diagram displaying the two different conformations adopted 
by Sx1a.   
The closed conformation is shown on the left hand side; in this conformation the Habc 
domain is folded back against the SNARE domain.  The open conformation is shown on the 
right hand side; in this conformation the Habc domain (amino-terminal domain) has no 
contact with the SNARE domain.  The two other SNARE proteins involved in the SNARE 
complex are show in red (SNAP-25) and blue (VAMP-2).  Taken from (Burgoyne and Morgan, 
2007). 
 
In the closed conformation the Habc domain folds over and interacts with the SNARE 
domain and prevents any interaction with other SNARE domains; this is a fusion 
incompatible state as it is incompatible with SNARE complex assembly (Dulubova et al., 
1999).  In the open conformation the Habc domain has no contact with the SNARE domain 
which therefore is free to interact with other SNARE domains to form a functional SNARE 
complex; this is a fusion compatible state (Dulubova et al., 1999). 
1.2.4 Syntaxin 16 (Sx16) 
Sx16 was first cloned and sequenced by Simonsen and colleagues (Simonsen et al., 1998).  
Sx16 was identified by searching the expressed sequence tag (EST) database for sequences 
which showed similarities to the C-termini of syntaxins (Simonsen et al., 1998).  The 
authors subsequently designed PCR primers to one EST which contained a 246 bp region 
that showed homology to the syntaxin family.  This allowed them to amplify full-length 
cDNA from HeLa and brain plasmid cDNA libraries.  The two longest PCR products 
generated from the HeLa plasmid cDNA library, syntaxin 16A (Sx16A) and syntaxin 16C 
(Sx16C), were identical except Sx16A contained a 161 bp insertion and a 12 bp deletion 
(Simonsen et al., 1998).  Sx16C also contains an in-frame stop codon in place of the 
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lacking the SNARE and TM domain of Sx16A (Simonsen et al., 1998).  The longest PCR 
product obtained from the brain cDNA plasmid library, Sx16B, was identical to Sx16A 
however it contained an additional 63 bp insertion (Simonsen et al., 1998). 
Profile-database searches identified four hypothetical proteins to which Sx16B could be 
aligned (Simonsen et al., 1998).  Two of these hypothetical proteins were from the plant, 
Arabidopsis thaliana (2P16.16 and T10M13.19), one from the nematode, Caenorhabditis 
elegans (ZC155.3) and one from the yeast, Saccharomyces cerevisiae (YOL018c).  Sx16B 
shows a 27-34% identity and 52-58% similarity to these hypothetical proteins (Simonsen et 
al., 1998).   
Testing the tissue distribution of Sx16, Simonsen and colleagues, probed a northern blot 
containing mRNAs from the human tissues, heart, brain, placenta, skeletal muscle, kidney 
and pancreas with a probe that would recognise all three splice variants of Sx16; however 
only one band, of approximately 5 kb was detectable in all of the tissues tested.  The 
author’s explanation for this was that the Sx16 mRNAs must contain large untranslated 
regions and suggest that the sizes of the mRNAs are too similar to be resolved.  Further 
attempts to probe the northern blot specifically for Sx16B, using a probe specific to the 63 
bp insert which is absent in both Sx16A and Sx16C was unsuccessful.  They therefore 
conclude that it is unclear to what extent the splice variants are expressed in the same or 
different tissues. 
Intracellular localisation of Sx16 was investigated using Myc-tagged versions of each of 
the Sx16 splice variants (A, B and C) expressed in baby hamster kidney-21 (BHK-21) cells 
(Simonsen et al., 1998).  Sx16A and Sx16B were found at a juxtanuclear structure, 
whereas Sx16C was found in the cytosol (Simonsen et al., 1998).  Confocal 
immunofluorescence microscopy, further demonstrated that Sx16A co-localises with the 
Golgi marker β-COP and also partially co-localises with the TGN marker, the mannose-6-
phosphate receptor (Simonsen et al., 1998).  Sx16A also showed a small amount of co-
localisation with the ER marker, calreticulun, however treatment of cells with 
cycloheximide demonstrated that Sx16A is only initially associated with the ER membrane 
prior to reaching its final destination at the Golgi (Simonsen et al., 1998). 
At a similar time a second group had also identified a novel syntaxin-like molecule from a 
human EST database, which they used as a probe in a human pancreas cDNA library (Tang 
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and the authors retained this name for their clone (Tang et al., 1998).  Sx16H shows a high 
level of homology to those Sx16 genes already deposited by Simonsen and colleagues in 
GenBank (Sx16A, B and C).  Sx16H is very similar to Sx16A and Sx16B, but not 
identical.  The N-terminal region of Sx16H is identical to Sx16C; however, Sx16H 
encodes a full-length version of the syntaxin (307 amino acids in length) whereas Sx16C 
encodes a truncated version of the protein (116 amino acids in length) (Tang et al., 1998). 
Testing the tissue distribution of Sx16H, Tang and colleagues probed a multiple tissue 
(heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas) northern blot with 
full-length Sx16H.  A single reactive band of approximately 6.5 kb was detected in all 
tissues tested, with slightly higher levels detected in the heart and pancreas.  They 
concluded that the presence of a reactive band in all tissues suggests that the protein has a 
general function (Tang et al., 1998).  
Intracellular localisation of Sx16H was investigated using an N-terminally Myc-tagged 
version of Sx16H expressed in cells being CV-1 (simian) in origin carrying the SV40 
genetic material (COS cells).  Confocal immunofluorescence microscopy demonstrated 
that Sx16H co-localises with the Golgi lectin marker lens culinaris agglutinin (LCA) as 
well as the Golgi SNARE protein of 28 kDa (GS28) and syntaxin 5 (Sx5).  Further 
treatment of cells with the drug brefeldin A (BFA) showed Sx16H to be localised to the 
Golgi stack. 
Following on from the data provided by those groups mentioned above, Dulubova and 
colleagues went on to characterise Sx16 (Dulubova et al., 2002).  They describe the three 
longest splice variants of Sx16 (A, B and H) as differing in an alternatively spliced region 
present after the sequence encoding the first 27 residues of Sx16 but prior to sequence 
encoding the Habc domain.  The shortest splice variant of Sx16, Sx16C, is identical to 
Sx16H, but has a stop codon present in the sequence encoding the second helix, Hb of the 
Habc domain.  Dulubova and colleagues also identified a fourth splice variant of Sx16, 
syntaxin 16D (Sx16D), also identical to Sx16H, but with a stop codon located between the 
sequence encoding the Habc domain and the SNARE domain.   
Testing the tissue distribution of Sx16, Dulubova and colleagues analysed equal amounts 
of homogenate from the mouse tissues; heart, brain, spleen, lung, liver, muscle, kidney and 
testis, for the presence of Sx16 using immunoblot analysis with an antibody specific to 
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brain, which was representative of full-length Sx16.  Prolonged exposure demonstrated 
that Sx16 was present in all of the tissues tested but this was at much lower level than that 
seen in brain.  The authors conclude that under normal conditions the shorter splice 
variants, Sx16C and Sx16D, are not present at steady-state levels.   
In summary five different splice variants of Sx16 have been identified; Sx16A, Sx16B, 
Sx16C (Simonsen et al., 1998), Sx16H (Tang et al., 1998), Sx16D (Dulubova et al., 2002).  
The three longest splice variants Sx16A, Sx16B and Sx16H encode membrane bound 
proteins (Dulubova et al., 2002, Sollner et al., 1993, Tang et al., 1998) which differ from 
each other in the region between the first 27 amino acids and the Habc domain (Dulubova 
et al., 2002).  Sx16C and Sx16D are identical to Sx16H, but encode truncated versions of 
the syntaxin, both of which lack a SNARE domain and transmembrane domain (Dulubova 
et al., 2002, Simonsen et al., 1998).  Sx16 was detected in all of the tissues tested, with 
slightly elevated levels detectable in human heart and pancreatic tissues (Simonsen et al., 
1998, Tang et al., 1998) and also in brain tissue prepared from mice (Dulubova et al., 
2002).  As only full-length Sx16 was detectable in these tissues, it was suggested that 
under normal conditions the shorter splice-variants are not present at steady-state levels 
(Dulubova et al., 2002).  Sx16A and B localise to a juxtanuclear structure with Sx16A co-
localising with the Golgi marker β-COP and also partially co-localising with the mannose-
6-phosphate receptor (Simonsen et al., 1998).  Sx16H co-localises with the Golgi lectin 
marker, LCA, as well as GS28 and Sx5 (Tang et al., 1998).  Further treatment of cells with 
the drug, BFA, showed Sx16H to be localised to the Golgi stack (Tang et al., 1998). 
1.2.5 Sx16 has been implicated in the trafficking of GLUT4 
Sx16, the syntaxin of interest in this study, and its binding partner, syntaxin 6 (Sx6) 
(Kreykenbohm et al., 2002, Mallard et al., 2002, Perera et al., 2003) have been implicated 
as playing an important role in insulin-regulated GLUT4 trafficking (Perera et al., 2003, 
Proctor et al., 2006, Shewan et al., 2003).   
In 2003, Shewan and colleagues provided the first link between these three proteins using 
confocal immunofluorescence microscopy which demonstrated that GLUT4 co-localises 
with Sx16 and Sx6 in a subdomain of the TGN that is morphologically distinct from the 
TGN38 compartment (Shewan et al., 2003).  This was further confirmed by the presence of 
Sx16 and Sx6 in immunoisolated GLUT4 vesicles (Shewan et al., 2003).  In order to 
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compartment, Shewan and colleagues utilised subcellular fractionation and immunoblot 
analysis to determine the location of Sx16 and Sx6 following insulin-stimulation (Shewan 
et al., 2003).  Their results confirmed that Sx16 and Sx6 are present in an insulin-
responsive compartment, as unlike TGN resident proteins, they are transported to the 
plasma membrane in response to insulin (Shewan et al., 2003).  This finding was further 
supported using a plasma membrane assay (Robinson et al., 1992) which demonstrated that 
Sx16 and Sx6 are present at higher levels at the plasma membrane of insulin treated cells 
compared to those cells under basal conditions (Shewan et al., 2003).  The kinetics at 
which Sx6 was delivered to the plasma membrane in response to insulin was identical to 
that of GLUT4, suggesting that these molecules are transported in the same population of 
vesicles (Shewan et al., 2003).   
Further evidence that Sx16 and Sx6 play a role in the trafficking of GLUT4, came from a 
second study performed by Perera and colleagues (Perera et al., 2003).  In this study the 
authors focused primarily on Sx6.  Initially, they utilised subcellular fractionation to 
demonstrate that Sx6, like GLUT4 and IRAP, is translocated to the plasma membrane in 
response to insulin in 3T3-L1 adipocytes.  Quantification of this data indicated that similar 
amounts of these three proteins are delivered to the plasma membrane following insulin-
stimulation.  Furthermore, immunoblot analysis of immunoisolated GLUT4-containing 
vesicles demonstrated that ~85% of cellular Sx6 is present in GLUT4-containing vesicles.   
To determine the functional role that Sx6 plays in adipocytes, Perera and colleagues 
utilised a recombinant adenovirus to overexpress a cytosolic version of Sx6 lacking its 
transmembrane domain (referred to as Sx6-cyto hereafter) (Perera et al., 2003).  This 
truncated version of Sx6 acts as an inhibitor of membrane fusion as it forms non-functional 
SNARE complexes (this has previously been demonstrated in studies utilising the syntaxin, 
Sx4 (Olson et al., 1997, Tellam et al., 1997b, Volchuk et al., 1996).  In order to monitor the 
trafficking of GLUT4 in those cells overexpressing Sx6-cyto, the authors utilised a glucose 
transport assay, which measures the uptake of radiolabelled 2-Deoxy-D-glucose (deGlc) in 
insulin treated and untreated cells.  Their results showed that although there was no change 
in the uptake of deGlc in insulin treated cells overexpressing Sx6-cyto, there was a 
significant increase in the rate of deGlc uptake under basal conditions.  To explain these 
findings the authors proposed that GLUT4 trafficking from the endosomal system into its 
insulin-sensitive storage compartment was impaired in cells overexpressing Sx6-cyto, they 
further hypothesised that this would result in an increased level of GLUT4 in recycling 
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the glucose transport assay described above to measure the rate of deGlc transport 
following insulin withdrawal in those cells overexpressing Sx6-cyto.  In agreement with 
their hypothesis they detected a decrease in the rate of deGlc transport to return to that of 
basal levels following insulin withdrawal.  The authors describe this effect as being due to 
a decrease in either the rate of GLUT4 endocytosis or the rate at which GLUT4 is 
sequestered from the recycling endosomes.  In order to investigate this, the authors 
analysed the distribution of GLUT4 within these cells at set time points following insulin 
withdrawal.  Their results showed an apparent decrease in the rate of GLUT4 endocytosis 
and sequestration from recycling endosomes; further implying that Sx6 does plays an 
important role in GLUT4 trafficking.  To further investigate whether or not Sx6 is involved 
in the trafficking of GLUT4 between the endosomal system/TGN and GSVs, the authors 
used iodixanol gradients.  These gradients can be used to separate GLUT4 that is present in 
the TGN/endosomes from that which is present in the GSVs (Hashiramoto and James, 
2000, Maier and Gould, 2000).  Their results suggest that Sx6 is involved in the sorting of 
GLUT4 into GSVs (Perera et al., 2003).   
Perera and colleagues also set about identifying other proteins present in adipocytes which 
interact with Sx6 and hence may also be involved in the trafficking of GLUT4 (Perera et 
al., 2003).  In particular the authors identified Sx16, which co-immunoprecipitates with 
Sx6.  Further investigation of the relationship between Sx16 and GLUT4 demonstrated that 
like Sx6, >85% of Sx16 is found in GLUT4 vesicles isolated by immunoadsorption.  In 
addition to this, Sx16, unlike Sx6, was found to be present in higher levels in the GSV 
fraction rather than the TGN/endosomal fraction of iodixanol gradients prepared from 
adipocytes.  Finally the authors investigated the phosphorylation of Sx6 and Sx16 in 
insulin treated and untreated adipocytes.  The authors demonstrate that only Sx16 is subject 
to phosphorylation and that this phosphorylation is decreased approximately 50% 
following insulin treatment. 
Following on from the data provided in those studies described above, Proctor and 
colleagues went on to further investigate the role of Sx16 in the trafficking of GLUT4 
(Proctor et al., 2006).  Like Perera and colleagues, Proctor and colleagues utilised a 
recombinant adenovirus to overexpress an inhibitory version of Sx16 (Sx16-cyto) which 
lacks its transmembrane domain (discussed above for Sx6).  Similar to those results 
obtained for Sx6-cyto, overexpression of Sx16-cyto decreased the rate at which deGlc 
transport was returned to that of basal levels following insulin withdrawal.  To further 
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oligonucleotides to knock-down the levels of Sx16 in 3T3-L1 adipocytes and subsequently 
utilised these cells to analyse the rate of deGlc transport following insulin withdrawal.  
Consistent with their previous findings, they detected a decrease in the rate at which deGlc 
transport was returned to that of basal conditions, following insulin withdrawal.  However, 
they also noticed a decrease in the rate of insulin-stimulated deGlc transport and further 
demonstrated that this effect was specific to the trafficking of GLUT4 as the endocytic 
trafficking of the Transferrin receptor (TfR) was unaffected.  Interestingly, the authors also 
noticed that the levels of GLUT4 were reduced by ~30% in these cells.  From these data, 
Proctor and colleagues hypothesise, that by knocking-down the levels of Sx16, the levels 
of GLUT4 present in the GSVs will also be reduced which in turn will result in a decrease 
in the amount of deGlc transported into the cell following insulin-stimulation and also an 
over-all decrease in the levels of GLUT4 present within these cell.  They further confirmed 
their hypothesis by demonstrating that there was a decrease in insulin-stimulated 
translocation of GLUT4 as well as a decreased level of GLUT4 present in these cells with 
levels being particularly depleted in those membrane fractions normally enriched in 
GLUT4 (eg GSVs). 
The three studies described above all support a common model in which Sx6 and Sx16 
play a role in the intracellular trafficking of GLUT4, functioning to control the entry of 
GLUT4 into the slow cycling pathway and also its entry into GSVs and hence suggest that 
these syntaxins function to regulate the insulin responsiveness of adipocytes (Perera et al., 
2003, Proctor et al., 2006, Shewan et al., 2003).  Consistent with this model, the discovery 
that Sx16 is a phosphoprotein which is dephosphorylated in response to insulin (Perera et 
al., 2003), makes Sx16 an extremely attractive candidate as a regulatory node of insulin-
regulated GLUT4 trafficking. 
Although, it is clear that the three studies described above have provided strong evidence 
for the involvement of Sx16 in insulin-regulated GLUT4 trafficking it has proven hard to 
gain molecular insight into the regulation of this, due to the experimental intractability of 
terminally differentiated insulin-sensitive cells.  As with many areas of cell biology a lot of 
our knowledge about the molecular mechanism that regulates membrane traffic has come 
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1.2.6 Trafficking in yeast and mammalian cells 
The molecular machinery that controls membrane trafficking has been highly conserved 
during evolution from yeast to mammalian cells (Ferro-Novick and Jahn, 1994).  This was 
demonstrated by the observation that the yeast SEC18 gene product can replace 
mammalian NSF in a cell free assay that reconstitutes membrane transport (Wilson et al., 
1989).  The striking similarities between yeast and mammalian cells has been confirmed as 
identification of different components involved in synaptic vesicle release at nerve endings 
and protein transport in yeast using both biochemical and genetic studies have found many 
homologous proteins (Figure 1.4) (reviewed in (Ferro-Novick and Jahn, 1994)).  Such 
studies have established yeast as a good model system to study membrane trafficking 
events. 
 
Figure 1.4 – Conservation of vesicle targeting and fusion machinery from yeast to man. 
Taken from (Ferro-Novick and Jahn, 1994). 
 
1.2.7 Identification and characterisation of the yeast t-SNARE, 
Tlg2p 
As discussed above (see Section 1.2.4), in silico analysis has identified Sx16 as being 
homologous to one hypothetical protein from the yeast strain, S. cerevisiae encoded by 
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In 1998, three independent groups characterised the protein encoded by YOL018c as the t-
SNARE, Tlg2p (Abeliovich et al., 1998, Holthuis et al., 1998, Seron et al., 1998).  Tlg2p is 
a 396 amino acid protein with a domain structure typical of syntaxins (Dulubova et al., 
2002).  It has a Habc (residues 70-187), a SNARE domain (residues 253-307) and a 
transmembrane domain (residues 317-334) (Dulubova et al., 2002).  In addition and 
unusual for a SNARE protein, Tlg2p also possesses a further 63 residues at its C-terminus 
(predicted to be lumenal) (Dulubova et al., 2002) which are not required for its function 
(Abeliovich et al., 1998). 
Tlg2p is localised to the TGN, co-localising and co-fractionating with the TGN markers, 
Kex2p and DPAP A (Holthuis et al., 1998) and also to the endosomal system, 
demonstrated by the exaggerated endosomal compartment that accumulated in Class E 
vacuolar protein sorting (vps) mutants (Abeliovich et al., 1998).   
Cells lacking Tlg2p (tlg2 ) are viable, however they display a variety of different 
phenotypes representative of defects in endocytosis (Abeliovich et al., 1998, Holthuis et 
al., 1998, Seron et al., 1998).  These include delayed turnover of the phermone receptors, 
Ste2p and Ste3p by the vacuole (Abeliovich et al., 1998, Holthuis et al., 1998, Seron et al., 
1998); defects in sorting of vacuolar proteases, such as carboxypeptidase Y (CPY), with 
approximately 15-20% of total CPY secreted in the late Golgi (p2) form (Abeliovich et al., 
1998); and defects in the retrieval of TGN resident proteins such as Kex2p (Abeliovich et 
al., 1998, Holthuis et al., 1998) and less significantly DPAP A (Holthuis et al., 1998).  
Tlg2p is also required for the recycling of the SNARE protein, Snc1p, through the early 
endosomes (Lewis et al., 2000); the delivery of the protein aminopeptidase I to the vacuole 
via the cytoplasm to vacuole (CVT) pathway (Abeliovich et al., 1999); and TGN 
homotypic fusion (Brickner et al., 2001).  tlg2  cells are also sensitive to osmotic stress 
(Abeliovich et al., 1998) and have a fragmented vacuolar morphology (Abeliovich et al., 
1998, Seron et al., 1998).   
It should be noted that cells lacking the t-SNARE, Tlg1p or the v-SNARE, Vti1p display 
some of those defects seen in tlg2  cells (Coe et al., 1999, Holthuis et al., 1998) and both 
co-immunoprecipitate with Tlg2p (Coe et al., 1999, Holthuis et al., 1998) indicating that 
these SNARE proteins participate in the same SNARE complex as Tlg2p.  Similarly the 
functionally redundant, v-SNAREs, Snc1p and Snc2p, were also found to co-
immunoprecipitate with Tlg2p (Abeliovich et al., 1998, Holthuis et al., 1998).  
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the v-SNARE) into two independent populations of liposomes allowed fusion via an in 
vitro liposome fusion assay, demonstrating that these SNARE proteins 
(Tlg2p/Tlg1p/Vti1p/Snc(1p or 2p)) can form functional SNARE complexes in vitro 
(Paumet et al., 2001).  The entry of Tlg2p into functional SNARE complexes, like many 
other SNARE proteins, is regulated by phosphorylation (Gurunathan et al., 2002).  This 
was demonstrated by the restoration of endocytosis in snc cells expressing a mutant 
version of Tlg2p (S90A) in which the serine residue targeted for PKA phosphorylation had 
been mutated to an alanine residue (Gurunathan et al., 2002).    
Consistent with in silico analysis which identified Sx16 as homologous to Tlg2p 
(Simonsen et al., 1998), the mammalian SNAREs Sx6 and Vti1a, have also been identified 
as the putative mammalian homologues of Tlg1p and Vti1p, respectively (Coe et al., 1999, 
Fischer von Mollard and Stevens, 1998).  These SNAREs are also involved in trafficking 
at the TGN in mammalian cells (Bassham et al., 2000, Mallard et al., 2002).  It should also 
be noted that Sx16, like Tlg2p, is a phosphoprotein which, intriguingly, is 
dephosphorylated upon insulin binding to its receptor (Perera et al., 2003).   
1.3 Overview of Membrane Fusion 
In vitro fusion assays (Weber et al., 1998)s and more recently the fusion of cells by flipped 
SNAREs (Hu et al., 2003) has provided substantial evidence to suggest that SNARE 
proteins are necessary and sufficient to catalyse membrane fusion (Hu et al., 2003, Weber 
et al., 1998).  However the rate at which fusion occurs in vitro is significantly slower than 
that observed in vivo, hence it is clear that other proteins are required to enhance the rate of 
fusion as well as regulate the process.  In fact, many other molecules are required for 
tethering, docking and fusing membranes (Figure 1.5) (reviewed in (Bonifacino and Glick, 
2004, Toonen and Verhage, 2003)). 
Membrane fusion is a multistep process that commences with the priming of SNAREs on 
both the target and the vesicular membrane (Toonen and Verhage, 2003).   This is an 
adenosine triphosphate (ATP) requiring process catalysed by NSF and a-SNAP (Mayer et 
al., 1996), which releases the SNARE proteins from their cis-SNARE complexes and 
promotes their interaction with cognate SNAREs present on the opposing membranes. 
Tethering follows the process of priming and is an important step involved in initiating 
membrane fusion as it holds the two membranes in close proximity (Toonen and Verhage, 
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small GTPases (Dunn et al., 1993, Novick and Brennwald, 1993, Zerial and McBride, 
2001).  Once the two membranes are in close proximity a proof reading mechanism is 
thought to act to ensure the correct pairing/association of a vesicle and target membrane 
before the committed step of docking (Bryant and James, 2003).  Finally, the transition of 
the trans-SNARE complex to the cis-SNARE complex (Lin and Scheller, 1997, Sutton et 
al., 1998) is a result of the fusion of the two phospholipid bilayers and the delivery of the 
vesicular content to the target organelle.  The associated SNARE proteins are then recycled 
via the action of NSF and its attachment protein, a-SNAP (Mayer et al., 1996).  The steps 
involved in membrane fusion are summarised in the following diagram. 
 
Figure 1.5 – A diagrammatic representation of the steps involved in membrane fusion.  
Sx1a is shown in red, SNAP25 is shown in green and synaptobrevin is shown in blue.  (1) 
Priming - Vesicles are recruited to the target membrane and the SNARE proteins present in 
the target membrane are released from cis-SNARE complexes.  (2) Tethering and docking – 
this step holds the vesicular and target membranes in close proximity (3) Formation of 
SNARE complexes – as a result of tethering and docking a trans-SNARE complex is formed 
this is subsequently changed to a cis-SNARE complex as a result of membrane fusion 
between the vesicular and target phospholipid bilayers and hence the delivery of the 
vesicular content shown in (4).  Taken from (Toonen and Verhage, 2003).  
 
1.3.1 SM Proteins  
One family of proteins that are required for SNARE-mediated membrane fusion in vivo are 
the SM proteins (Jahn, 2000, Toonen and Verhage, 2003).  There are four SM proteins 
found in yeast (Vps45p, Vps33p, Sly1p, Sec1p) and seven found in mammalian cells 
(Munc18a, Munc18b, Munc18c, mVps45, mVps33a, mVps33b, Sly1) (Dulubova et al., Marion S. Struthers, 2009    Chapter 1, 33 
 
2002).  SM proteins are arch-shaped peripheral membrane proteins of approximately      
60-70 kDa, which display a high level of homology along their entire length (Jahn, 2000).  
The first SM protein identified, Unc18, was discovered genetically in C. elegans (Brenner, 
1974). The mammalian homologue of Unc18, Munc18a, was later discovered in brain 
tissue by its ability to bind with high affinity to syntaxin (Hata et al., 1993) and was later 
cloned by homology screening based on its similarity to Unc18 and the Drosophila 
homologue, Rop (Garcia et al., 1994, Pevsner et al., 1994b).  Munc18a is an essential 
factor, involved in the release of neurotransmitters throughout the brain (Verhage et al., 
2000).  Mutation of Munc18a (also known as n-Sec1 or rb-Sec1) in mice results in 
paralysis and although deletion of Munc18a does not affect the development of neuronal 
tissue in null mutant embryos they die immediately after birth due to their inability to 
breath (Verhage et al., 2000).  SM proteins also play an essential role in yeast, as loss of 
function of any of the four SM proteins results in a block in membrane traffic (Cowles et 
al., 1994, Novick and Schekman, 1979, Ossig et al., 1991, Robinson et al., 1988, Wada et 
al., 1990).   
1.3.2 SM proteins regulate membrane fusion  
Most SM proteins bind to the syntaxin that is involved in the same transport step and since, 
SM proteins display a high level of homology along their entire length (Jahn, 2000) it is 
reasonable to assume that SM proteins would display a conserved mode of interaction with 
their cognate syntaxin(s) (Toonen and Verhage, 2003).  However to date at least three 
distinct modes of direct interaction between an SM protein and its cognate syntaxin have 
been identified (Burgoyne and Morgan, 2007, Toonen and Verhage, 2003).  Mode 1 – 
binding of an SM protein to its cognate syntaxin when it exists in a closed conformation; 
Mode 2 - binding of an SM protein to the extreme N-terminus of its cognate syntaxin; 
Mode 3 - Binding of an SM protein to its cognate syntaxin when it is in a complexed state.  
It should be noted that Mode 3 binding is not as well defined as Modes 1 and 2 as it has yet 
to be characterised structurally (Burgoyne and Morgan, 2007).   
1.3.2.1   Mode 1 binding 
The first example of an SM protein binding to its cognate syntaxin via Mode 1 binding was 
Munc18a binding to Sx1a (Misura et al., 2000).  This SM protein functions at the plasma 
membrane where it plays an important role in exocytosis (Pevsner et al., 1994b).  Munc18a 
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conformation (Misura et al., 2000).  Both the Habc domain and the SNARE domain of 
Sx1a participate in Munc18a binding, with approximately half of the interacting residues 
coming from the Habc domain (Figure 1.6) (Misura et al., 2000).  As Munc18a binds to 
Sx1a when it is in a closed conformation (see Section 1.2.3) it was thought to play an 
inhibitory role in membrane fusion by preventing Sx1a from forming SNARE complexes 
(Dulubova et al., 1999, Misura et al., 2000, Pevsner et al., 1994a).  However, the deletion 
of Munc18a does not result in constitutive membrane fusion and, in fact, causes a block in 
vesicular transport (Verhage et al., 2000). 
 
Figure 1.6 – A ribbon representation of the Munc18a-Sx1a interaction; Mode 1 binding. 
Domains 1, 2 and 3 of the SM protein, Munc18c are shown in blue, green and yellow, 
respectively.  The N-terminal region of Sx1a, containing the Habc domain, is shown in red 
and the C-terminal portion of Sx1a containing the SNARE domain is shown in purple.  Taken 
from (Misura et al., 2000). 
 
1.3.2.2  Mode 2 binding 
An example of an SM protein which binds to its cognate syntaxin via Mode 2 binding is 
Sly1p (Bracher and Weissenhorn, 2002).  This SM protein functions at the ER and the 
Golgi apparatus and has two binding partners, Ufe1p and Sed5p (Bracher and Marion S. Struthers, 2009    Chapter 1, 35 
 
Weissenhorn, 2002, Yamaguchi et al., 2002).  Mutational and structural studies of the 
Sed5p-Sly1p complex demonstrated that the N-terminal 20 amino acids of Sed5p are 
sufficient for Sly1p binding (Bracher and Weissenhorn, 2002, Yamaguchi et al., 2002).  In 
fact, the first ten amino acids of Sed5p are conserved amongst all of its homologues 
(Yamaguchi et al., 2002).  One residue that appears to play a critical role in the binding of 
Sed5p to Sly1p is a phenylalanine at residue number 10 (Yamaguchi et al., 2002).  The 
crystal structure of Sly1p in complex with the N-terminal 45 residues of Sed5p revealed 
that Phe10 of Sed5p interacts with Sly1p via a hydrophobic pocket on the surface of 
domain I of the SM protein, Sly1p (Figure 1.7) (Bracher and Weissenhorn, 2002); its 
mutation to an alanine residue completely abolishes their interaction (Yamaguchi et al., 
2002).  This phenylalanine residue is also conserved in the other binding partner of Sly1p, 
Ufe1p (however it is present at residue 9 rather than 10) (Yamaguchi et al., 2002) and also 
in the syntaxin Tlg2p/Sx16, which also adopts a similar mode of interaction with their 
cognate SM protein Vps45p/mVps45 (Carpp et al., 2006, Dulubova et al., 2002) (This is 
discussed in detail later).  In a reciprocal experiment, the substitution of any of the 
hydrophobic residues (L137, L140, A141, I153 and V156) present in the binding pocket on 
the outer surface of domain I of the SM protein, Sly1p, which surround F10 of Sed5p, to a 
lysine or arginine residue, also abolishes the interaction between Sed5p and Sly1p (Peng 
and Gallwitz, 2004).  Interestingly, abrogation of Mode 2 binding between Sly1p and 
Sed5p or Vps45p and Tlg2p does not appear to affect membrane trafficking in yeast 
(Carpp et al., 2006, Peng and Gallwitz, 2004).  This is in contrast to those studies which 
have been performed in mammalian systems where competing peptides blocking Mode 2 
binding between Sly1 and Sx5 have been demonstrated to disrupt Golgi morphology 
(Dulubova et al., 2003, Yamaguchi et al., 2002).  It should, however, be noted that this 
effect appears to be cell type specific (Williams et al., 2004).  Hence it is clear that further 
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Figure 1.7 – A graphical representation of the Sly1p-Sed5p interaction; Mode 2 binding. 
Domains 1, 2 and 3 (I, II and III) are shown in yellow, blue and grey respectively.  The N-
terminal peptide of Sed5p is show in red.  α-helices are represented by cylinders and β-
sheets are represented by arrows.  Taken from (Bracher and Weissenhorn, 2002). 
 
1.3.2.3  Mode 3 binding 
An example of an SM protein which binds to its cognate syntaxin, Sso1p, via Mode 3 
binding is Sec1p (Carr et al., 1999).  In contrast to both of the interactions described above, 
the SM protein, Sec1p does not associate with the monomeric syntaxin but is thought to 
preferentially bind to Sso1p when it is preassembled in the SNARE complex (Carr et al., 
1999).  Although there is no structural data, as yet, to confirm this, there is sufficient 
experimental evidence to support this hypothesis (Carr et al., 1999, Munson et al., 2000, 
Scott et al., 2004a).   It has been demonstrated that Sec1p co-precipitates all three of the 
SNARE proteins involved in exocytosis (Sso1p, Sec9p and Sncp) in a ratio resembling that 
found in the SNARE complex (Carr et al., 1999).  Furthermore, the utilisation of 
temperature sensitive mutants displaying defects in key enzymes (sec4-8 and sec18-1) 
involved in the cycle of membrane fusion allowing the accumulation of either the 
monomeric syntaxin (sec4-8) or SNARE complex intermediates (sec18-1) result in an 
increase in Sso1p co-precipitating with complexed Sec1p only (Carr et al., 1999).  These 
data were further enhanced by in vitro binding experiments which confirmed what had 
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(Sso1p/Sec9p) as well as the v-t-SNARE complex (Sso1p/Sec9p; Snc2p) (Scott et al., 
2004a). 
 
Figure 1.8 – Two different interpretations of how Sec1p may interact with the SNARE 
complex.   
Sso1p is shown in red, Snc2p is shown in dark blue, Sec9p is shown in green and the SM 
protein, Sec1p is shown in light blue.  Taken from (Toonen and Verhage, 2003). 
 
1.3.2.4  Other modes of binding 
SM proteins can also associate with their cognate syntaxins indirectly; an example of an 
SM protein which binds to its cognate syntaxin, Vps33p, via so-called ‘bridging’ proteins, 
is Vam3p (Sato et al., 2000).  In yeast the Vps-C complexes (class C core 
vacuole/endosome tethering (CORVET) complex and homotypic fusion and protein 
sorting (HOPS) complex) function at the late endosomes and vacuole (Nickerson et al., 
2009).  The Vps-C core complex present in both HOPS and CORVET is composed of the 
four different proteins Vps11p, Vps16p, Vps18p and Vps33p (Sato et al., 2000).  One of 
these components, the SM protein Vps33p, is thought to interact with the syntaxin Vam3p 
(Sato et al., 2000).  Vam3p plays an essential role in all forms of vacuolar fusion (Nichols 
et al., 1997, Sato et al., 2000, Wickner and Haas, 2000).  Vps33p can only interact with 
monomeric Vam3p when it is itself in a complexed state (Sato et al., 2000).  In 2000 Sato 
and colleagues reported the preferential binding of the Vps-C core complex to monomeric 
Vam3p, with no association occurring when Vam3p is involved in the trans-SNARE 
complex (Vam3p-Vti1p-Vam7p) (Sato et al., 2000).  
More recently it has become apparent that SM proteins may utilise more than one mode of 
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and Morgan, 2007, Toonen and Verhage, 2003).  For example, it has recently been 
demonstrated that the SM protein, Munc18a, can utilise Mode1 and Mode 2 binding to 
interact with Sx1a  at different stages in membrane fusion (Burkhardt et al., 2008, 
Dulubova et al., 2007, Rickman et al., 2007, Shen et al., 2007).  This is also the case for 
other SM proteins, such as Vps45p (discussed in detail later) (Carpp et al., 2006).     
1.3.2.5  SM proteins and non-syntaxin SNAREs 
SM proteins can also interact directly with non-syntaxin SNAREs (Carpp et al., 2006, Peng 
and Gallwitz, 2004).  This was first demonstrated in pull-down experiments, by the ability 
of wild-type Sly1p and a ‘pocket-filled’ mutant version of Sly1p (Sly1pL140K) to pull-
down the non-syntaxin SNAREs Bet1p, Bos1p, Sft1p and Gos1p (Peng and Gallwitz, 
2004).  The non-syntaxin SNARE, Ykt6p was also pulled-down however much higher 
quantities of Ykt6p were found to bind to the mutant version of Sly1p (Sly1pL140K) when 
compared to wild-type Sly1p (Peng and Gallwitz, 2004).  Further investigation of the 
interaction between Sly1p and these non-syntaxins demonstrated that the SNARE motif 
was essential for Sly1p binding and as demonstrated in the initial experiments this 
interaction does not require the hydrophobic pocket on the surface of Sly1p which is 
involved in Mode 2 binding (Peng and Gallwitz, 2004).  The interaction between Sly1p 
and the non-syntaxin SNAREs appears to affect their assembly into SNARE complexes as 
increasing the concentration of Sly1pL140K present in pull-down experiments reduces the 
amount of Bet1p and Bos1p that is pulled-down by Sed5p (Peng and Gallwitz, 2004).  The 
association of an SM proteins with a non-syntaxin SNARE has also been reported for the 
SM protein, Vps45p, which can bind directly to the SNARE domain of Snc2p, but cannot 
bind directly to Vti1p or Tlg1p (Carpp et al., 2006).  Like Sly1p, Vps45p binding to the 
non-syntaxin SNARE, Snc2p, occurs through a mode distinct from that used by the SM 
protein to interact with its cognate syntaxin, Tlg2p (Carpp et al., 2006).  
1.3.3 CPY trafficking and the identification of VPS genes 
1.3.3.1  CPY trafficking 
CPY is synthesised as an inactive precursor (preproCPY) on ER-bound ribosomes and is 
translocated across the ER membrane courtesy of its N-terminal ER signal peptide (Valls 
et al., 1987).  Upon delivery of preproCPY into the ER lumen the signal peptide is cleaved 
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modified form of proCPY is referred to as p1CPY (Blachly-Dyson and Stevens, 1987, 
Hasilik and Tanner, 1978b, Johnson et al., 1987).  From the ER, p1CPY is transported to 
the Golgi apparatus where it undergoes further oligosaccharide modifications, resulting in 
a 69 kDa Golgi-modified form of proCPY known as p2CPY (Stevens et al., 1982, Trimble 
et al., 1983).  At the late Golgi, p2CPY is sorted away from soluble proteins destined for 
secretion via the secretory pathway by its receptor, Vps10p (Marcusson et al., 1994).  
Vps10p and p2CPY are trafficked to the prevacuolar compartment (PVC) where they 
dissociate from each other (Deloche and Schekman, 2002, Hasilik and Tanner, 1978a, 
Seaman et al., 1997).  Vps10p is then recycled back to the late Golgi and p2CPY is 
transported to the vacuole where it is cleaved into its mature, active form (mCPY) by 
vacuolar proteases (Deloche and Schekman, 2002, Hasilik and Tanner, 1978a).   
The CPY trafficking pathway has been well characterised which has made it a good tool 
for studying those proteins involved in vacuolar sorting (Johnson et al., 1987, Stevens et 
al., 1982). 
1.3.3.2  Identification of the VPS genes 
The VPS genes were first identified utilising two independent screens which looked for 
mutants that were unable to efficiently delivery proteins to the vacuole (Bankaitis et al., 
1986, Jones, 1984, Rothman and Stevens, 1986).  The first of these screens used a hybrid 
protein which incorporated the N-terminal 433 amino acids of proCPY fused to an N-
terminally truncated version of the enzyme invertase, CPY-Inv433 (Bankaitis et al., 1986).  
Under normal conditions the enzyme invertase is trafficked via the secretory pathway 
where it functions by catabolising the fermentable carbon source, sucrose (Esmon et al., 
1987).  However the fusion protein used in this screen lacked the N-terminal peptide signal 
required for secretion of invertase and instead was trafficked to the vacuole courtesy of the 
signal peptide at the N-terminus of CPY (Bankaitis et al., 1986).  The screen was 
performed in yeast strains lacking an endogenous copy of the gene for invertase (SUC2) 
and hence mutants defective in the vacuolar delivery of the hybrid protein were the only 
strains able to grow in media containing sucrose as the sole fermentable carbon source 
(Bankaitis et al., 1986). 
The second screen also identified those mutants which missorted the vacuolar hydrolase, 
CPY.  Secreted pro-CPY is enzymatically active, even in those cells lacking active 
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CBZ-phenylalanyl-L-leucine (Kuhn et al., 1974).  The screen was performed in leucine 
auxotrophs lacking active vacuolar proteases (leu2 pep4-3) overproducing proCPY.  Only 
those mutants defective in vacuolar delivery of proCPY were able to grow well on media 
containing CBZ-pheleu, as the sole source of leucine, by virtue of their missorted CPY 
(Jones, 1984, Rothman and Stevens, 1986). 
Over 40 complementation groups were identified from these studies, which have 
subsequently been divided into six classes (A-F) corresponding to their vacuolar 
morphology (Banta et al., 1988, Robinson et al., 1988).  Class A vps mutants display wild-
type vacuolar morphology; Class B vps mutants have fragmented vacuoles; Class C vps 
mutants lack any identifiable vacuolar structures; Class D vps mutants are similar to Class 
A but display a large, single vacuolar structure and also have a defect in mother-to-
daughter cell vacuolar inheritance; Class E vps mutants contain novel endosome-like 
compartment in addition to normal vacuoles; Class F vps mutants contain a single large 
vacuolar structure that is encircled by smaller, fragmented structures (Banta et al., 1988, 
Robinson et al., 1988). 
1.3.4 Identification and characterisation of the SM protein, 
Vps45p 
The gene encoding Vps45p (VPS45) was cloned by two independent groups in 1994 by its 
ability to complement the CPY sorting defect (Piper et al., 1994) and the temperature-
conditional growth (Cowles et al., 1994) phenotype of strains containing vps45 alleles 
(Cowles et al., 1994, Piper et al., 1994).  Vps45p is a hydrophilic protein of 67 kDa, which 
displays homology to the SM family of proteins (Cowles et al., 1994, Piper et al., 1994).  
Cells lacking Vps45p (vps45 ) are viable but missort multiple vacuolar hydrolases such as 
CPY (approximately 75-85% of the Golgi-modified p2CPY); are temperature sensitive for 
growth and display a vacuolar morphology typical of that of the Class D vps mutants i.e. 
they have a large, single vacuolar structure and exhibit defects in mother-to-daughter cell 
inheritance (Cowles et al., 1994, Piper et al., 1994).  Approximately 65% of Vps45p is 
localised to the Golgi, co-fractionating with the Golgi marker protein, Kex2p (Cowles et 
al., 1994, Piper et al., 1994).  It has also been suggested that Vps45p associates with the 
endosomal compartments; however this could not be verified due to the lack of known 
marker proteins specifically associated with these structures (Cowles et al., 1994, Piper et 
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Two syntaxins, Tlg2p and Pep12p, both interact genetically and biochemically with 
Vps45p (Abeliovich et al., 1999, Brickner et al., 2001, Bryant and James, 2001, Burd et al., 
1997, Carpp et al., 2006, Dulubova et al., 2002, Nichols et al., 1998, Webb et al., 1997, 
Yamaguchi et al., 2002).  Vps45p is involved in transport at the early endosome, the TGN 
and the late endosome (Cowles et al., 1994, Piper et al., 1994).  Transport at the late 
endosomal compartment/PVC also requires the syntaxin Pep12p (Becherer et al., 1996).  
Unlike, Tlg2p, Pep12p does not bind directly to Vps45p; this was demonstrated through 
pull-down experiments utilising GST-tagged versions of Tlg2p and Pep12p (Bryant and 
James, 2001). 
1.3.5 Characterisation of the interaction between Vps45p and 
Tlg2p 
Initially the region of Tlg2p responsible for interacting with Vps45p was shown to exist in 
the first 230 amino acids of Tlg2p (Bryant and James, 2001); demonstrated by the inability 
of a truncated version of Tlg2p lacking the first 230 residues to recruit Vps45p to 
membranes (Bryant and James, 2001).  More recently, Dulubova and colleagues 
demonstrated that the first 33 amino acids of Tlg2p are necessary and sufficient to capture 
Vps45p in vitro (Dulubova et al., 2002).  Sequence alignment of Tlg2p and Sx16 (which 
has been shown to interact with the putative mammalian homologue of Vps45p, mVps45 
(Tellam et al., 1997a, Yamaguchi et al., 2002)) revealed several conserved residues that 
play an important role in the binding of Vps45p/mVps45 (shown in bold in Figure 1.9).  
These residues are similar to those present in the N-terminal peptide of Sed5p and Ufe1p 
which are involved in their binding to Sly1p (discussed in Section 1.3.2.2), in particular the 
phenylalanine residue at position 9 and 10 of Tlg2p and Sx16, respectively (Yamaguchi et 
al., 2002). 
 
Figure 1.9 – Sequence alignments of the first 33 amino acids of Tlg2p and Sx16. 
Those residues conserved between Tlg2p and Sx16 are shown in bold.  This is an 
adaptation of the data provided in (Dulubova et al., 2002). 
 
The interaction between Vps45p/mVps45 and Tlg2p/Sx16 can be abolished through 
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similar to that required to abolish the interaction between Sly1p and Sed5p (Yamaguchi et 
al., 2002).  These findings suggested that Tlg2p, utilises the putative hydrophobic pocket 
identified in domain I of Vps45p (Carpp et al., 2006) binding in a mode analogous to the 
‘pocket-mode’ of binding (Mode 2) captured in the Sly1p/Sed5p crystal structure, where 
the N-terminal peptide of the syntaxin inserts into a hydrophobic pocket on the outer 
surface of the SM protein (Bracher and Weissenhorn, 2002).  The analogy between 
Sly1p/Sed5p and Vps45p/Tlg2p binding was further confirmed utilising a ‘pocket-filled’ 
mutant version of Vps45p (Vps45pL117R), in which a leucine residue present in the 
hydrophobic binding pocket had been replaced by an arginine residue (Carpp et al., 2006).  
This mutant version of Vps45p is no longer capable of binding a Protein A (PrA) tagged 
version of Tlg2p and fails to co-precipitate with Tlg2p from yeast cells (Carpp et al., 
2006). 
As mentioned previously (Section 1.3.2.4), Vps45p utilises two different modes of binding 
to interact with its cognate syntaxin, Tlg2p, at two different stages in the SNARE complex 
assembly/disassembly cycle (Bryant and James, 2003, Carpp et al., 2006).  As discussed 
above, Vps45p binds to monomeric Tlg2p (Bryant and James, 2003, Carpp et al., 2006, 
Dulubova et al., 2002) using Mode 2 binding (Carpp et al., 2006, Dulubova et al., 2002); 
however Vps45p also binds to Tlg2p containing cis-SNARE complexes (Bryant and 
James, 2003) using Mode 3 binding (Carpp et al., 2006).  Mode 3 binding of Vps45p to 
cis-SNARE complexes was demonstrated using a double mutant version of Vps45p 
(Vps45pW244R/L117R) that can no longer bind to monomeric Tlg2p but can bind to 
assembled SNARE complexes (Carpp et al., 2006).  Mutation of the tryptophan residue at 
position 244 of Vps45p to an arginine residue produces a dominant-negative version of 
Vps45p (Vps45pW244R) that is capable of binding to monomeric Tlg2p via Mode 2 
binding and assembled SNARE complexes via Mode 2 and Mode 3 binding, however 
unlike wild-type Vps45p, this mutant version of Vps45p does not allow the SNARE 
complex assembly/disassembly cycle to proceed (Carpp et al., 2006).  Introduction of the 
‘pocket-filling’ mutation to this dominant-negative version of Vps45p, generates a double 
mutant version of Vps45p (Vps45pW224R/L117R) that is no longer capable of bind to 
monomeric Tlg2p via Mode 2 binding, but is capable of associating with assembled 
SNARE complexes via Mode 3 binding (Carpp et al., 2006).  Interestingly the introduction 
of the ‘pocket-filling’ mutation to the dominant negative version of Vps45p prevents it 
from exerting its dominant negative effect (Carpp et al., 2006).  This was an interesting 
finding as under normal circumstances abrogation of Mode 2 binding does not appear to 
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It has also been suggested that Vps45p may interact with Tlg2p using a mode analogous to 
that of Munc18a binding to Sx1a; Mode 1 binding (Bryant and James, 2001).  This 
requires Tlg2p to adopt a closed conformation akin to that of Sx1a (Bryant and James, 
2001).  However this is controversial and evidence for and against a closed conformation 
of Tlg2p exists (Bryant and James, 2001, Dulubova et al., 2002).  Evidence that Tlg2p can 
form a closed conformation was provided by the ability of a truncated version of Tlg2p, 
lacking its Habc domain (Tlg2 Habc) to partially complement the CPY trafficking defects 
observed in vps45  cells (Bryant and James, 2001).  Evidence against a closed 
conformation of Tlg2p comes from nuclear magnetic resonance (NMR) data which 
suggests that a bacterially produced construct of Tlg2p (residues 60-283) is unlikely to 
form a closed conformation (Dulubova et al., 2002).   
1.4 Cellular levels of syntaxins are regulated by their 
cognate SM protein 
As discussed above (see Section 1.3.2), SM proteins function to regulate membrane fusion 
by interacting with their cognate syntaxin.  More recently, it has also been suggested that 
SM proteins may regulate membrane fusion via an indirect mechanism, acting as 
chaperone-like molecules (Bryant and James, 2001, Toonen et al., 2005).  It has been 
demonstrated that the deletion of VPS45 results in the destabilisation of Tlg2p, resulting in 
a decrease of the cellular levels of Tlg2p by ~90% as assessed by immunoblot analysis 
(Bryant and James, 2001).  Tlg2p is degraded by the proteasome in vps45  cells (Bryant 
and James, 2001).  This conclusion was reached since, in contrast to vps45  cells 
containing proteasomal activity, vps45  cells in which proteasomal activity has been 
abolished (through mutation of either the catalytic subunits, Pre1p and Pre2p (pre1-1, 
pre2-2) or the regulatory domain, Cim3p (cim3-1) (Heinemeyer et al., 1993, Heinemeyer et 
al., 1991, Ghislain et al., 1993)) contain levels of Tlg2p that can easily be detected through 
immunoblot analysis (Bryant and James, 2001).  Inactivation of vacuolar proteases through 
the pep4-3 mutation, on the other hand, did not restore Tlg2p levels in vps45  cells (Bryant 
and James, 2001).  It should also be noted that this phenomenon is not specialised to yeast, 
for example it has been reported that levels of Sx1a are reduced in neuronal cells of 
Munc18a knockout mice (Verhage et al., 2000).   
Several explanations as to the role that SM proteins play in protecting their cognate 
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it has been suggested that SM proteins may be required for the correct synthesis and 
targeting of their cognate syntaxin (Rowe et al., 2001, Rowe et al., 1999).  Evidence for 
this comes from systems in which the syntaxin, Sx1a, is overexpressed resulting in 
aberrant membrane protrusions as a result of premature membrane fusions (Rowe et al., 
2001, Rowe et al., 1999).  However it is thought that this may be an artefact of 
overexpression as a similar phenomenon is not detected in cells lacking Munc18a, Unc18 
or Sec1p (Novick and Schekman, 1979, Verhage et al., 2000).  Similarly, the stabilisation 
of the syntaxin, Tlg2p in vps45  cells did not affect the localisation of Tlg2p, 
demonstrated using subcellular fractionation and fluorescence microscopy (Bryant and 
James, 2001).  Hence it has been suggested that a more likely explanation is that the 
reduced levels of the syntaxin present in cells lacking their cognate SM protein are a result 
of impaired stability at the site of action (Toonen and Verhage, 2003).  This later 
explanation is supported by the recent findings that the SM protein, Sly1p, protects the ER-
localised syntaxin, Ufe1p, from ER-associated degradation (ERAD) (Braun and Jentsch, 
2007).  However these findings also support the previous suggestion that SM proteins may 
stabilise their cognate syntaxin shortly after synthesis.  Hence further work is required to 
fully understand the role that SM proteins play in protecting their cognate syntaxin from 
degradation. 
1.4.1 Post-translational modifications of Tlg2p? 
1.4.1.1  Ubiquitination 
Ubiquitin is a highly conserved, 76 amino acid protein found ubiquitously in all eukaryotic 
cells (Hicke and Dunn, 2003).  Ubiquitination is the process, by which, Ubiquitin becomes 
covalently attached to a protein (Hicke and Dunn, 2003).  Ubiquitin is linked to its target 
protein via an isopeptide bond, connecting the carboxy group of the C-terminal glycine 
residue of ubiquitin to the ε-amino group of a lysine residue in the target protein (Hicke 
and Dunn, 2003).   
The addition of ubiquitin to a target protein requires the action of three enzymes; E1, a 
ubiquitin-activating enzyme; E2, a ubiquitin-conjugating enzyme; and E3, a ubiquitin 
ligase (Hicke and Dunn, 2003, Schwartz and Hochstrasser, 2003, Weissman, 2001).  E1 
initiates ubiquitination by adenylating the carboxy terminus of ubiquitin (Hicke and Dunn, 
2003, Schwartz and Hochstrasser, 2003, Weissman, 2001). This is ATP-dependent step, 
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active site of the E1 enzyme.  The E1 enzyme then tranfers ubiquitin to a cysteine residue 
in an E2 enzyme, a process known as transthiolation (Hicke and Dunn, 2003, Schwartz and 
Hochstrasser, 2003, Weissman, 2001). The ubiquitin moiety is finally transferred to the 
side chain of a lysine residue in the target protein, via the action of an E3 enzyme (Hicke 
and Dunn, 2003, Schwartz and Hochstrasser, 2003, Weissman, 2001).  An E3 enzyme can 
catalyse this final step, either directly, by forming a thioester bond with ubiquitin before 
transferring it to the substrate or indirectly by forming a bridge between the substrate and 
the activated E2 enzyme (Hicke and Dunn, 2003, Schwartz and Hochstrasser, 2003, 
Weissman, 2001).  This is dependent on whether or not the E3 enzyme contains a HECT 
(homologous to the E6-AP carboxy terminus) domain or a RING (really interesting new 
gene) domain, respectively (Hicke and Dunn, 2003, Schwartz and Hochstrasser, 2003, 
Weissman, 2001).  E3 enzymes are thought of as the key regulatory determinant of 
ubiquitination as they largely determine the substrate specificity and the timing of the 
process (Hicke and Dunn, 2003). 
Ubiquitination was first characterised as the signal for degradation of a protein by the 
proteasome; however ubiquitination can also have a variety of different effects within the 
cell (Hicke and Dunn, 2003).  These include endocytosis of membrane receptors and 
targeting of proteins for entry into multi-vesicular bodies (MVBs) for degradation via the 
vacuole/lysosome (Katzmann et al., 2002).  The outcome of a ubiquitinated substrate is 
dependent on whether a single ubiquitin moiety (monoubiquitination) or a chain of 
ubiquitin moieties (polyubiquitination) becomes covalently attached to the substrate 
protein and also the lysine residue in the ubiquitin moiety by which it is linked to 
subsequent ubiquitin moiety/moieties (Hicke and Dunn, 2003).  Polyubiquitination 
involves three key lysine residues within ubiquitin, Lysines 29, 48, 63 (Hicke and Dunn, 
2003).  Lys-48 linked polyubiquitination targets nuclear, cytosolic and ER membrane 
proteins for degradation by the large barrel-shaped multicatalytic protease complex known 
as the 26S proteasome (Chau et al., 1989, Hershko and Ciechanover, 1998, Thrower et al., 
2000).  Di- or tri-ubiquitin chains linked via Lys-63 are thought to regulate the endocytosis 
of some plasma membrane proteins (Fisk and Yaffe, 1999, Galan and Haguenauer-Tsapis, 
1997, Hoege et al., 2002).  Monoubiquitination functions to regulate proteins through the 
late secretory and endocytic pathways (Hicke, 2001, Hoege et al., 2002, Piper and Luzio, 
2007, Salghetti et al., 2001). 
As discussed previously in this section, proteins destined for proteasomal degradation 
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Tlg2p are regulated by the proteasome in vps45D cells (Bryant and James, 2001) this 
would suggest that Tlg2p is subject to polyubiquitination.   
1.4.1.2  Palmitoylation  
Members of the SNARE protein family are known substrates for palmitoylation.  For 
example SNAP-25 and Ykt6p, which both lack a transmembrane domain, require lipid 
modification for membrane association (Fukasawa et al., 2004, Veit et al., 1996).  
However palmitoylation is not restricted to those proteins lacking a transmembrane 
domain.  Lipid modification of transmembrane proteins occurs in the cytosolic portion of a 
protein and generally occurs adjacent or within the transmembrane domain; it should be 
noted that no signalling sequence appears to be required for palmitoylation (Yik and 
Weigel, 2002).  The significance of the lipid modification of proteins containing a 
transmembrane domain is unknown, however it has been suggested that this may affect the 
trafficking of proteins (Bijlmakers and Marsh, 2003).   
The SNARE partners of Tlg2p, the t-SNARE Tlg1p and the v-SNARE Snc2p, are 
modified by palmitoylation (Couve et al., 1995, Valdez-Taubas and Pelham, 2005).  This 
was demonstrated using the compound hydroxylamine which selectively removes 
thioester-linked palmitates (Chamberlain and Burgoyne, 1998).  The palmitoyltransferase 
responsible for the palmitoylation of Tlg2p, Snc2p and Snc1p was identified to be Swf1p 
(Valdez-Taubas and Pelham, 2005).  Swf1p belongs to a family of proteins that contain a 
DHCC cysteine-rich domain of 50 residues in length, which have been suggested to play a 
general role in palmitoylation (Putilina et al., 1999).  Palmitoylation has been proposed to 
increase the stability of proteins in vivo; this was demonstrated by the reduced half-life of a 
mutant version of epitope-tagged Snc1p, in which the target cysteine for palmitoylation 
had been mutated to a serine residue (Couve et al., 1995).  A similar trend was reported for 
the levels of Snc1p present in swf1  cells (Valdez-Taubas and Pelham, 2005).  Expression 
of a green fluorescent protein (GFP)-tagged version of Tlg1p in swf1  cells displayed a 
different intracellular location than that seen in wild-type cells; fluorescence of the GFP-
tag was mostly detected inside the vacuole instead of at the TGN/endosomal compartment 
as seen in wild-type cells (Valdez-Taubas and Pelham, 2005).  Confirmation that this effect 
was due to the non-palmitoylation of Tlg1p was demonstrated by mutating the cysteine 
residues that undergo palmitoylation to serine residues (Valdez-Taubas and Pelham, 2005).  
This non-palmitoylated version of Tlg1p no longer localises to the TGN of wild-type cells, 
but instead localises to the interior of the vacuole (Valdez-Taubas and Pelham, 2005).  Marion S. Struthers, 2009    Chapter 1, 47 
 
Further investigation of this demonstrated that non-palmitoylated Tlg1p is ubiquitinated; 
represented by the higher molecular weight bands detectable by both anti-Tlg1p and anti-
ubiquitin antibodies during immunoblot analysis of Tlg1p-immunoprecipitates from swf1  
cells which were either absent or at reduced levels in wild-type cells (Valdez-Taubas and 
Pelham, 2005).  Furthermore this ubiquitination requires the ubiquitin ligase Tul1p, as 
removal of Tul1p prevents the mislocalisation and degradation of GFP-tagged Tlg1p in 
swf1  cells (Valdez-Taubas and Pelham, 2005).  Tul1p is a RING domain ubiquitin ligase 
that recognises polar TM domains and targets them for degradation (Reggiori and Pelham, 
2002).  From these results, it was concluded that palmitoylated Tlg1p is protected from 
ubiquitination by Tul1p, which subsequently prevents its entry in MVBs and subsequent 
degradation by the vacuole (Valdez-Taubas and Pelham, 2005). 
It should be noted that two potential sites of palmitoylation have been identified for Tlg2p 
(Valdez-Taubas and Pelham, 2005).  
1.5 Aims  
1)  In silico analysis has demonstrated that Sx16 is homologous to Tlg2p (Simonsen et al., 
1998), however it has yet to be demonstrated whether or not these syntaxins are also 
functionally homologous.  Hence, the first aim of my work was to investigate whether or 
not Sx16 is a functional homologue of the yeast t-SNARE, Tlg2p.  This is an important 
question as it opens up the possibility of using the experimentally tractable yeast strain     
S. cerevisiae as a model organism to further investigate the role of mammalian Sx16 (for 
example the functional consequences of Sx16 phosphorylation). 
2)  Sx16 can interact with yeast Vps45p, in vitro (Dulubova et al., 2002), however it has 
yet to be confirmed whether or not they interact in vivo.  Hence, the second aim of my 
work was to investigate whether or not Sx16 interacts with Vps45p in vivo.  This will 
provide further confirmation as to whether or not Sx16 is a functional homologue of Tlg2p 
(outlined in aim 1) by demonstrating whether or not Sx16 utilises the same molecular 
machinery as Tlg2p when expressed in yeast. 
3)  SM proteins are thought to act as chaperone-like molecules (Toonen et al., 2005).  Cells 
lacking Vps45p (vps45 ) have reduced levels of Tlg2p (Bryant and James, 2001).  Hence 
the third aim of my work was to further investigate the regulation of steady-state levels of Marion S. Struthers, 2009    Chapter 1, 48 
 
Tlg2p in wild-type and vps45  cells, in the hope that this would give some in-sight into the 
mechanism by which the levels of Tlg2p are regulated by the SM protein, Vps45p. 
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 Marion S. Struthers, 2009    Chapter 2, 50 
 
2.1 Materials 
2.1.1 Reagents and Enzymes 
Chemical and any other reagents not mentioned below were purchased from Sigma-
Aldrich (Poole, UK), VWR (Poole, UK) or Fisher Scientific (Leicester, UK).  Ingredients 
used to synthesise media were purchased from both Melford Laboratories Ltd. (Suffolk, 
UK) and FORMEDIUM (Norwich, UK). Yeast lytic enzyme was obtained from MP 
Biomedicals (Aurora, USA). 
DNA restriction enzymes, Taq® polymerase, Pfu® polymerase, T4 DNA ligase, dNTPs,   
1 kb ladder and 6 x loading dye were obtained from either Promega (Southampton, UK) or 
New England Biolabs (Hitchin, UK).  Platinum Pfx® polymerase was obtained from 
Invitrogen (Paisley, UK).  Agarose MP was purchased from Roche Diagnostics 
(Mannheim, Germany) and Ethidium Bromide from Gene Choice (Maryland, USA).  Gel 
extraction was performed using the QIAquick® Gel Extraction Kit from QIAGEN (Hilden, 
Germany) and DNA purification performed using the Wizard® Plus SV Miniprep DNA 
Purification System manufactured by Promega (Southampton, UK). 
Protein gels were synthesized using a 30% acrylamide-bisacrylamide mixture (37.5:1 ratio) 
purchased from Severn Biotech Ltd (Kidderminter, UK).  Broad range protein markers 
were purchased from Bio-Rad (Hertfordshire, UK).  Nitrocellulose transfer membrane was 
obtained from Whatman (Dassel, Germany).  Enhanced chemiluminescence (ECL) 
solutions and secondary antibodies used in immunoblot analysis were purchased from GE 
Healthcare (Buckinghamshire, UK). 
2.1.2 Bacterial and Yeast Strains  
The bacterial (E. coli) and yeast (S. cerevisiae) strains used in this study are listed in Table 
2.1.   
2.1.3 Media 
Bacterial cells were grown in 2xYT (1.6% (w/v) Tryptone, 1% (w/v) Yeast Extract, 0.5% 
(w/v) NaCl).  Solid media was generated by the addition of 2% (w/v) micro agar.  Plasmid Marion S. Struthers, 2009    Chapter 2, 51 
 
selection was achieved by adding the antibiotic, Ampicillin, to the media at a final 
concentration of 100 µg/ml.    
Yeast cells were grown in YPD (1% (w/v) Yeast Extract, 2% (w/v) Peptone, 2% (w/v) 
Glucose).  Solid media was generated by the addition of 2% (w/v) micro agar.  Plasmid 
selection was achieved using minimal synthetic defined (selective) medium, SD (0.675% 
(w/v) Yeast Nitrogen Base without amino acid, 2% (w/v) Glucose) lacking specific amino 
acids –ura-met (0.185% (w/v) synthetic drop out: -ura-met); –ura-leu (0.183% (w/v) 
synthetic drop out: -ura-leu); -his (0.193% (w/v) synthetic drop out: -his).  Again, solid 
media was generated by the addition of 2% (w/v) mico agar.   
2.1.4 Antibodies 
2.1.4.1  Primary Antibodies 
Rat monoclonal antibodies (clone 3F10; 100  g/ml; catalogue number (cat #) 
11867423001) that specifically recognise the epitope YPYDVPDYA (derived from the 
human influenza hemagglutinin (HA) protein) were purchased from Roche (Mannheim). 
10 µl of this was utilized in immunoprecipitation experiments (see Section 2.2.18) and a 
1:50 dilution was used in immunofluorescence experiments (see Section 2.2.17).  
Polyclonal antibodies against Tlg2p were raised in rabbits immunised with peptides 
corresponding to residues 272-287 and 381-396 (this was performed by Eurogentec).  
Antibodies present in the antiserum were affinity purified using PrA-agarose (see Section 
2.2.11.1; ~0.4 mg/ml) and were generally used at a 1:100 dilution in immunoblot analysis.  
1:50 dilution of purified anti-Tlg2p antiserum was utilised in immunofluorescence 
experiments.  Polyclonal antibodies against Vps45p were raised in rabbits immunised with 
peptides corresponding to residues 14-28 and 563-577 (this was performed by Eurogentec).  
Antibodies specific to residues 563-577 of Vps45p were affinity purified from the rabbit 
antiserum using a SulfoLink Kit (Pierce Biotechnology, cat # 44895; see Section 2.2.11.2).  
Purified anti-Vps45p antibodies (~0.6 mg/ml) were used at a 1:500-1:1000 dilution for 
immunoblot analysis.  Polyclonal antibodies against Snc2p were raised in rabbits 
immunised with peptides corresponding to residues 11-25 and 72-86 (this was performed 
by Eurogentec).  Antibodies specific to residues 11-25 were affinity purified from the 
rabbit antiserum by Eurogentec.  Purified anti-Snc2p antibodies (~0.7 mg/ml) were used at 
a 1:1000 dilution for immunoblot analysis.  Mouse monoclonal anti-CPY antibodies (clone 
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used at a 1:50 dilution for immunoblot analysis.  15  l of a 1:10 dilution of rabbit 
polyclonal anti-CPY antiserum previously described in (Bryant and James, 2001) was used 
in pulse-chase experiments.  The following antibodies were used solely for immunoblot 
analysis.  Mouse monoclonal anti-HA antibodies (HA.11, clone 16B12; 2-3 mg/ml; cat # 
MMS-101R) were purchased from Covance (Cambridge Bioscience Ltd, UK) and were 
generally used at a 1:2000 dilution.  Rabbit polyclonal anti-Vti1p antiserum has previously 
been described in (Coe et al., 1999) and was used at a 1:1000 dilution. Mouse monoclonal 
anti-Vph1p antibodies (10D7-A7-B2; 250  g/ml; cat # A-6427) were purchased from 
Molecular Probes® (Eugene, Oregon) and were used at a dilution of 1:1000. Living 
Colours A.v mouse monoclonal antibodies (JL-8; cat # 632381) against Aequorea Victoria 
Green Fluorescent Protein (GFP; 1 mg/ml) was purchased from Clonetech Laboratories Inc 
(California, USA) and used at a dilution of 1:3000.  Mouse monoclonal antibodies (clone 
9E10, cat # 5546) that specifically recognise the epitope EQKLISEEDL (derived from the 
human p62
c-Myc protein) were purchased from Sigma-Aldrich (Poole, UK) and were used at 
a dilution of 1:100.  Rabbit polyclonal anti-Pgk1p antiserum has previously been described 
in (Piper et al., 1994) and was used at a 1:20000 dilution. 
2.1.4.2  Secondary Antibodies 
All secondary antibodies used in immunoblot analysis were conjugated to horseradish 
peroxidise (HRP) and were purchased from GE Healthcare (Buckinghamshire, UK).  Anti-
rabbit IgG, HRP-linked antibodies (cat # NA934) were used at a dilution of 1:5000; anti-
mouse IgG, HRP-linked antibodies (cat # NA931) were used at a dilution of 1:2000; anti-
rat IgG, HRP-linked antibodies (cat # 5546) were used at a dilution of 1:1000.  Secondary 
antibodies used in immunofluorescence experiments, Alexa Fluor® 488 donkey anti-rat 
IgG (2 mg/ml; cat # A21208) and Alexa Fluor® 594 donkey anti-rabbit IgG (2 mg/ml;    
cat # A21207), were purchased from Molecular Probes (Oregon, USA) and used at a 1:500 
dilution. 
2.2 Methods 
2.2.1 Isolation of yeast chromosomal DNA 
Yeast cells were grown overnight in the rich media, YPD.  The following morning the cells 
were harvested by centrifugation at 931 g for 2 mins and washed in 1.0 M Sorbitol, 0.1 M 
EDTA (pH 7.5).  The resultant cell pellet was resuspended in 0.4 ml of 1.0 M Sorbitol,   Marion S. Struthers, 2009    Chapter 2, 53 
 
0.1 M EDTA (pH 7.5).  15 µl of yeast lytic enzyme (15 mg/ml) was added to the cells prior 
to incubating at 37
oC for 30 mins.  The resultant spheroplasts were harvested by 
centrifugation at 3610 g for 2 mins and resuspended in 500 µl of Tris-EDTA (TE) buffer 
(10 mM Tris-HCl pH 8, 1 mM EDTA pH 8).  90 µl of freshly made lysis buffer (0.25 M 
EDTA, 0.4 M Tris, 2% (w/v) SDS, pH 8) was added to the spheroplasts and the cells lysed 
at 65
oC for 30 mins.  80 µl of 5 M potassium acetate (KOAc) was added to the lysed cells 
prior to a 2 hour incubation on ice.  Precipitated proteins and cell debris was removed 
using centrifugation at 16160 g for 15 mins at 4
oC.  The supernatant was transferred to a 
fresh tube to which 1 ml of ice-cold ethanol was added.  The resultant precipitated DNA 
was then collected by centrifugation at 16160 g for 15 mins.  The pellet was washed with 
70% (v/v) ethanol and subsequently dried.  Finally the pellet was resuspended in 100 µl of 
TE.  1 µl of this was used as a template for PCR amplification (Section 2.2.3.1). 
2.2.2 Purification of plasmid DNA from bacteria 
Plasmid DNA was routinely obtained from bacterial cultures using the Promega Wizard® 
Plus SV Miniprep kit by Promega (Southampton, UK).  1  l of a 1:10 dilution of purified 
plasmid DNA (~1 mg/ml) was used as a template for polymerase chain reaction (PCR) 
amplification and 50 ng used for site-directed mutagenesis (SDM) (see Section 2.2.3.1 and 
2.2.3.2). 
2.2.3 Molecular Cloning    
The oligonucleotides used in PCR amplification or SDM are listed in Table 2.2.  These 
were synthesized either by Yorskshire Bioscience Ltd (York, UK) or Vhbio Ltd 
(Gateshead, UK) and were resuspended in nuclease free water to a final concentration of 
50 pmol/µl.   
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2.2.3.1  Polymerase Chain Reaction (PCR) 
PCR recipe:                                                                                                                           
10 mM dNTPs     5  l                                                                               
50 mM MgSO4    5  l               
10x Pfx® buffer                  5  l                           
Enhancer    5  l                                      
dH20  26  l        
Forward primer (50 pmol/ l stock)    1  l                                     
Reverse primer (50 pmol/ l stock)    1  l                  
Template DNA     1  l                                 
Pfx® DNA polymerase    1  l 
Programme:                               
Step 1 = 95ºC         1 min                     
Step 2 = 94ºC         1 min                   
Step 3 = 55ºC         1 min  *                                         
Step 4 = 68ºC   (1 min/kb)                   
Step 5 = 68ºC     10 mins                     
Step 6 = 4ºC            hold 
Steps 2-4 were repeated for 30 cycles. 
* the annealing temperature varied between different PCR reactions depending on the 
melting temperature (Tm) of the primers used. 
DNA fragments were routinely resolved electrophoretically through 0.6-1.0% (w/v) 
agarose gels, typically 0.8% (w/v) in Tris-acetate (TAE) buffer (0.04 M Tris-acetate,  
0.001 M EDTA).  Gel extraction was performed using the QIAquick® Gel Extraction Kit 
from QIAGEN (Hilden, Germany). 
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2.2.3.2  Site-Directed Mutagenesis (SDM)             
SDM recipe:                     
10 mM dNTPs      1  l               
10x Pfu® buffer      5 µl                       
dH2O (to a final volume of)     50  l                   
Forward primer (50pmol/ l stock)  125 ng        
Reverse primer (50pmol/ l stock)  125 ng        
Template DNA    50 ng               
Pfu® polymerase      1  l 
Programme:                              
Step 1 = 95ºC     1 min                  
Step 2 = 95ºC   50 secs                  
Step 3 = 60ºC   50 secs *                  
Step 4 = 68ºC    (2 mins/kb)                  
Step 5 = 68ºC    7 mins                  
Step 6 = 4ºC       hold 
Steps 2-4 are repeated for 18 cycles. 
* the annealing temperature was increased to 68ºC in certain SDM reactions in order to 
decrease the occurrence of false positives and to improve mutagenesis efficiency. 
1  l (10 units) of the restriction enzyme, DpnI, was added to the SDM reaction mixture 
after completion.  A further incubation of 1 hour at 37ºC was performed to catalyse DpnI 
digestion of the methylated parental DNA.  5 µl of the DpnI treated SDM reaction mixture 
was transformed into the E. coli host strain XL-1 Blue (see Section 2.2.7.1).  
2.2.4 TA cloning 
PCR products (generated as described above in Section 2.2.3.1) to be cloned into       
pCR
®2.1 - TOPO
®, which has 3’ thymine overhangs, were treated with Taq® polymerase 
to generate 3’ adenosine overhangs.   Marion S. Struthers, 2009    Chapter 2, 56 
 
Recipe:                   
PCR product    10  l               
10x Taq® buffer      1 µl                           
25 mM MgCl2   0.6  l                      
Taq® polymerase      1 ml          
dNTPs   0.5 ml         
The reaction was performed at 72°C for 20 mins. 
TA cloning could then be performed using the TA Cloning® kit (Invitrogen).  4 ml of 
Taq® treated PCR product was added to 0.5 µl of pCR
®2.1 - TOPO
® vector in a sterile 
eppendorf tube.  The 3’ thymine overhangs on the vector and the 3’ adenosine overhangs 
on the Taq® treated PCR product were allowed to anneal at room temperature for 5 mins.  
The reaction was terminated by adding 0.5  l of salt solution.  The whole reaction mixture 
was transformed into TOP10 cells (see Section 2.2.7.1).  The transformants were plated 
onto 2 x YT containing Ampicillin (100  g/ml), which had been pre-treated with 40  l of 
X-Gal (from a stock solution of 20 mg/ml in Dimethylformamide (DMF)) and incubated 
overnight at 37
oC.  The following day white colonies were selected as these represent those 
cells successfully transformed with pCR
®2.1 - TOPO
® containing the gene of interest. 
2.2.5 Plasmid Construction 
The oligonucleotides and plasmids used in this study are listed in Tables 2.2 and 2.3, 
respectively. 
pNB701 (constructed by Dr. Nia J. Bryant, University of Glasgow, UK) was created using 
SDM to remove a SalI site present in the polylinker region of a plasmid ((provided by Rob 
Piper, University of Iowa, IA) which contains the coding sequence for RS-ALP (retention 
sequence-Alkaline phosphatase) under the control of the CUP1 promoter (Bryant et al., 
1998) in pRS316 (Sikorski and Hieter, 1989)).  The significance of this was that the 
majority of the PHO8 ORF was removed from the plasmid, pNB701, when it was digested 
with the restriction enzymes, XhoI and SalI.  Homologous recombination could then be 
used to introduce a coding sequence of interest immediately after the CUP1 promoter.  
This was achieved by transforming PCR products (containing the gene of interest flanked 
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3’ UTR of PHO8) and Xho1/Sal1 digested pNB701 into the yeast strain, SF838-9D (see 
Figure 3.1).  
pMSS001 was constructed by amplifying the human Sx16A Open Reading Frame (ORF; 
accession number AAB69282) from cDNA kindly provided by Prof. Gwyn Gould 
(University of Glasgow, U.K.) by PCR using the oligonucleotide primers 105 and 106 
(detailed in Table 2.2).  The resultant PCR product consisting of the Sx16A ORF flanked 
by sequences homologous to the 3’ end of the CUP1 promoter and the proximal end of the 
3’ UTR of PHO8  was then used to repair gapped (XhoI/SalI digested) pNB701 by 
homologous recombination. 
pMAZ002 was constructed by introducing sequence encoding the HA-tag 
(YPYDVPDYA) between the CUP1 promoter and 5’-hSx16A sequence of pMSS001, by 
SDM using the oligonucleotides 258 and 259 (detailed in Table 2.2). 
pMAZ006 was constructed by amplifying the TLG2 ORF from yeast chromosomal DNA 
(prepared from SF838-9D) by PCR using the oligonucleotide primers, 314 and 311 
(detailed in Table 2.2).  The resultant PCR product containing sequence encoding Tlg2p 
with a HA-tag immediately after the initiating methionine, flanked by sequences 
homologous to the 3’ end of the CUP1 promoter and the proximal end of 3’ UTR of 
PHO8, was then used to repair gapped (XhoI/SalI digested) pNB701 by homologous 
recombination. 
pMAZ007 was constructed in a manner similar to that employed to make pMAZ006.  The 
murine syntaxin 4 (Sx4) ORF (accession number P70452) was amplified from the plasmid 
pQE30-Syntaxin 4 (provided by Luke Chamberlain, University of Edinburgh, U.K.) using 
the oligonucleotide primers 315 and 313 (detailed in Table 2.2).  The resultant PCR 
product containing sequence encoding Sx4 with a HA-tag immediately after the initiating 
methionine, flanked by the sequences homologous to the 3’end of the CUP1 promoter and 
the proximal end of the 3’ UTR of PHO8, was then used to repair gapped (XhoI/SalI 
digested) pNB701 by homologous recombination. 
pMAZ001 was constructed by amplifying the TLG2 ORF from yeast chromosomal DNA 
(prepared from SF838-9D) by PCR using the oligonucleotide primers 267 and 268 
(detailed in Table 2.2).  Chromosomal DNA from SF838-9D was utilized as template DNA 
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to a segment of DNA 500 kb upstream of the initiating ATG and 300 kb downstream as a 
means to incorporate the endogenous promoter and 3’ UTR.  The resultant PCR product 
was TA cloned into pCR
®2.1-TOPO
® and further subcloned into the XhoI-XbaI sites of 
pRS416 (Sikorski and Hieter, 1989) to generate pMAZ001. 
pMAZ017 was constructed by introducing a BamHI and SalI sites after the first 99 bp of 
the TLG2 ORF in pMAZ001.  This was achieved by SDM using the oligonucleotides 316 
and 317 (detailed in Table 2.2) and generated the intermediate plasmid, pMAZ016.  The 
HIS3 coding sequence was subsequently amplified by PCR using the oligonucleotide 
primers 269 and 270 (detailed in Table 2.2).  The resultant PCR product was TA cloned 
into pCR
®2.1-TOPO
® and further subcloned into the BamHI-SalI sites of pMAZ016, to 
generate pMAZ017.   
pMAZ027 was constructed by using SDM to introduce a BamHI site prior to the initiating 
ATG of the TLG2 ORF in pMAZ017 using the oligonucleotides 397 and 398 (detailed in 
Table 2.2).  The first 99 bp of the TLG2 ORF were removed by digesting with BamHI 
(taking advantage of the newly introduced BamHI site and that already present after the 
first 99 bp in pMAZ017).  Two stop codons were subsequently introduced after the HIS3 
ORF by SDM using the oligonucleotides 395 and 396 (detailed in Table 2.2) 
pMAZ028 (K26R), pMAZ030 (5KR) and pMAZ033 (3KR) were constructed by SDM, 
using pMAZ017 as template DNA and the oligonucleotides 214 and 215; 333, 334, 335 
and 336; 407 and 408 (detailed in Table 2.2), respectively. 
pMAZ029 was constructed by introducing two stop codons immediately after the HIS3 
ORF in pMAZ017 by SDM using the oligonucleotides 395 and 396 (detailed in Table 2.2).   
pMAZ038 was constructed using SDM to introduce two stop codons directly after the 
sequence encoding the transmembrane domain in the TLG2 ORF present in pMAZ006 
using the oligonucleotides 380 and 381 (detailed in Table 2.2). 
Plasmids pSGS025, pSGS036, pSGS043 and pSGS044 were constructed by Dr Scott G. 
Shanks (University of Glasgow, UK.).  pSGS025 and pSGS036 were created by 
amplifying sequence encoding HA-tagged Sx16A and HA-tagged murine Sx4 from 
pMAZ002 and pMAZ007 by PCR using the oligonucleotide primers 301 and 303; 308 and Marion S. Struthers, 2009    Chapter 2, 59 
 
310, respectively.  The resultant PCR product flanked by XbaI and XhoI restriction sites 
was ligated into the XbaI-XhoI sites of pVT102u (Vernet et al., 1987). 
pSGS043 and pSGS044 were created by amplifying sequence encoding residues 231-396 
of Tlg2p and 206-303 of Sx16A from the plasmids pHA-Tlg2 (Seron et al., 1998) and 
pSGS025 by PCR using oligonucleotides 383 and 384;  382 and 303, respectively.  The 
resultant PCR products flanked by XbaI and XhoI restriction sites were subsequently 
ligated into the XbaI-XhoI sites of pVT102u (Vernet et al., 1987). 
pALA001 was constructed by Alicja Drozdowska (University of Glasgow, UK).  The 
human Sx16A ORF (accession number AAB69282) was amplified from a cDNA kindly 
provided by Prof. Gwyn Gould (University of Glasgow, U.K.) by PCR using the 
oligonucleotide primers 286 and 287 (detailed in Table 2.2).  The resultant PCR product 
was TA cloned into pCR
®2.1-TOPO
® and further subcloned into the NdeI-XhoI sites of 
pCOG022 (Carpp et al., 2006), generating pALA001. 
pCOG039 was constructed by Dr. Lindsay N. Carpp (University of Glasgow, UK).  A     
C-terminally HA-tagged version of Tlg2p was amplified from a yeast chromosomal 
preparation of SF838-9D by PCR using the oligonucleotide primers 63 and 66 (detailed in 
Table 2.2).  This resultant PCR product containing sequence encoding Tlg2p with an HA-
tag immediately before the terminating stop codon, flanked by sequence homologous to the 
3’end of the CUP1 promoter and the proximal end of 3’ UTR of PHO8, was then used to 
repair gapped (XhoI/SalI digested) pNB701 by homologous recombination. 
pCAL1 was constructed by Christopher Antony Lamb (PhD student, University of 
Glasgow, UK).  SDM was used to mutate the sequence encoding methionine 342 and 
phenylalanine 344 in the DSK2 ORF in pGEX-DSK2UBA to sequence encoding an arginine 
and alanine, respectively, using the oligonucleotides 352 and 353 (detailed in Table 2.2). 
All constructs generated during the course of this study were sequenced to ensure that no 
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2.2.6 DNA sequencing 
DNA sequencing was performed by The Sequencing Service (School of Life Sciences, 
University of Dundee, Scotland) using Applied Biosystems Big-Dye Ver 3.1 chemistry on 
an Applied Biosystems model 3730 automated capillary DNA sequencer.   
2.2.7 Transformation of E. coli and S. cerevisiae 
2.2.7.1  E. coli 
Competent E. coli cells were prepared as follows.  A 5 ml overnight culture of E. coli 
grown in the rich media, 2xYT, was used to inoculate 500 ml of the same media.  Cells 
were then grown at 37ºC with constant shaking until they reached mid-log phase (an 
Optical Density at 600 nm (OD600) of 0.4-0.6).  Cells were harvested using centrifugation 
at 2095 g for 10 mins at 4ºC.  The resultant cell pellet was resuspended in 50 ml of ice-cold 
0.1 M CaCl2 and left on ice for 1 hour.  Cells were repelleted by centrifugation at 2095 g 
for 10 mins at 4ºC, before resuspension in 20 ml of ice-cold storage buffer (0.1 M 
CaCl2/15% Glycerol).  Competent cells were divided into 50 µl aliquots and stored at         
-80°C. 
Competent E. coli cells were transformed as follows.  2  l of plasmid DNA was added to 
50 ml of XL-1 Blue competent cells (generated above) in 1.5 ml eppendorf tubes.  Tubes 
were inverted to ensure proper mixing, and left on ice for 30 mins.  The cells were heat 
shocked for 45 secs at 42
oC before adding 900 ml of 2xYT.  The competent bacterial cells 
were allowed to recover for 1 hour at 37
oC, before harvesting by centrifugation at 16160 g 
for 5 mins and resuspension in 150 ml 2xYT.  The cells were finally plated onto 2xYT 
containing Ampicillin (100 mg/ml) and incubated overnight at 37
oC.  
2.2.7.2  S. cerevisiae 
Competent yeast cells were prepared as follows.  An overnight culture was used to 
inoculate 50 ml of the rich media, YPD, at an OD600 of 0.2.  Cells were grown at 30ºC with 
constant shaking until they reached mid-log phase (OD600 of 0.5-1.0) at which point they 
were harvested by centrifugation at 3610 g for 2 mins.  The cell pellet was washed in 
approximately 10 ml of LiTE-Sorb (0.1 M LiOAc, 10 mM Tris-HCl pH 7.6, 1 mM EDTA, 
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LiTE-Sorb.  The competent cells were rested on ice for 20 mins prior to transformation 
with DNA. 
Competent yeast cells were transformed as follows.  200 ml of 70% (w/v) PEG-3350 was 
added to 200 ml of competent yeast cells in 1.5 ml eppendorf tubes, which were inverted to 
ensure proper mixing.  10  l of DNA was added and again the tubes were mixed by 
inversion.  No vortexing was performed, as this would have damaged the fragile, 
competent cells.  The cells were incubated at 30
oC with shaking for 30-45 mins.  After this 
incubation step the cells were heat shocked for 20 mins at 42
oC, before harvesting in a 
microcentrifuge at 3610 g for 2 mins.  The resultant cell pellet was resuspended in 100 ml 
of sterile distilled water (dH2O), plated onto selective media and incubated for 2-4 days at 
30
oC.  The selective media, on which the cells were plated, was dependent on the genotype 
of the yeast strain and the selective marker of the plasmid.  
2.2.8 Rescue of plasmid DNA from S. cerevisiae 
A volume of cells equivalent to an OD600 of 5 was harvested by centrifugation at 3610 g 
for 2 mins at room temperature.  The supernatant was discarded and the resultant cell pellet 
resuspended in 500 ml of buffer S (100 mM K2PO4 pH 7.2, 10 mM EDTA, 50 mM           
b-mercaptoethanol, 50 mg/ml zymolyase).  These cells were incubated at 37
oC for 30 mins 
before lysing by vortexing briefly in the presence of 100  l of lysis buffer (25 mM Tris,   
pH 7.5, 25 mM EDTA, 2.5% (w/v) SDS) and incubating for 30 mins at 65
oC.  166 ml of    
3 M KOAC was added prior to incubating on ice for 10 mins.  The precipitated proteins 
were pelleted using micorcentrifugation at 16160 g for 10 mins at 4
oC.  The supernatant, 
containing DNA, was collected and 0.8 ml of ice-cold ethanol added.  The samples were 
then left on ice for 10 mins.  The precipitated DNA was then collected using centrifugation 
at 16160 g and subsequently washed with 70% ethanol (v/v), air dried and resuspended in 
40  l of dH20.  20  l of the DNA was generally used to transform competent XL-1 Blue 
cells (see Section 2.2.7.1). 
2.2.9 Electrophoretic separation of proteins 
Electrophoretic separation of proteins was achieved using discontinuous SDS 
polyacrylamide gel electrophoresis (SDS-PAGE) as outlined by (Laemmli, 1970).  Gels 
were composed of a stacking region (5% (v/v) acrylamide, 0.25 M Tris-HCl pH 6.8, 0.2% 
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Tris-HCl pH 8.8, 0. 2% (w/v) SDS).  Gels were run in a tris-glycine electrophoresis buffer     
(25 mM Tris-HCl, 250 mM glycine, 0.1% (w/v) SDS).  Protein samples analysed by   
SDS-PAGE were generally denatured by heating for 5 mins at either 65°C (for detection of 
polytopic membrane proteins, such as Ste3p and Gap1p) or 95ºC, in 2 x LSB (100 mM 
Tris-HCl pH 6.8, 4% (w/v) SDS, 20% (v/v) glycerol, 0.2% (w/v) bromophenol blue,     
10% (v/v) b-Mercaptoethanol).  
Protein separation was visualised by incubating the gel in Coomassie Brilliant Blue 
solution (0.25 g Coomassie Brilliant Blue R250 in methanol:dH20:glacial acetic acid 
(4.5:4.5:1 v/v/v)) for 1 hour, followed by destaining in destain solution (5% (v/v) 
methanol, 10% (v/v) glacial acetic acid) until bands were clearly visible. 
2.2.10  Immunoblot Analysis 
A Bio-Rad Trans-Blot® SD cell was used to transfer proteins from polyacrylamide gels to 
nitrocellulose membranes (Whatman Protran, 0.45 m pore size).  The gel, nitrocellulose 
membrane and 6 pieces of Whatman 3 mm paper were all presoaked in semi-dry transfer 
buffer (50 mM Tris-HCl, 40 mM glycine, 0.037% (w/v) SDS, 10% (v/v) methanol).  The 
gel and nitrocellulose membrane were then sandwiched between the 6 sheets of Whatman 
paper and any air bubbles removed.  A constant current of 180 mA was applied for 30 mins 
(for one gel) up to 60 mins (for four gels).  After the proteins were transferred onto the 
nitrocellulose membrane, the membrane was blocked in 5% (w/v) non-fat dried milk in 
PBS/T (140 mM NaCl, 3 mM KCl, 1.5 mM KH2PO4, 8 mM Na2HPO4, 0.1% (v/v) Tween) 
for at least 30 mins.  This step prevents the non-specific association of antibodies to the 
nitrocellulose.   Alternatively, membranes probed with anti-CPY antibody were incubated 
with 5% (w/v) non-fat dried milk in TBS/T (20 mM Tris-HCl pH 7.5, 500 mM NaCl,     
0.1% (v/v) Tween).  The blocked membrane was then incubated with primary antibody 
diluted in 1-5% (w/v) non-fat dried milk in either PBS/T or TBS/T for 2 hours.  The 
percentage of non-fat dried milk used was dependent on the purity/specificity of the 
primary antibody.  Non-specifically bound primary antibody was subsequently washed off, 
leaving only the antibody specifically bound to the protein of interest, by washing the 
membrane for 6 times with 5 mins intervals between each wash.  Again, the buffer used for 
washing was dependent on the primary antibody, either PBS/T or TBS/T.  Next, the 
membrane was exposed to the appropriate secondary antibody diluted in 5% (w/v) non-fat 
dried milk in either PBS/T or TBS/T for 1 hour.  Following another 6 x 5 mins washes, 
protein bands were visualised using enhanced chemiluminescence (ECL). Marion S. Struthers, 2009    Chapter 2, 63 
 
2.2.11  Antibody purification 
2.2.11.1  IgG Affinity Purification  
2 ml of 50% PrA-agarose slurry (Sigma-Aldrich) was allowed to settle before being 
washed with 10 ml of PBS (140 mM NaCl, 3 mM KCl, 1.5 mM KH2PO4, 8 mM 
Na2HPO4).  500 µl of PBS was added to 500 µl of sera and the diluted sera filtered through 
a 0.22 µm filter.  The filtered serum was added to the agarose and incubated at 4ºC for       
1 hour with constant rotation.  The agarose was subsequently washed three times with 10 
ml of PBS.  At this stage the agarose was either incubated with more sera or eluted.  
Elution was achieved by adding 6 times 0.5 ml of elution buffer (50 mM Glycine pH 2.5).  
The six elution fractions collected were treated as follows: the first elution fraction was 
neutralized with 25 µl of 1 M Tris pH 10 and fractions 2-6 were neutralized with 70 µl of  
1 M Tris pH 10.  The fractions with the highest protein concentration (measured by their 
absorbance at 280 nm) were pooled and dialysed overnight against 5 L of PBS. 
2.2.11.2  Peptide Affinity Purification 
Peptide affinity purification was performed using the Sulfolink® kit (Pierce 
Biotechnology; cat # 44895). 
First the peptide (supplied by Eurogentec) was coupled to the SulfoLink® Coupling gel 
column.  This was achieved by equilibrating the column with 8 ml of coupling buffer     
(50 mM Tris, 5 mM EDTA-Na, pH 8.5).  15.5 mg of the hydrogenated peptide was 
rehydrated in 2-3 ml of coupling buffer and added to the column.  The immobolised 
peptide was incubated with end-over-end rotation at room temperature for 15 mins, 
followed by an additional 30 mins without mixing at room temperature.  The column was 
drained and subsequently washed with 6 ml of coupling buffer.  Non-specific binding sites 
on the matrix were blocked to prevent non-specific association with the column; this can 
occur when the column becomes exposed to proteins which contain free sulfhydryl groups.  
Blocking of the matrix was achieved by applying a 0.05 M cysteine solution to the column, 
followed by a 15 min incubation with end-over-end rotation and a static 30 min incubation 
at room temperature.  Subsequently the column was drained and washed with 12 ml of 
wash solution (1.0 M NaCl, 0.05% (w/v) NaN3) followed by 4 ml of degassed PBS 
containing 0.05% (w/v) NaN3.  2 ml PBS containing 0.05% (w/v) NaN3 was further 
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of the column to within 1 mm of the gel bed, this prevents the column from drying out as 
well as the resuspension of the packed gel bed.  At this stage the column was ready to 
utilise in the purification of antibodies from the immunised sera.  Purification was 
performed under static conditions. 
The purification protocol involved equilibrating the column with 6 ml of Sample Buffer 
(PBS).  Next, 1.5 ml of sera was added to the column and allowed to enter the matrix 
completely; this was followed by the addition of 0.2 ml of Sample Buffer.  The bottom cap 
was replaced on the column and a further 0.5 ml of Sample Buffer applied.  The top cap 
was subsequently replaced and the column incubated at room temperature for 1 hour.  The 
matrix was washed with 12 ml of Sample Buffer (PBS) and the bound antibodies eluted 
using 8 ml of Elution Buffer (100 mM Glycine, pH 2.5-3.0).  1 ml fractions were collected 
and neutralized by the addition of 100  l of 1 M Tris, pH 7.5.  Elutions were monitored by 
measuring the absorbance at 280 nm, and those fractions with the largest value of 
absorbance, pooled and dialysed at 4ºC, overnight, against 5 L PBS. 
2.2.12  Preparation of yeast whole cell lysates for immunoblot 
analysis 
To assess the steady-state levels of protein in yeast whole cell lysates, cells grown to mid-
log phase (OD600 of 0.5-1.0) were harvested by centrifugation at 3610 g for 2 mins.  The 
resultant cell pellets were washed in distilled water (dH20) and resuspended at                 
100 OD600 units/ml in Twirl Buffer (50 mM Tris pH 6.8, 5% (w/v) SDS, 8 M Urea, 10% 
(v/v) Glycerol, 0.2% (w/v) Bromophenol Blue, 10% (v/v) β-mercaptoethanol).  Whole cell 
lysates were generated by incubating for 10 mins at 65ºC, followed by brief vortexing.  
The denatured proteins contained within 10 µl of whole cell lysate were separated by  
SDS-PAGE prior to immnoblot analysis. 
2.2.13  Testing copper toxicity and osmotic sensitivity   
Yeast cells transformed with the appropriate plasmids were grown to mid-log phase 
(O.D600 0.6-1.0) in the selective media, SD-ura-met containing 50  M CuCl2.  Cells were 
harvested by centrifugation at 3610 g for 2 mins and the resultant cell pellet was 
resuspended at an OD600 of 0.8 in sterile dH2O.  Subsequent dilutions of this culture were 
performed generating cultures with a final OD600 of 0.8, 0.08, 0.008, 0.0008.  5 µl of each 
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50 µM CuCl2 (to investigate copper toxicity) or SD-ura-met containing both 50  M CuCl2 
and 1.5 M KCl (to investigate osmotic sensitivity). 
2.2.14  Trichloroacetic Acid (TCA) precipitation of secreted 
proteins 
Yeast cells transformed with the appropriate plasmids were grown to an OD600 of 1.0 in   
20 ml of the selective media, SD-ura-met, containing 50  M CuCl2.  Cells were harvested 
by centrifugation at 931 g for 2 mins and 18 ml of the supernatant collected.  Ice-cold TCA 
(50% (w/v)) was added to a final concentration of 10% (v/v) and the samples incubated on 
ice for a minimum of 30 mins.  The precipitated proteins were collected by centrifugation 
at 16160 g for 10 mins at 4
oC.  The resultant pellets were washed with ice-cold acetone and 
re-pelleted at 16160 g for 10 mins at 4
oC before being left to air dry at room temperature.  
The precipitated proteins were finally resuspended in LSB (500 mM Tris    pH 6.8, 10% 
(v/v) glycerol, 5% (w/v) SDS, 0.2% (w/v) Bromophenol Blue, 10% (v/v)     b-
mercaptoethanol), vortexed and incubated at 95ºC for 5 mins.  5 ml of a saturated      Tris-
HCl solution at pH 8.0 was added to any samples that had turned yellow in colouration 
(resulting from a low pH).  The precipitated proteins were separated using SDS-PAGE and 
the amount of CPY secreted assessed using immunoblot analysis with an antibody specific 
to CPY. 
2.2.15  Ste3p receptor endocytosis assay 
Yeast cells transformed with the appropriate plasmids were grown for one generation    
(i.e. until they reached an OD600 of 0.4-0.6)  in 50 ml of the selective media, S-Raf/Gal-
ura-leu (0.675% (w/v) Yeast Nitrogen Base without amino acid, 0.183% (w/v) synthetic 
complete drop-out: -ura-leu,  2% (w/v) raffinose, 2% (w/v) galactose) before adding 
glucose at a final concentration of 3% (v/v).  The addition of glucose switches off the 
expression of Myc-tagged Ste3p from the GAL1 promoter allowing the degradation of 
Ste3p-Myc to be monitored.  Cells were collected immediately after the addition of glucose 
(time-point 0) and again after a 20, 40 and 60 min incubation at 30ºC.  Further degradation 
of Ste3p was prevented by incubating the cells on ice in the presence of 15 mM NaN3.  
Cells collected at the 0, 20, 40 and 60 min time-points were harvested by centrifugation at 
3610 g for 2 mins and lysed by the resuspending in Twirl Buffer (5% (w/v) SDS, 8 M 
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β-mercaptoethanol) at a volume equivalent to 100 OD600/ml and incubating for 10 mins at 
65 ºC.  The denatured proteins present in whole cell lysates were separated by SDS-PAGE 
and the amount of Ste3p-Myc at time-points 0, 20, 40 and 60 min was assessed using 
immunoblot analysis with an antibody specific to the Myc-tag. 
2.2.16  FM4-64 and Vacuolar labelling   
Vacuolar membrane morphology and endocytosis dynamics were monitored using the 
lipophilic styryl dye, N-(3-triethylammoniumpropyl)-4-(p-diethylaminophenylhexatrienyl) 
pyridium dibromide (FM4-64).  The method used was similar to that described in detail in 
(Vida and Emr, 1995).   
Yeast cells transformed with the appropriate plasmids were grown in the selective media, 
SD-ura-met, containing 50 µM CuCl2 until they reached mid-log phase (OD600 of 0.8-1.0). 
The cells were harvested by centrifugation at 3610 g for 2 mins and resuspended in chilled 
media, SD-ura-met, to a final concentration of 20-40 OD600/ml.  FM4-64 was added to the 
culture at a final concentration of 30 mM from a stock solution of 1 mM in Dimethyl 
Sulfoxide (DMSO).  Henceforth the cells were kept in the dark.  They were incubated with 
FM4-64 for 30 mins at 0
oC before being harvested by centrifugation at 3610 g for 2 mins 
at 0
oC.  The chase period was initiated by resuspending the cells in fresh pre-warmed 
media, SD-ura-met, at a concentration of 10-20 OD600/ml.  Cells were collected after 10 
and 45 mins and NaN3 added to the cells at a final concentration of 15 mM to terminate the 
chase period.  Cells were kept on ice until they were visualized using fluorescence and 
differential interference contrast (DIC) microscopy. 
2.2.17  Immunofluorescence 
Yeast cells transformed with the appropriate plasmids were grown in 10 ml of the selective 
media, SD-ura-met, containing 50 µM CuCl2 until they reached mid-log phase (O.D.600 
0.6-1.0).  Pre-fixing of the cells was achieved by incubation at room temperature for 1 hour 
in the presence of 3.7% (v/v) formaldehyde.  Fixation was performed by resuspending the 
pre-fixed cells in 2 ml of fixative (45 µM NaOH, 4% (w/v) paraformaldehyde, 0.1 M 
KH2PO4) and leaving at room temperature overnight (16 hours) with constant agitation.  
The following day the fixed cells were harvested by centrifugation at 3610 g for 2 mins, 
resuspended in 750  l TEβ (200 mM Tris pH 8, 20 mM EDTA, 1% (v/v)                           
β-mercaptoethanol) and incubated for 10 mins at 37ºC.  Fixed cells were subsequently Marion S. Struthers, 2009    Chapter 2, 67 
 
spheroplasted by resuspending in 1 ml of spheroplasting buffer (1.2 M Sorbitol, 50 mM 
KPi pH 7.3, 1 mM MgCl2, 15  l of 15 mg/ml yeast lytic enzyme) and incubating at 30ºC 
for 45 mins.  The spheroplasts were permeabilised at room temperature for 5 mins in the 
presence of 2.5% (w/v) SDS in 1.2 M Sorbitol.  The permeabilised cells were washed once 
with 1 ml Sorbitol, and resuspended in 400  l of 1.2 M Sorbitol.   
Permeabilised cells contained within 40 µl of cells prepared as described above were 
allowed to adhere to Poly-L Lysine coated mutliwell slides (40  l of cells were added to 
each well) for 15 mins.  The liquid was removed from the wells before washing twice with 
PBS-BSA (PBS + 5 mg/ml BSA).  Non-specific binding sites on the cells were blocked by 
incubating for an hour in a humid container in the presence of 30  l of a 1:100 dilution of 
donkey sera made up in PBS-BSA.  The blocking solution was removed and 30  l of the 
primary antibody solution containing anti-HA and anti-Tlg2p (both at a 1:50 dilution; see 
Section 2.1.4.2) was added to the wells and left to incubate at room temperature for            
2 hours.  Subsequently the wells were washed seven times with PBS-BSA before the 
secondary antibodies were added (Alexa Fluor® 488 donkey anti-rat IgG and Alexa 
Fluor® donkey anti-rabbit IgG at a 1:50 dilution; see Section 2.1.4.2).  The cells were left 
for a further hour in a dark humid environment.  Again the cells were washed with PBS-
BSA nine times.  The mounting solution, Immu-mount (Thermo Electron Corperation, 
Pittsburgh), was added to the wells and coverslips fixed and sealed.  Cells were visualised 
using a 100x oil immersion objective on a Zeiss LSM410 laser confocal imaging system.  
Image sets were processed and overlaid using Adobe Photoshop™. 
2.2.18  Immunoprecipitation from yeast cell lysates 
Yeast cells transformed with the appropriate plasmids were grown at 25°C for one 
generation (OD600 0.4-0.6) in 500 ml of SD-ura-met containing 50 µM CuCl2.  For 
temperature sensitive experiments only, cells were either left at 25°C or transferred to the 
non-permissive temperature of 37°C for 30 mins.  Cells were harvested by centrifugation 
at 931 g for 2 mins and the resultant cell pellets washed in 10 ml of YPD-Sorb (50% (v/v) 
YPD, 50% (v/v) 2.4 M sorbitol) before spheroplasting for 1 hour in the presence of 5 ml 
YPD-Sorb to which 15 µl β-mercaptoethanol and 50 ml Yeast Lytic Enzyme (15 mg/ml) 
had been added.  Spheroplasts were lysed by resuspending in 5 ml of lysis buffer (200 mM 
sorbitol, 100 mM KoAc, 1% (v/v) Triton-X, 50 mM KCl, 20 mM Tris-HCl pH 6.8) and 
incubating for 1 hour at 4ºC.  The lysates were collected by pelleting the cell debris using 
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15 mins with 50 ml of PrA-agarose to remove those proteins that non-specifically bind to 
the agarose.  1.1 ml of lysate was collected after pelleting the PrA-agarose using 
centrifugation at 7370 g for 5 mins and incubated with 10 µl of anti-HA antibody for         
2 hours at 4°C.  50 ml of PrA-agarose was subsequently added and the samples left 
incubating for a further 1 hour at 4°C with constant agitation.  The PrA-agarose was then 
washed three times with 1 ml of lysis buffer and the bound proteins eluted by heating at 
100°C for 5 mins in the presence of 30 µl LSB.  The eluted proteins were analysed using 
SDS-PAGE immunoblot analysis with antibodies specific to Vps45p and the HA-tag. 
2.2.19  Pulse-Chase Experiments 
Yeast cells transformed with the appropriate plasmids were grown to mid-log phase (not 
exceeding an OD600 of 1.0) in the selective media, SD-ura-met, containing 50  M CuCl2, at 
which point a volume of cells equivalent to an OD600 of 1.0 was harvested by 
centrifugation at 3610 g for 2 mins.  The resultant cell pellets were resuspended in 
labelling media (SD-met, 50  M CuCl2, 50 mM Kphos pH 5.7, 2 mg/ml BSA) to which  
20  l of label, Promix L-[
35S] in vivo cell labeling mix SJQ0079 (Amersham) was added 
and incubated for 10 mins at 30ºC.  100  l of chase (5 mg/ml cysteine/methionine) was 
added to the cells and a 500  l sample collected immediately (time-point 0) with another 
being collected following a 30 mins incubation at 30ºC.  20  l of 1 M NaN3 was added to 
each sample immediately, following its collection, to prevent any subsequent trafficking of 
CPY.  Cells collected at time point 0 and after 30 mins were harvested by centrifugation at 
3610 g for 2 mins.  The supernatant was removed into a fresh tube and 100  l of 10 x IP 
Buffer (0.9 M Tris pH 8.0, 1% (w/v) SDS, 1% (v/v) Triton X-100, 0.02 M EDTA pH 8.0) 
was added.  The samples were then incubated at 100ºC for 5 mins.  The cell pellets were 
spheroplasted by resuspending in 150 µl Spheroplasting Buffer (1.4 M Sorbitol, 50 mM 
Tris pH 7.4, 2 mM MgCl2 10 mM NaN3 to which 3 µl of β-mercaptoethanol and 15 µl of 
lyticase per ml were added immediately before use) followed by an incubation of 1 hour at 
30ºC.  At this stage 50 µl of 2% (v/v) SDS was added to the spheroplasts which were 
subsequently boiled at 100ºC for 5 mins.  Generally, at this stage, the samples were stored 
overnight at -20°C.  The following day, 100 µl of 10 x IP-SDS (0.9 M Tris pH 8.0,         
1% (v/v) Triton X-100, 0.02 M EDTA pH 8.0), 700 µl dH20 and 50 µl of ZYSORBIN 
(ZEMED® Laboratories, Invitrogen) were added to the spheroplasts and 400 µl dH20 and 
50 µl ZYSORBIN added to the supernatant.  Samples were then incubated on ice for       
15 mins before pelleting the ZYSORBIN and associated proteins by microcentifuging at 
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ZYSORBIN.  The resultant supernatants were transferred to fresh tubes containing 15 µl of 
a 1:10 dilution of anti-CPY antiserum (see Section 2.1.4.1) and the solution vortexed 
briefly before reincubating on ice for 90 mins.  50 µl of ZYSORBIN was then added to 
each tube and the solutions left on ice for a further 45 mins.  The ZYSORBIN was pelleted 
by centrifugation at 16160 g for 1 min, and the resultant pellet washed twice with 1 ml IP 
Buffer (0.09 M Tris pH 8.0, 0.1% (w/v) SDS, 0.1% (v/v) Triton X-100, 0.002 M EDTA  
pH 8.0) before eluting in 15 µl of 2 x LSB at 100°C for 5 mins.  The ZYSORBIN was 
separated from the eluted proteins using microcentrifugation at 16160 g for 1 min and      
10  l of the eluted proteins separated by SDS-PAGE (7.5% (v/v) polyacrylamide gel).  The 
resultant gel was fixed by incubating in fixative (25% (v/v) Methanol, 10% (v/v) Acetic 
Acid) for 30 mins.  The fixative was removed by washing the gel in dH2O.  The gel was 
subsequently incubated for a further 30 mins in the presence of the water soluble fluor 
Sodium Salicylate (at a final concentration of 1 M), washed in dH20, dried down and a 
piece of Medical X-ray film (Kodak) placed on the gel and left for 2-3 days at -80ºC.   
2.2.20  Recombinant Protein Expression and Purification 
Chemically competent BL21 Star™ (DE3) cells (Invitrogen) were transformed with 
plasmids, pCOG025 (Carpp et al., 2006), pALA001, pFB09/1, pGEX-DSK2UBA or pCAL1 
driving the expression of the appropriate fusion proteins (Tlg2cyto-PrA, Sx16Acyto-PrA, 
Sx4cyto–PrA, GST-UBA and GST-mutUBA, respectively).  5 ml overnight cultures of 
transformed cells were used to inoculate 500 ml of Terrific Broth medium containing      
100 µg/ml of the antibiotic Ampicillin.  Cells were grown at 37ºC with constant rotation 
until they reached mid-log phase (O.D.600 0.5-0.7) before protein expression was induced 
by the addition of Isopropyl-β-D-1-thiogalactopyranoside (IPTG), at a final concentration 
of 1 mM, for 4 hours.  Cells were harvested using centrifugation at 3273 g for 20 mins.  
Cell pellets were washed in 20 ml of PBS and stored at -20ºC.  Frozen cell pellets were 
thawed on ice and resuspended in 20 ml of PBS.  Lysis was then performed by incubating 
the cells on ice in the presence of Lysozyme at a final concentration of 1 mg/ml for          
30 mins, followed by 6 times 20-sec bursts of sonication (Sanyo Soniprep 150) with 
intervals of 20 secs rests on ice.  Lysed cells were clarified by centrifugation at 48400 g for 
25 mins at 4ºC. 
 Marion S. Struthers, 2009    Chapter 2, 70 
 
2.2.20.1  Purification of PrA-tagged proteins 
500  l of settled IgG Sepharose™ 6 Fast Flow (GE Healthcare) was equilibrated by 
washing in 2 ml of TST (Tris-saline Tween 20 (TST); 50 mM Tris-HCl pH 7.6, 150 mM 
NaCl and 0.05% Tween 20) followed by 1 ml of HAc pH 3.4 (0.5 M acetic acid adjusted to 
pH 3.4 with ammonium acetate), 1 ml of TST, 1 ml of HAc pH 3.4 and 2 ml of TST.  The 
equilibrated Sepharose was then incubated with clarified E. coli lysate (prepared as 
described above in Section 2.2.20) for 2 hours at 4ºC with rotation.  Unbound proteins 
were removed by centrifugation at 70 g for 2 mins and the pelleted sepharose washed        
8 times with TST.  Proteins bound to the IgG Sepharose were assessed by eluting a small 
fraction of beads (20  l) using 0.5 M HAc pH 3.4.  An equivalent volume of 2 x LSB was 
then added prior to incubation at 95ºC for 5 mins. 5 µl of a saturated Tris-HCl solution at 
pH 8.0 was added to each of the samples to increase their pH.  The Sepharose was then 
pelleted by centrifugation at 70 g for 2 mins and the proteins present in the eluate separated 
by SDS-PAGE.  The amount and purity of purified proteins were assessed by Coomassie 
staining the gel. 
2.2.20.2  Purification of GST-tagged proteins 
600  l of glutathione-Sepharose™ 4B (GE Healthcare) suspension was washed 3 times 
with 1 ml PBS, resuspended in 0.5 ml of PBS and added to a cleared E. coli lysate 
(prepared as described above in Section 2.2.20).  The Sepharose was incubated with the 
lysate for 1 hour at 4ºC with constant rotation.  At the end of this incubation the Sepharose 
was washed a further 3 times with 1 ml PBS.  Finally, the beads were resuspended in a 
volume of PBS (supplemented with protease inhibitors (1 tablet of complete protease 
inhibitors (Roche)/50 ml PBS)) equivalent to the volume of settled beads.  The levels of 
recombinant proteins associated with the sepharose was analysed by diluting a sample of 
the sepharose (5 µl) 1:5 with LSB.  Proteins were eluted from the sepharose by heating at 
65ºC for 10 mins and separated from the Sepharose by centrifugation at 70 g for 1 min.  
The recombinant proteins that were associated with the beads were compared to purified 
GST (as a means to monitor whether or not the fusion proteins had degraded) as well as 
BSA standards of known protein content.  Comparison was performed by separating the 
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2.2.21  Pull-down assays 
2.2.21.1  Vps45p pull-downs from yeast lysates 
Yeast cells transformed with the appropriate plasmids were grown to mid-log phase (OD600 
of 0.6-1.0) in 100 ml of the selective media, SD-ura-met.  The cells were then pelleted at 
931 g for 2 mins, before resuspending in 100 µl of binding buffer (40 mM Hepes.KOH    
pH 7.4, 150 mM KCl, 1 mM DTT, 1 mM EDTA, 0.5% NP-40) per OD600.  A volume of 
glass beads equivalent to half the volume of resuspended cells was added and the cells 
lysed by vortexing four times for 30 sec each time with 1 min intervals on ice.  Unlysed 
cells and the glass beads were pelleted by centrifugation at 70 g for 5 mins.  A sample of 
lysate was saved for later analysis.  Lysates were then added to Sepharose pre-bound by 
Tlg2-PrA, Sx16-PrA or Sx4-PrA (see Section 2.2.20.1) and the beads incubated overnight 
at 4ºC mixing end-over-end.  The beads were then harvested, the supernatant removed and 
the Sepharose washed three times with TST.  Finally, proteins bound to the beads were 
eluted by the addition of 40  l HAc pH 3.4; 20 l of the eluate was removed and incubated 
at 95ºC for 5 mins in the presence of 20  l of 2 x LSB.  5 µl of a saturated Tris-HCl 
solution at pH 8.0 was added to each of the samples to increase their pH.  The eluted 
proteins were separated by SDS-PAGE prior to immunoblot analysis with an antibody 
specific to the HA-tag. 
2.2.21.2  Ubiquitin pull-downs from yeast lysates 
Yeast cells transformed with the appropriate plasmids were grown in 50 ml of the selective 
media, SD-ura-met, containing 100  M CuCl2, until they reached mid-log phase (OD600 of 
0.6-1.0).  They were then harvested at 931 g for 2 mins and spheroplasted by incubating at 
30°C for 1 hour in the presence of 5 ml YPD-Sorb (50% (w/v) YPD, 50% (w/v) 2.4 M 
sorbitol) containing 15 µl of β-mercaptoethanol and 50 µl of Yeast Lytic Enzyme.  
Spheroplasts were collected by centrifugation at 2095 g for 5 mins and subsequently lysed 
in 250 µl lysis buffer (200 mM Sorbitol, 100 mM KoAc, 1% (v/v) Triton-X, 50 mM KCl, 
20 mM Pipes pH 6.8, 3 mM NEM, 1 tablet of complete protease inhibitors (Roche)/50 ml 
PBS) for 1 hour at 4°C, mixing end-over-end.  The cell lysates were cleared by 
centrifugation at 12470 g for 15 mins at 4ºC.  10 µl of the lysate was collected and treated 
by adding 10 µl of 2 x LSB, followed by 15 mins incubation at 65°C (this sample is 
representative of the yeast cell lysate).  100 µl of the cleared lysate was added to 10 µl of 
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2.2.20.1) and rotated at 4°C for 2 hours.  Beads were subsequently washed 3 times with     
1 ml of PBS.  Proteins were eluted from the beads by the addition of 20  l of LSB 
followed by a 15 min incubation at 65ºC.  The eluted proteins were separated from the 
Sepharose by centrifugation at 70 g for 1 min and analysed using SDS-PAGE and 
immunoblot analysis with antibodies specific to Tlg2p, the HA-tag or the GFP-tag. 
2.2.22  Functional assay for degradation of Tlg2p 
Yeast cells transformed with the appropriate plasmids were grown to mid-log phase 
(O.D600 0.6-1.0) in the selective media, SD-ura-met.  Cells were subsequently harvested by 
centrifugation at 3610 g for 2 mins.  The resultant cell pellets were resuspended in sterile 
dH2O at an OD600 of 0.8.  Subsequent dilutions of this culture were performed generating 
cultures with a final OD600 of 0.8, 0.08, 0.008, 0.0008.  5 µl of each culture was spotted 
onto SD-ura-met and SD-his. 
2.2.23  Hydroxylamine Treatment 
The method used was similar to that described in detail in (Valdez-Taubas and Pelham, 
2005). 
Yeast cells transformed with the appropriate plasmids were grown to mid-log phase      
(OD 600 of 0.6-1.0) in 50 ml of the selective media, SD-ura-met, containing 100 µM CuCl2.  
Cells were harvested using centrifugation at 931 g for 2 mins and the resultant cell pellets 
resuspended in 5 ml of YPD-Sorb (50% (v/v) YPD, 50% (v/v) 2.4 M sorbitol), to which  
15 µl of β-mercaptoethanol and 50 µl of yeast lytic enzyme were added and incubated at 
30°C for 1 hour.  The spheroplasts were then collected by centrifugation at 2,095 g for       
5 mins and lysed by resuspending in 250 µl of lysis buffer (200 mM Sorbitol, 100 mM 
KoAc, 1% (v/v) Triton-X, 50 mM KCl, 20 mM Pipes pH 6.8, 3 mM NEM, 1 tablet of 
complete protease inhibitors (Roche)/50 ml PBS) and incubating for 1 hour at 4°C, mixing 
end-over-end.  The cell lysates were cleared by centrifugation at 12470 g for 15 mins at 
4ºC.  The protein concentration of the cell lysates was estimated using the Bradford protein 
assay (see Section 2.2.24), 100  g of protein extract, in a volume no greater than 50  l, 
was then incubated with either 600  l of 1 M Hydroxylamine-HCl pH 7.4 or 600  l of 1 M 
Tris-HCl for 1 hour at room temperature.  A mixture of chloroform-methanol (650  l 
chloroform, 150  l methanol) was added to each reaction mixture and the samples 
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upper phase removed carefully without disturbing the proteins present in the interphase.  
450  l methanol (100% (v/v)) was added, the samples vortexed and proteins pelleted using 
centrifugation at 16160 g for 2 mins.  The pelleted proteins were air dried before 
resuspending in 100  l of LSB (lacking the reducing agent β-mercaptoethanol) prior to 
incubation at 65ºC for 15 mins.  20  l of these precipitated proteins were separated using 
SDS-PAGE prior to immunoblot analysis with antibodies specific to the HA-tag.   
2.2.24  Bradford protein assay 
Protein concentration was estimated using the Bradford protein assay.  A 1 mg/ml stock of 
bovine serum albumin (BSA) dissolved in dH2O was used to generate standards of known 
protein concentration (0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0 mg/ml) by diluting in 
dH2O.  20  l of each of the standards and 20  l of a 1:100 dilution of protein extract(s) 
(diluted in dH20) were mixed in separate 1 cm pathlength disposable cuvettes with 1 ml of 
Quick Start™ Bradford Dye Reagent (Bio-Rad Laboratories, Inc.).  The absorbance of 
each solution was measured at 595 nm and a graph constructed of the absorbance at       
595 nm against protein concentration for the protein standards.  The Bradford protein assay 
gives a hyperbolic curve, which at low protein concentrations gives a relatively straight 
line.  The equation of the linear range of this graph was utilised to calculate the 
concentration of proteins present in the protein extract(s). 
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Table 2.1 - E. coli and S. cerevisiae strains used in this study 
E. coli strains used in this study: 
Strain   Genotype  Source 
BL-21 Star™ 
(DE3) 
F
- ompT hsdSB(rB
-mB
-) gal dcm rne131 (DE3)  Invitrogen 
TOP10  F
- mcrA D(mrr-hsdRMS-mrcBC) f80lacZDM15 
DlacX74 recA1 araD139 D(ara-leu)7697 galK rpsL 
(Str
R) endA1 nupG 
Invitrogen 
XL1 
Competent 
Blues 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´ proAB lacIqZ M15 Tn10 (Tetr)]. 
Invitrogen 
S. cerevisiae strains used in this study: 
Strain  Genotype  Construction  Reference 
RPY10  MATa ura3-52 leu2-3, 
112 his4-519 ade6 gal2 
  (Piper et al., 
1994) 
SF838-9D  MATa ura3-52 leu2-3, 
112 his4-519 ade6 gal2 
pep4-3 
  (Rothman and 
Stevens, 1986) 
SEY6210  MATa ura3-52 his3-
 200 lue2-3, 112 lys2-
801 trp1- 901 suc2- 9 
ade2-101 
  (Robinson et al., 
1988) 
RMY8  MATa ura3-52 his3-
 200 lue2-3, 112 lys2-
801 trp1- 901 suc2- 9 
ade2-101 pep4-3 
EcoRI  digested pPLO2010 
(Nothwehr et al., 1995) was 
used to disrupt PEP4 in 
SEY6210 
Constructed by 
Dr. Rebecca K. 
McCann (This 
study) 
NOzY4  MATa ura3-52 leu2-3, 
112 his4-519 ade6 gal2 
tlg2 ::Kan
r   
  (Bryant and 
James, 2001) 
NOzY2  MATa ura3-52 leu2-3, 
112 his4-519 ade6 gal2 
vps45 ::Kan
r   
  (Bryant and 
James, 2001) 
NOzY3  MATa ura3-52 leu2-3, 
112 his4-519 ade6 gal2 
pep4-3 tlg2 ::Kan
r   
  (Bryant and 
James, 2001) 
NOzY1  MATa ura3-52 leu2-3, 
112 his4-519 ade6 gal2 
pep4-3 vps45 ::Kan
r   
  (Bryant and 
James, 2001) 
MSY001  MATa ura3-52 his3-
 200 lue2-3, 112 lys2-
801 trp1- 901 suc2- 9 
ade2-101 tlg2 ::Kan
r   
NotI digested pUG7 (Seron 
et al., 1998) used to disrupt 
TLG2 in SEY6210 
(Seron et al., 
1998) 
LCY007  MATa ura3-52 his3-
 200 lue2-3, 112 lys2-
801 trp1- 901 suc2- 9 
ade2-101 vps45 ::Kan
r   
SmaI/SphI digested 
pNOz13 (Bryant and James, 
2001) used to disrupt 
VPS45 in SEY6210 
Constructed by 
Dr Lindsay N. 
Carpp (This 
study) 
LCY011  MATa ura3-52 leu2-3, 
112 sec18-1 tlg2 ::Kan
r  
NotI digested pUG7 (Seron 
et al., 1998) used to disrupt 
TLG2 in SEY5186 (Emr et 
al., 1984) 
Constructed by 
Dr. Lindsay N. 
Carpp (This 
study) 
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Table 2.2 - Oligonucleotides used in this study 
Oligo  Description  Sequence 
105  CUP1SX16A  GATATTAAGAAAAACAAACTGTACAATCAATC
AATCAATCATCACATACCATGGCCACCAGGCG
TTTAACCGAC 
106  3’UTRSX16A  ATTATAACGTATTAAATAATATGTGAAAAAAG
AGGGAGAGTTAGATAGGATTATCGAGACTTCA
CGCCAACGAG 
258  CUP1HASX16A  AATCAATCATCACATAAAATGTACCCATACGA
TGTTCCGGATTACGCTGCCACCAGGCGTTTAAC
C 
259  reverse complement of 
258 
GGTTAAACGCCTGGTGGCAGCGTAATCCGGAA
CATCGTATGGGTACATTTTATGTGATGATTGA
TT 
314  CUP1HATLG2  GATATTAAGAAAAACAAACTGTACAATCAATC
AATCAATCATCACATAAAATGTACCCATACGA
TGTTCCGGATTACGCTTTTAGAGATAGAACTA
ATTTATTTTT 
311  3’UTRTLG2  ATTATAACGTATTAAATAATATGTGAAAAAAG
AGGGAGAGTTAGATAGGATCAAAGTAGGTCAT
CCAAAGCAT 
315  CUP1HASX4  GATATTAAGAAAAACAAACTGTACAATCAATC
AATCAATCATCACATAAAATGTACCCATACGA
TGTTCCGGATTACGCTCGCGACAGGACCCACG
AGTTG 
313  3’UTRSX4  ATTATAACGTATTAAATAATATGTGAAAAAAG
AGGGAGAGTTAGATAGGATTATCCAACGGTTA
TGGTGATGC 
63  CUP1TLG2  GATATTAAGAAACTGTACAATCAATCAATCAA
TCATCACATAAAATGTTTAGAGATAGAACTAAT
TA 
66  3’UTRHATLG2  ATTATAACGTATTAAATAATATGTGAAAAAAG
AGGGAGAGTTAGATAGGATCAAGCGTAATCC
GGAACATCGTATGGGTAAAGTAGGTCATCCAA 
301  XbaIHASX16A  AATCTAGATGTACCCATACGATGTTCCG 
303  XhoISX16A  AACTCGAGTTATCGAGACTTCACGCC 
308  XbaIHASX4  AAATCTAGATGTACCCATACGATGTTCCGGAT
TACGCTCGCGACAGGACCCACGAGTTG 
310  XhoISX4  AAACTCGAGTTATCCAACGGTTATGGTGATGCC 
383  XbaIHATLG2( 2-230)  AATCTAGATGTACCCATACGGATGTTCCGGAT
TACGCTACGTTGCAGAGACAGCAACAG 
384  XhoITLG2  AACTCGAGTCAAAGTAGGTCATCCAAAGC 
382  XbaIHASX16A( 2-
205) 
AATCTAGATGTACCCATACGGATGTTCCGGAT
TACGCTTTAGTTCTGGTGGACCAGAAC 
286  NdeISX16A(1-278)  CATATGGCCACCAGGCGTTTAACC 
287  XhoISX16A(1-278)  CTCGAGCTTCCGATTCTTCTTTTGATACTG 
267  XhoITLG2  GGCTCGAGTCAACTGACCCCTTCTTTTTACC 
268  XbaITLG2  CGTCTAGACAAAACAAAAACTTGCCCCGAGC 
269  BamHIHIS3  CGGGATCCATGACAGAGCAGAAAGCCCTAG 
270  SalIHIS3  ACGTCGACCATAAGAACACCTTTGGTGGAGG 
316  TLG2BamHISalITLG2  TTGGGCGATGATCAAGGATCCAAAGTCGACGAT
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317  reverse complement of 
316 
TACCCATTTCAATATCGTCGACTTTGGATCCTTG
ATCATCGCCCAAG 
214  TLG2K26RTLG2  ACTTTCTCATCTGGGAGAGCACCCTTGGGCG 
215  reverse complement of 
214 
CGCCCAAGGGTGCTCTCCCAGATGAGAAAGT 
333  TLG2K189R, K193R, 
K198RTLG2 
TTGAAATTCTTGAACAGAGATGATTTGAGACCT
ATCCGCAATAGAGCCAGTGCAGAGAAC 
334  reverse complement of 
334 
GTTGTGTGCACTGGCTCTATTGCGGATAGGTCT
CAAATCATCTCTGTTCAAGAATTTCAA 
335  TLG2K218R, 
K229RTLG2 
GAGGCAGCAAGAGAGAGAAGAGAGGGCCTCGA
TATTGAAGACTATTCAAGAAGGACGTTGCAGAG
A 
336  reverse complement of 
335 
TCTCTGCAACGTCCTTCTTGAATAGTCTTCAATA
TCGAGGCCCTCTCTTCTCTCTCTTGCTGCCTC 
352  DSK2M342R, 
F344ADSK2 
GACAACTAAACGACAGGGGCGCCTTCGATTTCG
ATAGAAAC 
353  reverse complement of 
352 
GTTTCTATCGAAATCGAAGGCGCCCCTGTCGTT
TATTGGTC 
407  TLG2K305R, K311R, 
K315RTLG2 
GCAACACACTACCAGAGAAGAACTCAAAGATGT
AGAGTCATTTTATTACTAACA 
408  reverse complement of 
407  
TGTTAGTAATAAAATGACTCTACATCTACATCTT
TGAGTTCTTCTCTGGTAGTGTGTTGC 
380  TLG2 CSTOP, 
STOP3’UTR 
TTCTTTGTTATGTTGAAATGATGACCACATGGCG
GTGGC 
381  reverse complement of 
380 
GCCACCGCCATGTGGTCATCATTTCAACATAAC
AAAGAA 
397  BamHITLG2  GGCAGTCGTTACAAACGGATCCATGTTTAGAGA
TAGAAG 
398  reverse complement of 
397 
CTTCTATCTCTAAACATGGATCCGTTTGTAACGA
CTGCC 
395  HIS3STOP, 
STOPTLG2 
CCAAAGGTGTTCTTATGTAGTAGGATTATTGAA
ATGGGTAC 
396  reverse complement of 
395 
GTACCCATTTCAATATCCTACTACATAAGAACA
CCTTTGG 
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Table 2.3  - Plasmids used in this study 
Plasmid   Description  Reference 
pLO2010  pep4-3- H3 in pRS306  (Nothwehr et al., 
1995) 
pVT102u  Yeast expression plasmid (2 , URA3)   (Vernet et al., 1987) 
pSGS025  Yeast expression plasmid (2 , URA3) encoding a HA-
tagged version of human Sx16A from the ADH1 
promoter 
Constructed by Dr. 
Scott G. Shanks 
(This study) 
pSGS036  Yeast expression plasmid (2 , URA3) encoding a HA-
tagged version of human Sx4 from the ADH1 promoter 
Constructed by Dr. 
Scott G. Shanks 
(This study) 
pHA-Tlg2  Yeast expression plasmid (2 , URA3) encoding a HA-
tagged version of yeast syntaxin, Tlg2p from the ADH1 
promoter 
(Seron et al., 1998) 
pSGS043  Yeast expression plasmid (2 , URA3) encoding a HA-
tagged truncated version of the yeast syntaxin, Tlg2p, 
lacking the first 230 residues. 
Constructed by Dr. 
Scott G. Shanks 
(This study) 
pSGS044  Yeast expression plasmid (2 , URA3) encoding a HA-
tagged truncated version of the human syntaxin, 
Sx16A, lacking the first 205 residues.  
Constructed by Dr. 
Scott G. Shanks 
(This study) 
pNB701  Yeast expression plasmid (CEN, URA3) encoding 
Pho8p from the CUP1 promoter  
Constructed by Dr. 
Nia J. Bryant (This 
study) 
pMAZ002  Yeast expression plasmid (CEN, URA3) encoding a 
HA-tagged version of human Sx16A from the CUP1 
promoter 
This study 
pMAZ006  Yeast expression plasmid (CEN, URA3) encoding a 
HA-tagged version of yeast syntaxin, Tlg2p from the 
CUP1 promoter 
This study 
pMAZ007  Yeast expression plasmid (CEN, URA3) encoding a 
HA-tagged version of mouse Sx4 from the CUP1 
promoter 
This study 
pSL2099  Yeast expression plasmid (CEN, LEU2) encoding a 
Myc-tagged version of yeast Ste3p from the GAL1 
promoter 
(Davis et al., 1993) 
pNB706  Yeast expression plasmid (CEN, URA3) encoding wild-
type HA-Vps45p 
(Carpp et al., 2006) 
pNB708  As pNB706 encoding HA-Vps45pL117R  (Carpp et al., 2006) 
pET-
Duet™-1 
ColE1 ori Ampr lacI; E. coli expression vector  Novagen 
pCOG022  E. coli expression plasmid encoding two synthetic 
repeats of the IgG binding domains of S. aureus protein 
A 
(Carpp et al., 2006) 
pCOG025  E. coli expression plasmid encoding a C-terminally 
PrA-tagged truncated version of Tlg2p (cytosolic 
residues 1-318) 
(Carpp et al., 2006) 
pALA001  E. coli expression plasmid encoding a C-terminally 
PrA-tagged truncated version of Sx16A (cytosolic 
residues 1-269).  
Constructed by 
Alicja Drozdowska 
(This study) 
pFB09/1  E. coli expression plasmid encoding a C-terminally 
PrA-tagged truncated version of Sx4 (cytosolic 
residues 1-273). 
Constructed by Dr. 
Fiona Brandie (This 
study) Marion S. Struthers, 2009    Chapter 2, 78 
 
pCOG070  Yeast expression plasmid (2 , URA3) encoding a HA-
tagged version of the yeast SM protein Vps45p from 
the VPS45 promoter  
(Carpp et al., 2006) 
pCOG071  Yeast expression plasmid (2 , URA3) encoding a HA-
tagged mutant version of the yeast SM protein Vps45p 
(L117R) from the VPS45 promoter 
(Carpp et al., 2006) 
pCOG039  Yeast expression plasmid (CEN, URA3) encoding a C-
terminally HA-tagged version of the yeast syntaxin 
Tlg2p from the CUP1 promoter 
Constructed by Dr. 
Lindsay N. Carpp 
(This study) 
pMAZ038  Yeast expression plasmid (CEN, URA3) encoding a 
HA-tagged truncated version of Tlg2p (residues 1-336) 
This study 
pGEX-
DSK2UBA 
E. coli expression plasmid encoding a GST-tagged 
version of the Ubiquitin associated domain (residues 
328-373 of the yeast adaptor protein Dsk2p) 
(Funakoshi et al., 
2002) 
pCAL1  E. coli expression plasmid encoding a GST-tagged 
mutant version of the Ubiquitin associated domain 
(M324R and F344A) 
Constructed by 
Christopher A. 
Lamb (This study) 
P2313  Yeast expression plasmid (CEN, URA3) encoding C-
terminally GFP-tagged Gap1p from the CUP1 
promoter 
(Scott et al., 2004b) 
pRS416  Yeast expression plasmid (CEN, URA3)   (Sikorski and 
Hieter, 1989) 
pMAZ004  2148 bp fragment encoding the yeast syntaxin, Tlg2p 
under the control of its own promoter and 3’ UTR 
flanked by XhoI and XbaI sites in pCR2.1
®-TOPO
®. 
This study 
pMAZ001  Yeast expression plasmid (CEN, URA3) encoding the 
yeast syntaxin Tlg2p from the TLG2 promoter. 
This study 
pMAZ005  663 bp fragment encoding the yeast enzyme 
Imidazoleglycerol-phosphate dehydratase, His3p 
flanked by BamHI and SalI sites in pCR2.1
®-TOPO
®. 
This study 
pMAZ016  As pMAZ001, but with a BamHI and SalI site 
introduced after codon 33 of TLG2. 
This study 
pMAZ017  Yeast expression plasmid (CEN, URA3) encoding a 
fusion protein incorporating the yeast syntaxin Tlg2p 
and the enzyme Imidazoleglycerol-phosphate 
dehydratase, His3p 
This study 
pMAZ027  As pMAZ017, but encoding the enzyme 
Imidazoleglycerol-phosphate dehydratase, His3p under 
the control of the TLG2 promoter and 3’UTR 
This study 
pMAZ028  As pMAZ017, but with the lysine at position 26 
mutated to an arginine residue (K26R) 
This study 
pMAZ029  As pMAZ017, but encoding the first 33 amino acids of 
Tlg2p fused to full length His3p under the control of 
the TLG2 promoter and 3’UTR 
This study 
pMAZ030  As pMAZ017, but with the five lysines at positions 
190, 194, 199, 219 and 230 mutated to arginine 
residues (5KR) 
This study 
pMAZ033  As pMAZ017, but with three lysines mutated at 
positions 306, 312 and 316 mutated to arginine 
residues (3KR) 
This study 
 
pCR
®2.1 - 
TOPO
® 
ColE ori Amp
r Kan
r lacZα, TA cloning vector  Invitrogen  
The work presented in this chapter has been published in (Struthers et al., 2009) 
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3.1 Introduction 
In silico analysis has previously identified Tlg2p as being homologous to the mammalian 
protein, Sx16 (Simonsen et al., 1998).  This chapter describes experiments directed 
towards investigating whether Sx16 and Tlg2p are also functional homologues.  This was 
an important question to ask since, if the two syntaxins are functional homologues, it 
would open up the possibility of using yeast as a model system to study the role of 
mammalian Sx16.  Using yeast as a model system to study the function of Sx16 offers a 
number of advantages over studying the syntaxin in mammalian cells alone, since yeast 
cells are much more experimentally tractable.  There are a number of precedences for this 
type of approach in the literature, since the molecular machinery that regulates membrane 
traffic in eukaryotic cells is conserved from yeast to humans (Ferro-Novick and Jahn, 
1994).   
In order to address whether Sx16 is a functional homologue of Tlg2p, I chose to express 
the mammalian syntaxin in yeast cells lacking endogenous Tlg2p and ask whether it could 
complement for the loss of the yeast syntaxin.  There are five different splice variants of 
Sx16: Sx16A, Sx16B, Sx16C (Simonsen et al., 1998), Sx16H (Tang et al., 1998) and 
Sx16D (Dulubova et al., 2002) (see Section 1.2.4).  In this study I selected the splice 
variant Sx16A to investigate whether or not Sx16 and Tlg2p are functional homologues.  
This splice variant has previously been used to study the trafficking of GLUT4 in 3T3-L1 
adipocytes (Proctor et al., 2006).  Yeast cells lacking Tlg2p (tlg2  mutant cells) display 
multiple phenotypes as a result of impaired traffic through the endosomal system 
(Abeliovich et al., 1998, Holthuis et al., 1998, Seron et al., 1998).  Phenotypes of tlg2  
cells include osmotic sensitivity (Abeliovich et al., 1998); incorrect trafficking of vacuolar 
proteases (Abeliovich et al., 1998); abnormal vacuolar morphology (Abeliovich et al., 
1998, Seron et al., 1998) and impaired delivery of endocytosed material to the vacuole 
(Holthuis et al., 1998, Abeliovich et al., 1998, Seron et al., 1998).  For my studies it was 
important that expression of Sx16 was not grossly elevated compared to the levels of Tlg2p 
normally found in yeast.  This was important because SNARE proteins contain a large 
amount of coiled-coil sequence which makes them notoriously ‘sticky’, i.e. they are prone 
to interact with non bona fide partners under non-physiological conditions, such as 
overexpression or in vitro binding studies (Fasshauer et al., 1999, Tsui and Banfield, 2000, 
Yang et al., 1999).  Indeed it has previously been reported, in yeast, that the overexpression 
of the vacuolar syntaxin, Vam3p, can compensate for loss of the endosomal SNARE 
Pep12p and vice versa (Darsow et al., 1997, Gotte and Gallwitz, 1997).  This is unlikely to Marion S. Struthers, 2009    Chapter 3, 81 
 
be due to the formation of a bona fide SNARE complex since this effect is not observed if 
Vam3p or Pep12p are expressed at, or close to, endogenous levels (Gotte and Gallwitz, 
1997).  For this reason, it was also important to include a second mammalian syntaxin in 
my study, so that I could ensure that any observed complementation of tlg2  phenotypes 
by Sx16 was specific to the Tlg2p in silico homologue.  For this purpose I chose 
mammalian syntaxin 4 (Sx4).       
This chapter describes the construction of vectors that drive expression of the mammalian 
syntaxins Sx16 and Sx4 in yeast cells.  Also documented here is the ability of Sx16 to 
complement multiple endocytic trafficking defects displayed by tlg2  mutant yeast cells. 
3.2 Heterologous expression of mammalian syntaxins, 16 
and 4 in yeast 
In order to heterologously express mammalian syntaxins in yeast, it was necessary to place 
the ORFs encoding the proteins downstream of a yeast promoter.  Initially the syntaxins 
were cloned into the plasmids pVT102u (Vernet et al., 1987), under the control of the 
ADH1 promoter.  ADH1 encodes the fermentative isozyme, alcohol dehydrogenase, which 
is responsible for the last step of the glycolytic pathway; the reduction of acetaldehyde to 
ethanol (Dickinson et al., 2003, Lutstorf and Megnet, 1968).  The cloning of the syntaxins 
into pVT102u was performed by Dr Scott Shanks (University of Glasgow, UK) generating 
pSGS025 (encoding HA-Sx16) and pSGS036 (encoding HA-Sx4).  A similar vector 
encoding HA-Tlg2p, pHA-Tlg2 (Seron et al., 1998) was also used in the complementation 
experiments.  However, expression from the ADH1 promoter is constitutive and strong, 
and it was a concern that this might lead to expression of the syntaxins at grossly elevated 
levels when compared to that of endogenous Tlg2p.  To address this concern, I constructed 
a second set of vectors, utilising the inducible CUP1 promoter.  CUP1 encodes the copper 
methallothionen protein which aids in the process of metal ion detoxification by tightly 
chelating copper ions (Butt et al., 1984).  The higher the concentration of copper ions in 
the media, the greater the amount of the protein produced from the CUP1 promoter 
(Mascorro-Gallardo et al., 1996).  This feature of the CUP1 promoter makes it an 
extremely useful tool for regulating the expression of heterologous proteins in yeast, since 
the level of expression of an ORF placed downstream of the CUP1 promoter can be 
controlled by the regulating the concentration of copper ions present in the media in which 
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versions of Tlg2p, Sx16, or Sx4 was placed under control of the CUP1 promoter using the 
“gap-repair” strategy outlined in Figure 3.1.  
 
Figure 3.1 – Schematic diagram of the homologous recombination strategy used to create 
pMAZ002, pMAZ006, pMAZ007 (please see following text for details). 
 
Initially, the plasmid pNB701 was digested with the restriction enzymes XhoI and SalI to 
remove most of the coding sequence for RS-ALP (retention sequence-alkaline 
phosphatase) (Bryant et al., 1998).  The resultant “gapped plasmid” (A in Figure 3.1) and 
PCR products (B in Figure 3.1), which encode the desired syntaxin flanked by sequences Marion S. Struthers, 2009    Chapter 3, 83 
 
homologous to the 3’ end of the CUP1 promoter and the 5’ end of the 3’ UTR of PHO8, 
were co-transformed into yeast (strain SF838-9D).  “Gap-repair” of pNB701 (C in Figure 
3.1) was performed in yeast through homologous recombination and the transformants 
selected by their ability to grow on media lacking uracil (SD-ura-met).  To ensure that 
homologous recombination had been successful, expression of the desired syntaxin was 
screened using immunoblot analysis.  Finally the plasmid was rescued from yeast 
identified as producing the desired syntaxin, and sequenced (as described in Sections 2.2.8 
and 2.2.6).  The overall procedure is summarised below in Figure 3.2. 
 
Figure 3.2 – Flow chart showing an overview of homologous recombination and the steps 
that follow 
 
A more detailed description of how plasmids pMAZ002 (encoding HA-Sx16) and 
pMAZ007 (encoding HA-Sx4) were generated is described below. 
For pMAZ002 the human Sx16A ORF (accession number AAB69282) was amplified from 
a cDNA kindly provided by Prof. Gwyn Gould (University of Glasgow, U.K.) by PCR 
using the oligonucleotide primers shown in Figure 3.3.   Marion S. Struthers, 2009    Chapter 3, 84 
 
 
Figure 3.3 – Sx16 oligonucleotide primer sequences 
 
This generated PCR product containing the Sx16 ORF flanked by sequences homologous 
to the 3’ end of the CUP1 promoter and the proximal end of the 3’ UTR of PHO8 (both 
underlined in Figure 3.3).  This fragment was then used to repair the gapped plasmid, 
pNB701, by co-transforming yeast (strain SF838-9D) with XhoI/SalI digested pNB701 and 
PCR product.  Seven transformants capable of growing on selective media lacking uracil 
(SD-ura-met) were screened for the expression of Sx16 using immunoblot analysis with an 
antibody specific to Sx16 (Figure 3.4).  Expression of Sx16 from the CUP1 promoter was 
induced by the addition of 200  M CuCl2 to the media in which these transformants were 
grown.  
 
Figure 3.4 – Screening co-transformed yeast for Sx16 expression 
Whole cell lysates prepared from equal numbers of yeast (SF838-9D) cells (1 OD600 
equivalents) co-transformed with PCR product (Sx16 ORF flanked by sequences 
homologous to the 3’ end of the CUP1 promoter and the proximal end of the 3’ UTR of 
PHO8) and XhoI/SalI digested pNB701 were screened for Sx16 expression using 
immunoblot analysis with an antibody specific to Sx16.  A whole cell lysate prepared from   
1 OD600 equivalents of SF838-9D cells transformed with the empty vector, pNB701, was 
included in the immunoblot analysis as a negative control (-) and a whole cell lysate 
prepared from adipocytes (kindly provided by Dr Kirsty Proctor, University of Glasgow, UK) 
was included as a positive control (+).  Expression of Sx16 from the CUP1 promoter was 
induced by the addition of 200  M CuCl2 to the selective media (SD-ura-met) in which these 
transformants were grown. 
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Three of the seven transformants screened expressed Sx16 (lanes 2, 3 and 4 of Figure 3.4).  
These transformants were selected and the plasmids encoding Sx16 rescued and sequenced 
(as described in Section 2.2.8 and 2.2.6).  Following DNA sequencing to confirm the 
constructs, one plasmid was selected and named pMSS001.   
To create pMAZ002 sequence encoding the HA-tag was introduced immediately after the 
initiating methionine of Sx16 in pMSS001 using SDM with the oligonucleotide primers 
shown in Figure 3.5. 
 
Figure 3.5 – SDM oligonucleotide primer sequences used to introduce the HA-tag to Sx16. 
 
To ensure that the HA-tag had been successful introduced, five plasmids generated during 
the SDM of pMSS001 were transformed into the yeast strain, SF838-9D.  The 
transformants were then screened for the expression of HA-tagged Sx16 using immunoblot 
analysis with an antibody specific to the HA-tag.  Expression from the CUP1 promoter 
was induced by the addition of 200  M CuCl2 to the selective media, SD-ura-met, in which 
these transformants were grown. 
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Figure 3.6 - Screening yeast for HA-Sx16 expression 
Whole cell lysates prepared from equal numbers of yeast (SF838-9D) cells (1 OD600 
equivalents) transformed with plasmids generated during the SDM reaction were screened 
for expression of HA-Sx16 using immunoblot analysis with an antibody specific to the HA-
tag.  A whole cell lysate prepared from 1 OD600 equivalents of SF838-9D cells transformed 
with the empty vector, pNB701, was also included in the immunoblot analysis as a negative 
control (-).  Expression of HA-Sx16 from the CUP1 promoter was induced by the addition of 
200  M CuCl2 to the selective media, SD-ura-met, in which these transformants were grown. 
 
Each of the five plasmids transformed into the yeast strain, SF838-9D, expressed an     
HA-tagged version of Sx16, confirming that the SDM treatment had been successful 
(Figure 3.6).  To ensure that no errors had been introduced during the SDM reaction, the 
coding sequences in these newly synthesised plasmids were checked by DNA sequencing.  
One plasmid was subsequently selected and named pMAZ002. 
pMAZ007 was constructed in a manner similar to that of pMAZ002.  The murine Sx4 ORF 
(accession number P70452) was amplified from the plasmid pQE30-Sx4 (provided by 
Luke Chamberlain, University of Edinburgh, U.K.) using the oligonucleotide primers 
shown in Figure 3.7.  The resulting PCR product, containing sequence encoding Sx4 with 
an HA-tag immediately after the initiating methionine (encoded by the bold sequence in 
Figure 3.7) flanked by sequences homologous to the 3’ end of the CUP1 promoter and the 
proximal end of the 3’ UTR of PHO8 (underlined in Figure 3.7), was then used to repair 
gapped pNB701 as outlined in Figures 3.1 and 3.2. 
 
Figure 3.7 – HA-Sx4 oligonucleotide primer sequences 
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Co-transformed yeast (SF838-9D) capable of growing on the selective media, SD-ura-met, 
were screened to identify those expressing HA-tagged Sx4.  This was achieved using 
immunoblot analysis with an antibody specific to the HA-tag (Figure 3.8). 
 
Figure 3.8 – Screening of co-transformed yeast for HA-Sx4 expression. 
Whole cell lysates prepared from equal numbers of yeast (SF838-9D) cells (1 OD600 
equivalents) co-transformed with PCR product (HA-Sx4 ORF flanked by sequences 
homologous to the 3’ end of the CUP1 promoter and the proximal end of the 3’ UTR of 
PHO8) and XhoI/SalI digested pNB701 were screened for HA-Sx4 expression using 
immunoblot analysis with an antibody specific to the HA-tag.  A whole cell lysate prepared 
from 1 OD600 equivalents of SF838-9D cells transformed with the empty vector, pNB701, was 
also included in the immunoblot analysis as a negative control (-).  Expression of HA-Sx4 
from the CUP1 promoter was induced by the addition of 200  M CuCl2 to the selective 
media, SD-ura-met, in which these transformants were grown. 
 
Of the seven transformants screened, four expressed proteins recognisable by the anti-HA 
antibody.  These four transformants were selected (lanes 2, 3, 4 and 7 in Figure 3.8) and 
the plasmids rescued (as described in Section 2.2.8).  Each of the coding sequences in the 
newly synthesised plasmids was checked by DNA sequencing.  This was necessary as 
homologous recombination can, in some cases result in the expression of truncated 
proteins (lane 3 in Figure 3.8).  Following DNA sequencing one plasmid was selected and 
named pMAZ007. 
3.3 Comparison of the expression of HA-tagged Tlg2p 
and endogenous Tlg2p 
As mentioned above (in Section 3.1) an important consideration for this study was to 
express the mammalian syntaxins at similar levels to those at which Tlg2p is found in 
wild-type yeast cells.  This was to address the concern that overexpression of syntaxins 
may force incorrect SNARE partnering and complex formation (Darsow et al., 1997, Gotte 
and Gallwitz, 1997).  In order to compare the levels of the heterologously expressed 
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pMAZ002 and pMAZ007 expressing HA-Tlg2p from the CUP1 promoter; pMAZ006.  
This was achieved using PCR to amplify the TLG2 ORF from yeast chromosomal DNA, 
using the oligonucleotides shown in Figure 3.9.  The resulting PCR product, containing 
sequence encoding Tlg2p with an HA-tag immediately after the initiating methionine 
(encoded by the bold sequence shown in Figure 3.9) flanked by the sequences homologous 
to the 3’end of the CUP1 promoter and the proximal end of the 3’ UTR of PHO8 
(underlined in Figure 3.9), was then used to repair gapped pNB701 (outlined in Figure 3.1 
and 3.2). 
 
Figure 3.9 – HA-TLG2 oligonucleotide primer sequences 
 
As described above (in Section 3.2) yeast (SFS838-9D) co-transformed with PCR product 
and XhoI/SalI digested pNB701 were screened for HA-Tlg2p expression using immunoblot 
analysis with an antibody specific to the HA-tag (Figure 3.10) and the plasmid encoding 
HA-Tlg2p isolated using the procedure detailed in Figure 3.2. 
 
Figure 3.10 - Screening of co-transformed yeast for HA-Tlg2p expression. 
Whole cell lysates prepared from equal numbers of yeast (SF838-9D) cells (1 OD600 
equivalents) co-transformed with PCR product (HA-TLG2 ORF flanked by sequences 
homologous to the 3’ end of the CUP1 promoter and the proximal end of the 3’ UTR of 
PHO8) and XhoI/SalI digested pNB701 were screened for HA-Tlg2p expression using 
immunoblot analysis with an antibody specific to the HA-tag.  A whole cell lysate prepared 
from 1 OD600 equivalents of SF838-9D transformed with the empty vector, pNB701, was 
included in the immunoblot analysis as a negative control (-).  Expression of HA-Tlg2p from 
the CUP1 promoter was induced by the addition of 200  M CuCl2 to the selective media (SD-
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It was important to decide the concentration of copper that should be used express the three 
syntaxins.  In order to do this, I carried out a copper titration; cells lacking endogenous 
Tlg2p (NOzY3; SF838-9D tlg2 ) were transformed with pMAZ002 (encoding HA-Sx16), 
pMAZ006 (encoding HA-Tlg2p) or pMAZ007 (encoding HA-Sx4).   These transformants 
were then grown in selective media (SD-ura-met) containing different concentrations of 
copper ions (0, 25, 50, 75, 100 or 150 µM CuCl2).  Proteins contained within whole cell 
lysates prepared from equal numbers of these transformants (1 OD600 equivalents) were 
separated by SDS-PAGE.  The levels of the individual syntaxins were then assessed using 
immunoblot analysis with an antibody specific to the HA-tag. 
 
Figure 3.11 - Copper titration to assess optional copper concentrations for syntaxin 
expression. 
NOzY3 (SF838-9D tlg2∆) cells transformed with the plasmids pMAZ006 (encoding HA-Tlg2p), 
pMAZ002 (encoding HA-Sx16) or pMAZ007(encoding HA-Sx4) were grown in selective media 
containing different concentrations of CuCl2, namely 0, 25, 50, 75, 100 and 150 M.  Whole 
cell lysates prepared from equal numbers of these transformants (1 OD600 equivalents) were 
prepared and analysed using immunoblot analysis with an antibody specific to the HA-tag.  
Levels of the v-SNARE, Vti1p, were also assessed using immunoblot analysis to control for 
equal loading. 
 
The expression of HA-Tlg2p and HA-Sx16 increases with copper concentration.  However 
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(Figure 3.11).  50 µM CuCl2 was selected as the concentration of copper to be added to the 
media to drive the expression of Tlg2p, Sx16 and Sx4.  This concentration is not high 
enough to introduce any of the toxic effects of copper (Kagi et al., 1979, Macreadie et al., 
1989), but is sufficient to give an easily detectable amount of the syntaxins.  
I next went on to compare the levels of HA-Tlg2p expressed from pMAZ006 (in the 
presence of 50 µM CuCl2) to that of endogenous Tlg2p.  Cells lacking endogenous Tlg2p 
(NOzY3; SF838-9D tlg2 ) were transformed with either pNB701 (empty vector) or 
pMAZ006 (encoding HA-Tlg2p).  Transformants were then grown in selective media 
containing 50 µM CuCl2 to induce the expression of HA-Tlg2p.  Whole cell lysates 
prepared from equal numbers of these transformants (1 OD600 equivalents) were run 
alongside a whole cell lysates prepared from an equivalent number (1 OD600 equivalents) 
of wild-type (SF838-9D; containing Tlg2p at normal, endogenous levels) and tlg2  
(NOzY3; SF838-9D tlg2 ) cells transformed with the empty vector, pNB701, which were 
also grown under the same conditions.  The levels of Tlg2p present in these whole cell 
lysates was then assessed using immunoblot analysis with an antiserum that specifically 
recognise Tlg2p (Figure 3.12a).  Expression of HA-Tlg2p from the vector pHA-Tlg2 
(Seron et al., 1998) was also screened at the same time as a means to compare the 
expression from the endogenous promoter, the inducible promoter (CUP1) and the 
constitutive promoter (ADH1) (Figure 3.12b).  
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Figure 3.12 – A comparison of endogenous Tlg2p expression and HA-Tlg2p expression 
controlled by the yeast promoters CUP1 and ADH1. 
a) Wild-type cells (WT; SF838-9D) transformed with pNB701 (empty vector) and tlg2∆ cells 
(NOzY3; SF838-9D tlg2∆) cells transformed with either pNB701 (empty vector) or pMAZ006 
(encoding HA-Tlg2p) were grown to mid-log phase in the selective media, SD-ura-met, 
containing 50 µM CuCl2.  Levels of Tlg2p present in whole cell lysates prepared from equal 
numbers of these transformants (1 OD600 equivalents) were analysed using immunoblot 
analysis with an antiserum specific to Tlg2p.  Levels of the vacuolar ATPase subunit, 
Vph1p, were also assessed using immunoblot analysis to control for equal loading.  b) tlg2∆ 
cells (NOzY3; SF838-9D tlg2∆) transformed with pVT102u (empty vector), pMAZ006 (driving 
HA-Tlg2p expression from the CUP1 promoter) or pHA-Tlg2 (driving HA-Tlg2p* expression 
from the control of the ADH1 promoter) were grown to mid-log phase in the selective media, 
SD-ura-met, containing 50 µM CuCl2.  Levels of Tlg2p present in whole cell lysates prepared 
from equal numbers of these transformants (1 OD600 equivalents) were analysed using 
immunoblot analysis with an antiserum specific to Tlg2p.  Levels of the vacuolar ATPase 
subunit, Vph1p, were also assessed using immunoblot analysis to control for equal loading. 
 
Figure 3.12 demonstrates that Tlg2p expression from the inducible CUP1 promoter (at    
50 µM CuCl2) and the constitutive ADH1 promoter does not differ greatly from the 
expression achieved by the endogenous promoter.  Hence it is apparent that either 
expression system could be utilised in complementation experiments. 
In order to compare the levels of Sx16 and Sx4 expression from the plasmids pMAZ002 
and pMAZ007 to that of Tlg2p from pMAZ006, the HA-tag was utilised.  This enabled me 
to use immunoblot analysis to directly compare the levels of protein expressed from the 
three constructs.  This would not be possible using antibodies against the three different 
proteins as there would be no way of controlling for any differences in the affinity that the 
different antibodies would have for their syntaxins.  Thus, cells lacking endogenous Tlg2p 
(NOzY3; SF838-9D tlg2 ) were transformed with pNB701 (empty vector), pMAZ006 
(encoding HA-Tlg2p), pMAZ002 (encoding HA-Sx16) or pMAZ007 (encoding HA-Sx4).  
Expression was induced by the addition of 50 µM CuCl2 to the selective media, SD-ura-
met, in which these transformants were grown.  Proteins contained within whole cell 
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separated by SDS-PAGE and the levels of the syntaxins compared using immunoblot 
analysis with an antibody specific to the HA-tag.    
 
Figure 3.13 - Expression of HA-Tlg2p, HA-Sx16, HA-Sx4 in tlg2∆ cells.   
Cells lacking endogenous Tlg2p (NozY3; SF838-9D tlg2∆) were transformed with pNB701 
(empty vector), pMAZ006 (encoding HA-Tlg2p), pMAZ002 (encoding HA-Sx16) or pMAZ007 
(encoding HA-Sx4).  Expression was induced by the addition of 50 µM CuCl2
 to the selective 
media, SD-ura-met, in which these transformants were grown. Proteins contained within 
whole cell lysates prepared from equal numbers of these transformants (1 OD600 
equivalents) were separated by SDS-PAGE prior to immunoblot analysis with an antibody 
specific to the HA-tag.  Levels of the vacuolar ATPase subunit, Vph1p, were also assessed 
using immunoblot analysis to control for equal loading. 
 
Both HA-Sx4 and HA-Sx16 are expressed at levels which exceeds that of HA-Tlg2p 
(Figure 3.13).  Although HA-Sx4 and HA-Sx16 appear to be somewhat overexpressed, as 
long as HA-Sx4 does not complement the function of Tlg2p then the possibility of the 
overexpression of HA-Sx16 being responsible for complementation can be ruled out. 
3.4 Copper toxicity 
Heavy metal ions, such as copper, are known to be toxic to yeast at high levels (Kagi et al., 
1979).  It has previously been reported that copper resistant strains can grow in the 
presence of greater than 0.3 mM CuSO4; where as copper sensitive strains cannot 
(Macreadie et al., 1989).  As a means of investigating whether or not the chosen copper 
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of NOzY3 (SF838-9D tlg2 ) cells expressing the HA-tagged syntaxins on selective plates 
(SD-ura-met) with and without copper chloride. 
 
Figure 3.14 – Testing for copper sensitivity 
Wild-type cells (WT; SF838-9D) transformed with pNB701 (empty vector) and cells lacking 
endogenous Tlg2p (tlg2∆; NOzY3; SFS838-9D tlg2∆) transformed with either pNB701 (empty 
vector), pMAZ006 (encoding HA-Tlg2p), pMAZ007 (encoding HA-Sx4) or pMAZ002 (encoding 
HA-Sx16) were grown to mid-log phase in the selective media, SD-ura-met, containing 50 µM 
CuCl2.  Cells were then harvested and resuspended at an OD600 of 0.8 in sterile dH2O; 
subsequent serial dilutions were performed, generating cultures with an OD600 of 0.8, 0.08, 
0.008 and 0.0008.  5 µl of each of these cultures was then spotted onto SD-ura-met (control) 
and SD-ura-met + 50 µM CuCl2 and their growth monitored over several days at 30ºC.   
 
It is evident that the presence of 50µM CuCl2 in the media does not have any effect on the 
growth of the cells, hence copper toxicity can be ruled out as a limiting factor in the 
experiments which follow. 
3.5 Functional analysis 
3.5.1 Osmotic sensitivity 
Yeast defective in vacuolar and/or endocytic trafficking often show sensitivity to osmotic 
stress (Banta et al., 1988).  Cells lacking endogenous Tlg2p show a decreased growth rate 
on media containing abnormally high concentrations of salt (Abeliovich et al., 1998).  In 
order to investigate whether or not Sx16 would complement the function of Tlg2p, yeast 
cells lacking endogenous Tlg2p (NOzY3; SF838-9D tlg2 ) transformed with pMAZ006 
(encoding HA-Tlg2p), pMAZ002 (encoding HA-Sx16) or pMAZ007 (encoding HA-Sx4) 
were grown to mid-log phase in the presence of 50  M CuCl2 before spotting onto 
selective media (SD-ura-met + 50 µM CuCl2) containing high concentrations of the salt 
potassium chloride (KCl). Marion S. Struthers, 2009    Chapter 3, 94 
 
 
Figure 3.15 – Expression of human Sx16 complements the osmotic sensitivity phenotype of 
tlg2∆ mutant cells. 
Wild-type cells (WT; SF838-9D) transformed with pNB701 (empty vector) and cells lacking 
endogenous Tlg2p (tlg2∆; NOzY3; SFS838-9D tlg2∆) transformed with either pNB701 (empty 
vector), pMAZ006 (encoding HA-Tlg2p), pMAZ007 (encoding HA-Sx4) or pMAZ002 (encoding 
HA-Sx16) were grown to mid-log phase in the selective media, SD-ura-met, containing 50 µM 
CuCl2.  Cells were then harvested and resuspended at an OD600 of 0.8 in sterile dH2O; 
subsequent serial dilutions were performed, generating cultures with an OD600 of 0.8, 0.08, 
0.008 and 0.0008.  5 µl of each of these cultures was then spotted onto SD-ura-met + 50 µM 
CuCl2 (control) and SD-ura-met + 50 µM CuCl2 + 1.5 M KCl (+ 1.5 M KCl) and their growth 
monitored over several days at 30ºC.   
 
Cells lacking endogenous Tlg2p (tlg2 ), but expressing either HA-Tlg2p or HA-Sx16, 
have a similar growth rate to that seen for wild-type cells (WT + pNB701).  In comparison, 
cells lacking endogenous Tlg2p (tlg2 ) but expressing HA-Sx4 show a reduced growth 
rate similar to that of tlg2  cells harbouring the empty vector (tlg2  + pNB701).  Hence in 
this assay the expression of human Sx16 complements the osmotic sensitivity phenotype of 
tlg2  mutant cells in a manner indistinguishable from Tlg2p; in contrast Sx4 does not. 
3.5.2 Trafficking of intracellular proteins – CPY 
The vacuolar protease, CPY, is synthesised at the ER where it undergoes N-linked 
glycosylation; generating a 67 kDa ER-modified form of proCPY referred to as p1CPY 
(Blachly-Dyson and Stevens, 1987, Hasilik and Tanner, 1978b, Johnson et al., 1987).  
p1CPY is then trafficked from the ER to the Golgi apparatus where it undergoes further 
oligosaccharide modifications, resulting in a 69 kDa Golgi-modified form of proCPY 
known as p2CPY (Stevens et al., 1982, Trimble et al., 1983).  At the late Golgi, p2CPY is 
sorted away from the secretory pathway by its receptor Vps10p (Marcusson et al., 1994).  
p2CPY and Vps10p are trafficked to the PVC, where they dissociate and Vps10p is 
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Seaman et al., 1997).  p2CPY is subsequently delivered to the vacuole where it is cleaved 
by vacuolar proteases into a 61 kDa active form of CPY, known as mature CPY (mCPY) 
(Deloche and Schekman, 2002, Hasilik and Tanner, 1978a).   
Cells lacking endogenous Tlg2p are unable to correctly sort CPY and as a result secrete a 
small amount of the Golgi-modified form of CPY, p2CPY, from the cell (Abeliovich et al., 
1998).  In order to investigate whether or not Sx16 would complement this CPY trafficking 
defect, the CPY secreted from wild-type cells (SF838-9D) transformed with empty vector 
(pVT102u) was compared to that of cells lacking endogenous Tlg2p (NOzY3; SFS838-9D 
tlg2 ) transformed with either empty vector (pVT102u) or plasmids driving the expression 
of HA-Sx16 (pSGS025), HA-Sx4 (pSGS036) or HA-Tlg2p (pHA-Tlg2).  TCA 
precipitation was used to collect the secreted proteins from the media in which these cells 
had grown (see Section 2.2.14) and the presence of secreted CPY was then assessed using 
immunoblot analysis with an antibody specific to CPY. 
 
Figure 3.16 – Expression of human Sx16 complements the CPY trafficking defects of tlg2∆ 
mutant cells  
Wild-type (WT; SF838-9D) cells transformed with pVT102u (empty vector) and tlg2∆ cells 
transformed with pVT102u (empty vector), pSGS025 (encoding HA-Sx16), pSGS036 
(encoding HA-Sx4) or pHA-Tlg2 (encoding HA-Tlg2p) were grown to mid-log phase in the 
selective media, SD-ura-met.  Equal numbers (18 OD600 equivalents) of these cells were then 
harvested and the proteins present in the resulting supernatant precipitated by the addition 
of TCA at a final concentration of 10% (v/v).  The precipitated proteins were then separated 
using SDS-PAGE and the secretion of CPY assessed using immunoblot analysis with an 
antibody specific to CPY.  A whole cell lysate prepared from 1 OD600 equivalents of SF838-
9D cells transformed with the empty vector, pNB701, was also included in the immunoblot 
analysis as a positive control.   
 
It is evident from Figure 3.16 that there is no detectable secretion of CPY from wild-type 
cells (WT) when compared to cells lacking endogenous Tlg2p (tlg2 ).  The expression of 
HA-Tlg2p or HA-Sx16 reduces CPY secretion of tlg2  cells to levels similar to that seen 
with wild-type cells.  In contrast expression of HA-Sx4 in tlg2  cells did not prevent the Marion S. Struthers, 2009    Chapter 3, 96 
 
incorrect sorting and secretion of CPY.  Hence, human Sx16 complements for the loss of 
Tlg2p with respect to trafficking of the vacuolar protease CPY, whereas Sx4 does not.  
3.5.3 Ste3p receptor endocytosis 
Mating haploid yeast cells secrete two different types of pheromone known as a and α 
factor (Davis et al., 1993).  Haploid yeast cells secreting a-factor are known as a type and 
those secreting α factor are known as α type (Davis et al., 1993).  Each type of haploid cell 
expresses the opposite type of receptor on its cell surface, for example an a type haploid 
cell will express an α receptor and vice versa (Davis et al., 1993).  Binding of pheromone 
to its receptor allows mating to occur between two haploid cells (Herskowitz, 1989). 
Phermone receptors belong to the G-protein coupled receptor family (Naider and Becker, 
2004).  The α-factor receptor is more commonly known as Ste2p and the a-factor receptor 
as Ste3p (Naider and Becker, 2004).  Ste2p and Ste3p are both subject to two different 
modes of endocytosis; ligand-dependent mode and ligand-independent constitutive mode 
(Davis et al., 1993).  Upon internalisation the pheromone receptors are trafficked to the 
vacuole for degradation (Davis et al., 1993).  
It has previously been shown that cells lacking Tlg2p have a defective vacuolar endocytic 
pathway, one consequence of this is an inability of proteins endocytosed from the plasma 
membrane, such as Ste2p and Ste3p, to reach the vacuole and be degraded (Holthuis et al., 
1998, Abeliovich et al., 1998, Seron et al., 1998).   Ste3p endocytosis can be followed by 
measuring the rate at which the receptor is degraded by vacuolar proteases (Davis et al., 
1993).  In wild-type cells Ste3p turnover is rapid, with a half-life of approximately 20 
mins,  however cells lacking endogenous Tlg2p show a reduced rate of Ste3p trunover, 
with a half-life of approximately 45 mins (Abeliovich et al., 1998).   
In order to measure the turnover of Ste3p, expression must be controlled in such a way that 
it could be switched off to follow the degradation from a defined time-point.  This strategy 
removes any confusion that would arise from the equilibrium between degradation and 
synthesis.  Previously Ste3p turnover has been measured using different techniques such as 
radiolabelled pulse-chase (Abeliovich et al., 1998, Davis et al., 1993, Seron et al., 1998) 
and glucose repression (Davis et al., 1993), the kinetics of both parallel each other (Davis 
et al., 1993).  In the experiments described below glucose repression was used to measure 
the turnover of Ste3p in wild-type and tlg2  cells.  This involved using the plasmid 
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expresses a Myc-tagged version of Ste3p under the control of the GAL1 promoter.  In the 
presence of media containing the sugar galactose (S-Raf/Gal-ura-leu), the GAL1 promoter 
is switched on and hence promotes the expression of Ste3p-Myc.  However upon the 
addition of a more favourable sugar source, such as glucose to the media, the GAL1 
promoter becomes switched off and Ste3p-Myc degradation from the time-point of glucose 
addition can be monitored using immunoblot analysis with an antibody specific to the 
Myc-tag.  The expression of a Myc-tagged version of Ste3p makes it possible to 
distinguish between endogenously expressed Ste3p and that controlled by the GAL1 
promoter.  This is important as otherwise, it would be impossible to monitor the 
degradation of Ste3p in those cells containing the wild-type gene (STE3). 
Ligand-independent endocytosis and degradation of Ste3p-Myc was monitored using the 
MATα strain RPY10 and its isogenic tlg2  derivative NOzY4 (RPY10 tlg2 ).   NOzY4 
(RPY10 tlg2 ) cells were co-transformed with plasmids expressing Ste3p-Myc (pSL2099) 
and the desired syntaxin (HA-Sx16 from pSGS025, HA-Sx4 from pSGS036, HA-Tlg2p 
from pHA-Tlg2).  As a means of a positive and negative control for this experiment both 
RPY10 and NOzY4 (RPY10 tlg2 ) cells were co-transformed with pSL0299 (Ste3p-Myc) 
and pVT102u (empty vector).  Selection of co-transformed plasmids was achieved using 
the selective media, SD-ura-leu.  Co-transformed cells were then grown on selective media 
containing galactose and raffinose (S-Raf/Gal-ura-leu) for one generation (i.e. until the 
Optical Density at 600 nm doubles) before adding glucose.  The point of glucose addition 
was taken as time-point zero, after which cells were collected every 20 mins and the levels 
of Ste3p-Myc monitored by preparing whole cell lysates, upon which immunoblot analyses 
were performed.  This work was done in collaboration with Dr Scott Shanks (University of 
Glasgow, UK). 
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Figure 3.17 - Expression of Sx16 overcomes the block in Ste3p endocytosis observed in 
tlg2∆ cells. 
Ste3p degradation in wild-type cells co-transformed with pSL2099 (Ste3p-Myc) and the 
empty vector (pVT102u) was compared to that of cells lacking endogenous Tlg2p (tlg2∆) co-
transformed with pSL2099 (Ste3p-Myc) and either pVT102u (empty vector), pHA-Tlg2 (HA-
Tlg2p), pSGS025 (HA-Sx16) or pSGS036 (HA-Sx4).  Co-transformed cells were grown on 
selective media containing galactose and raffinose (S-Raf/Gal-ura-leu) for one generation 
(i.e. until the Optical Density at 600 nm doubles) before adding glucose.  Cells were 
collected immediately after glucose addition (time-point 0) and again after 20, 40 and 60 
mins.  Further degradation of Ste3p-Myc was prevented by the addition of NaN3 to a final 
concentration of 15 mM.  Equal numbers (1 OD600 equivalents) of these cells were then 
analysed using immunoblot analysis with an antibody specific to the Myc-tag.  Levels of the 
vacuolar ATPase subunit, Vph1p, were also assessed using immunoblot analysis to control 
for equal loading. 
 
As mentioned above, the half-life of Ste3p is approximately 20 mins and 45 mins in wild-
type and tlg2  cells, respectively (Davis et al., 1993, Abeliovich et al., 1998).  This is in 
agreement with the data presented in Figure 3.17.  The introduction of HA-Tlg2p and HA-
Sx16 to tlg2  cells increases the rate of Ste3p degradation to a rate comparable to that seen 
in wild-type cells; in contrast the introduction of HA-Sx4 has no effect.  From this, I 
conclude that Sx16 complements the function of Tlg2p, with respect to the endocytic 
trafficking of the a-factor receptor, Ste3p, whereas Sx4 does not. 
3.5.4 FM4-64, vacuolar labelling  
Another technique which can be utilised to follow endocytic trafficking to the vacuole in 
yeast is to follow delivery of the lipophillic styryl dye, N-(3-triethylammoniumpropyl)-4-
(p-diethylaminophenylhexatrinyl) more commonly known as FM4-64, from the plasma 
membrane to the vacuole (Vida and Emr, 1995).  One of the main advantages of using 
FM4-64 apposed to other dyes is that FM4-64 is specifically trafficked to the vacuolar 
membrane via the endocytic pathway (Vida and Emr, 1995).  
FM4-64 was used to investigate whether Sx16 would complement the function of Tlg2p by 
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wild-type cells (RPY10) transformed with empty vector (pVT102u) was compared to that 
of cells lacking endogenous Tlg2p (NOzY4; RPY10 tlg2 ) transformed with either empty 
vector (pVT102u) or plasmids driving the expression of HA-Tlg2p (pHA-Tlg2), HA-Sx16 
(pSGS025) or HA-Sx4 (pSGS036).  Transformants grown to mid-log phase were labelled 
with FM4-64 at 0ºC for 30 mins.  The dye was subsequently removed and a chase period 
initiated by resuspending the cells in fresh prewarmed media (SD-ura-met) lacking     
FM4-64.  Cells were incubated for 10 mins and 45 mins at 30ºC after which time the chase 
period was terminated by the addition of NaN3.  Cells were then kept on ice until they were 
visualised using fluorescence and DIC microscopy.  This work was done in collaboration 
with Dr Scott Shanks (University of Glasgow, UK). 
 
Figure 3.18– Expression of Sx16 promotes efficient FM4-64, vacuolar labelling in tlg2∆ cells. 
Trafficking of the lipophillic styryl dye, FM4-64, in wild-type cells (WT; RPY10) transformed 
with pVT102u (empty vector) was compared to that of tlg2∆ cells (NOzY4; RPY10 tlg2∆) 
transformed with pVT102u (empty vector), pHA-Tlg2 (encoding HA-Tlg2p), pSGS025 
(encoding HA-Sx16) or pSGS036 (encoding HA-Sx4).  Transformants were grown to mid-log 
phase in SD-ura-met, before harvesting and resuspending in the rich media, YPD.  FM4-64 
was then added to these cultures at final concentration of 30 µM and the cells incubated at 
0ºC for 30 mins.  The dye was subsequently removed and a chase period initiated by 
resuspending the cells in fresh prewarmed media (SD-ura-met) lacking FM4-64.  Cells were 
incubated for 10 mins and 45 mins at 30ºC after which time the chase period was terminated 
by the addition of NaN3 at a final concentration of 15 mM.  Cells were then kept on ice until 
they were visualised by fluorescent and DIC microscopy.  The scale bars displayed in the 
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Figure 3.18 demonstrates that after a 10 min chase, the lipophillic styryl dye, FM4-64 
clearly labels the vacuolar membrane of wild-type cells, as previously reported in (Vida 
and Emr, 1995).  Clear vacuolar labelling is also displayed in tlg2  cells expressing HA-
Tlg2p and HA-Sx16.  In contrast, FM4-64 does not reach the vacuole in tlg2  cells 
containing empty vector or expressing HA-Sx4 and instead appears to concentrate in small 
cytosolic puncta within the cell (Figure 3.18).  This is similar to the phenotype of that seen 
in wild-type cells incubated at 15ºC (Vida and Emr, 1995) in which FM4-64 is trapped in 
an endocytic compartment to which GFP-Tlg2p co-localises (Abeliovich et al., 1998).  
These results demonstrate that trafficking of FM4-64 to the vacuole is impaired in tlg2  
cells and uncorrected by the expression of HA-Sx4.  Although FM4-64 successfully labels 
the vacuolar membrane within tlg2  cells after a 45 min chase, the labelled vacuole 
appears to be more fragmented than that of wild-type cells; a phenotype which has 
previously been described for tlg2  cells (Seron et al., 1998).  It should however be noted 
that tlg2  cells expressing either HA-Tlg2p or HA-Sx16 (but not those expressing HA-
Sx4) have a vacuolar morphology similar to that of wild-type cells (Figure 3.18). 
These data demonstrate a delayed trafficking of FM4-64 to the vacuolar membrane of 
tlg2  cells as well as describing the fragmented vacuolar morphology of these cells.  The 
replacement of Tlg2p or the introduction of Sx16 to tlg2  cells complements both of these 
phenotypes whereas Sx4 does not.  These findings support those previously found when 
investigating Ste3p endocytosis and hence support the hypothesis that Sx16 is a functional 
homologue of the yeast t-SNARE, Tlg2p. 
3.5.5 Immunofluorescence analysis of syntaxin localisation  
The syntaxins Tlg2p and Sx16 are both localised to the Golgi apparatus in yeast and 
mammalian cells, respectively (Holthuis et al., 1998, Simonsen et al., 1998, Tang et al., 
1998).  Tlg2p co-localises and co-fractionates with the yeast TGN markers Kex2p and 
DPAP A (Holthuis et al., 1998) and Sx16 co-localises with the mammalian Golgi marker 
β-COP and also partially co-localises with the TGN marker, the mannose-6-phosphate 
receptor (Simonsen et al., 1998).  If Sx16 and Tlg2p are functional homologues they will 
likely co-localise to the same region within yeast cells.  In order to investigate whether or 
not heterologously expressed Sx16 co-localises with endogenous Tlg2p 
immunofluorescene was used.  Wild-type cells (SF838-9D) transformed with the plasmids, 
pMAZ002 (HA-Sx16) or pMAZ006 (HA-Tlg2p) were grown in media (SD-ura-met) 
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then spheroplasted and permeabilised.  These cells were then attached to Poly-L-Lysine 
coated slides and double labelled with the primary antibodies, anti-Tlg2p and anti-HA, 
before incubating with the secondary antibodies, Alex Fluor® 594 donkey anti-rat (which 
binds to the primary anti-HA antibody and has an excitation/emission maxima of ~590 
nm/617 nm (orange-red)) and Alex Fluor® 488 donkey anti-rabbit (which binds to the 
primary anti-Tlg2p antibody and has excitation/emission maxima of ~495 nm/519 nm 
(cyan-green)).  The localisation of Tlg2p, HA-Tlg2p and HA-Sx16 was then visualised 
using confocal microscopy. 
 
Figure 3.19– Sx16 co-localises with both endogenous Tlg2p and HA-Tlg2p. 
Localisation of HA-Sx16 and HA-Tlg2p was compared to that of endogenous Tlg2p in     
wild-type cells transformed with pMAZ002 (HA-Sx16) or pMAZ006 (HA-Tlg2p).  
Transformants were grown in the selective media SD-ura-met containing   50 µM CuCl2, 
fixed and treated with the primary antibodies (anti-Tlg2p and anti-HA).  Rabbit anti-Tlg2p 
was visualised with the secondary antibody, Alex Fluor® 488 donkey anti-rabbit, and the rat 
anti-HA antibody visualised using Alex Fluor® 594 donkey anti-rat.  The images captured 
were overlaid to look for co-localisation of HA-Sx16 with endogenous Tlg2p (lower panel) 
and also the co-localisation of HA-Tlg2p with endogenous Tlg2p (upper panel). 
 
Figure 3.19 indicates that both HA-Sx16 and HA-Tlg2p co-localise with endogenous 
Tlg2p.  However further work is required to reduce the background staining detected with 
the anti-Tlg2p antibody possibly by introducing further washing or a higher dilution factor.  
Control experiments should also be performed to confirm that binding of the antibodies is 
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previously been shown, in this chapter, that Sx4 does not complement the function of 
Tlg2p.   
3.6 Discussion 
The experiments performed in this chapter support the hypothesis that Sx16 is a functional 
homologue of the yeast t-SNARE, Tlg2p.  This was demonstrated by the ability of the 
heterologous expressed splice variant of human Sx16, Sx16A, to complement for the loss 
of Tlg2p, by correcting the trafficking defects displayed in tlg2  mutant cells.  These 
include osmotic sensitivity (Figure 3.15), incorrect trafficking of vacuolar proteases such 
as CPY (Figure 3.16), impaired endocytosis (Figure 3.17 and 3.18) and vacuolar 
morphology (Figure 3.18).  Preliminary data also suggests that Sx16 co-localises with 
endogenous Tlg2p (Figure 3.19) however further work is required to provide conclusive 
evidence of this.    
The work presented in this chapter has been published in (Struthers et al, 2009) 
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4.1 Introduction 
 SNARE proteins represent the minimal machinery required for membrane fusion in vitro 
(Hu et al., 2003, Weber et al., 1998); however, it is clear that there are a number of other 
factors required in vivo.  A family of proteins, essential for SNARE-mediated membrane 
fusion in vivo, are the SM proteins.  Loss of function mutations in SM genes results in a 
block in membrane fusion as demonstrated in the organisms S. cerevisiae (Cowles et al., 
1994, Novick and Schekman, 1979, Ossig et al., 1991, Robinson et al., 1988, Wada et al., 
1990),  D. melanogaster (Harrison et al., 1994) and C. elegans (Hosono et al., 1992).  SM 
proteins are arched-shaped peripheral membrane proteins of approximately 60-70 kDa 
(Bracher and Weissenhorn, 2002, Jahn, 2000, Misura et al., 2000).  There are four SM 
proteins found in yeast (Vps45p, Vps33p, Sly1p, Sec1p) and seven found in mammalian 
cells (Munc18a, Munc18b, Munc18c, mVps45, mVps33a, mVps33b, Sly1) (Dulubova et 
al., 2002).  The primary effectors of SM proteins are syntaxins (Jahn, 2000, Toonen and 
Verhage, 2003). 
The SM protein Vps45p binds with high affinity to Tlg2p (Bryant and James, 2001) and 
regulates the entry of the syntaxin into SNARE complexes in vivo (Bryant and James, 
2001).  This chapter builds upon the findings presented in Chapter 3 that established Sx16 
as a functional homologue of Tlg2p, and demonstrates that Sx16 utilises Vps45p when 
expressed in yeast.   
4.2 Sx16 and Tlg2p share the same mode of interaction 
with the SM protein, Vps45p 
4.2.1 Yeast Vps45p binds Sx16 via Mode 2 binding 
The SM protein Vps45p binds with high affinity to Tlg2p (Bryant and James, 2001, Carpp 
et al., 2006, Dulubova et al., 2002), using a mode of binding analogous to that captured by 
the Sly1p/Sed5p crystal structure (Bracher and Weissenhorn, 2002) with the N-terminus of 
the syntaxin inserting into a putative hydrophobic pocket on the outer surface of the SM 
protein (Carpp et al., 2006, Dulubova et al., 2002). 
In Chapter 3, I provided evidence to demonstrate that Sx16 is a functional homologue of 
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utilises the same molecular machinery as Tlg2p when expressed in yeast.  Tlg2p-mediated 
membrane fusion requires the function of the SM protein Vps45p (Bryant and James, 
2001) which binds the syntaxin with high affinity using at least two modes of binding 
(Mode 2 and Mode 3; see Section 1.3.2) (Carpp et al., 2006, Dulubova et al., 2002).  
Consistent with its identification as a homologue of Tlg2p, Sx16 has previously been 
shown to bind to the mammalian homologue of Vps45p (mVps45) and also to yeast 
Vps45p in vitro (Dulubova et al., 2002).  The interaction between Vps45p/mVps45 and 
Sx16 can be abolished through mutation of the N-terminal peptide of Sx16 (Dulubova et 
al., 2002).  This suggests that Sx16, like Tlg2p, utilises the putative hydrophobic pocket 
identified in domain 1 of Vps45p (Carpp et al., 2006).  Binding in a mode analogous to the 
‘pocket-mode’ of binding (Mode 2) captured in the Sly1p/Sed5p crystal structure, where 
the N-terminal peptide of the syntaxin inserts into a hydrophobic pocket on the outer 
surface of the SM protein (Bracher and Weissenhorn, 2002).  This interaction can also be 
abolished through a mutation in the SM protein, Vps45p (L117R) which disrupts the 
hydrophobic pocket by introducing an arginine residue that is not only larger than leucine, 
but is also positively charged (Carpp et al., 2006).  To ask whether this mutation also 
abolishes the binding of Vps45p to Sx16, a pull-down approach using proteins produced in 
E. coli was undertaken.  
Plasmids pCOG025 (Carpp et al., 2006), pALA001 and pFB09/1 encoding the cytosolic 
domains of either Tlg2p, Sx16 or Sx4 fused in-frame to two IgG-binding domains from 
Staphylococcus aureus PrA at their C-terminus (Tlg2-PrA, Sx16-PrA and Sx4-PrA, 
respectively) were used to transform BL21 Star™ (DE3) cells (an E. coli strain which is 
utilised to improve expression of proteins in a T7 promoter based expression system 
(Invitrogen)).  5 ml of the transformants were grown to mid log-phase in 500 ml of Terrific 
Broth containing ampicillin (100 µg/ml).  Protein expression was induced by the addition 
of IPTG (at a final concentration of 1 mM) and the cultures returned to 37°C for 4 hours 
with continuous shaking.  Cells were harvested by centrifugation and subsequently lysed 
by sonication (see Section 2.2.20 for details).  The proteins of interest were then purified 
on IgG Sepharose and the bound proteins analysed using SDS-PAGE (Figure 4.1).  
The ability of these proteins to capture Vps45p, provided by yeast lysates, was then 
investigated.  This was achieved by incubating the immobilised PrA-fusion proteins with 
whole cell lysates prepared from equal numbers (15 OD600 equivalents) of NOzY1 (SF838-
9D vps45 ) cells expressing HA-tagged versions of either wild-type Vps45p or a version 
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(HA-Vps45pL117R), respectively (Carpp et al., 2006).  As a control, the SM protein, 
Munc18c, was also incorporated in the pull-down experiment.  Munc18c binds specifically 
to Sx4 and was included as a means of checking that the Sx4-PrA fusion protein had folded 
properly.  The ability of Sx4-PrA to bind to Munc18c, but not Vps45p would also indicate 
that the interaction between Vps45p and Tlg2p/Sx16 is specific.  Purified Munc18c was 
kindly donated by Dr Veronica Aran (University of Glasgow, UK).  Following incubation 
with the purified SM proteins the bound material was washed and eluted (as described in 
Section 2.2.21.1).  Proteins contained in the eluates were separated using SDS-PAGE and 
subsequently immunoblotted with antibodies specific to the HA-tag and Munc18c.   
 
Figure 4.1 – Monomeric Sx16 and Tlg2p both interact with yeast Vps45p via Mode 2 binding. 
Equal amounts of each of the immobilised PrA-fusion proteins (Tlg2p-PrA, Sx16-PrA and 
Sx4-PrA) were incubated overnight at 4ºC with whole cell lysates prepared from 15 OD600 
equivalents of NOzY1 (SF838-9D vps45∆) cells transformed with either pCOG070 (wild-type 
HA-Vps45p) or pCOG071 (HA-Vps45pL117R).  As a control equal amounts of the 
immobilised PrA-fusion proteins (Tlg2p-PrA, Sx16-PrA and Sx4-PrA) were also incubated 
with purified Munc18c (kindly provided by Dr Veronica Aran, University of Glasgow, UK).  
Proteins contained in the eluates were separated using SDS-PAGE prior to immunoblot 
analysis with antibodies specific to the HA-tag and Munc18c.  10% of the yeast lysate and 
2% of the purified Munc18c were also included in the immunoblot analysis.  Please note that 
this work was done in collaboration with Dr Scott Shanks (University of Glasgow, UK). 
 
Figure 4.1 clearly shows that both C-terminally PrA-tagged cytosolic versions of Tlg2p 
and Sx16 (Tlg2-PrA and Sx16-PrA) efficiently capture HA-tagged wild-type Vps45p from 
the yeast lysate, whereas C-terminally PrA-tagged Sx4 (Sx4-PrA) does not.  In contrast 
neither Tlg2p nor Sx16 bind the HA-tagged pocket-filled mutant version of Vps45p 
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mammalian Sx16 interact with yeast Vps45p (Dulubova et al., 2002), and indicate that this 
is via the same mode of binding; Mode 2.  Although Sx4 does not associate with either 
wild-type or mutant Vps45p it is capable of associating with its cognate mammalian SM 
protein Munc18c.  In contrast neither Sx16 nor Tlg2p interact with mammalian Munc18c.  
This demonstrates the specificity between SM protein/syntaxin pairing and further supports 
the finding that Sx16 is a functional homologue of Tlg2p. 
4.2.2 Vps45p binds Sx16-containing cis-SNARE complexes in 
yeast 
Originally it was thought that SM proteins used distinct modes of binding to interact with 
their cognate syntaxins (reviewed in (Burgoyne and Morgan, 2007, Toonen and Verhage, 
2003)).  For example, the SM protein Munc18a was thought to interact with its cognate 
syntaxin, Sx1a, only via Mode 1 binding (Hata et al., 1993, Pevsner et al., 1994b).  
However it is now becoming increasingly apparent that SM proteins can utilise multiple 
modes of binding to interact with their cognate syntaxins.  For example, the SM protein, 
Munc18a can interact with Sx1a using both Mode 1 and Mode 2 binding (Burkhardt et al., 
2008, Dulubova et al., 2007, Rickman et al., 2007, Shen et al., 2007). 
Vps45p also uses two different modes of binding to interact with its cognate syntaxin, 
Tlg2p, at two different stages in the SNARE complex assembly/disassembly cycle (Bryant 
and James, 2003, Carpp et al., 2006).  Vps45p not only binds to the monomeric Tlg2p 
using Mode 2 binding but can also bind to assembled SNARE complexes using Mode 3 
binding; both of these interactions can be detected in vivo and in vitro (Bryant and James, 
2003, Carpp et al., 2006, Dulubova et al., 2002).  cis-SNARE complexes can be 
accumulated by blocking the action of the AAA-ATPase that is ordinarily responsible for 
their dissociation (Rouiller et al., 2002).  Thus, yeast cells harbouring the temperature 
sensitive allele of SEC18 (sec18-1) accumulate cis-SNARE complexes following 
incubation at the restrictive temperature of 37°C (Grote et al., 2000).  
In order to determine whether Vps45p also associates with Sx16-containing cis-SNARE 
complexes, I used sec18-1 cells to accumulate cis-SNARE complexes containing Sx16 in 
place of Tlg2p.  This was achieved by expressing Sx16 in yeast cells harbouring the  
sec18-1 allele, but lacking endogenous Tlg2p (LCY011; SEY5186 tlg2 , sec18-1).  
LCY011 cells transformed with the plasmids pNB701 (empty vector), pMAZ002 
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selective media, SD-ura-met, containing 50  M CuCl2 for one generation (OD600 of 0.4-
0.6).  At this stage, cells were either kept at 25°C or transferred to the restrictive 
temperature of 37°C, for 90 mins.  The mutant Sec18p is no longer functional at 37ºC, 
resulting in an accumulation of cis-SNARE complexes in these cells.  Immunoprecipitation 
from yeast cell lysates (prepared from equal numbers of cells, 40 OD600 equivalents) was 
performed at 4ºC for 2 hours using an antibody specific to the HA-tag followed by an hour 
incubation with PrA agarose.  Proteins contained in the immunoprecipitates were separated 
by SDS-PAGE prior to immunoblot analysis with antibodies specific to Vps45p and the 
HA-tag.  It should be noted that the HA-specific antibodies used for immunoprecipitation 
and immunoblot analysis were raised in different hosts, rat and mouse respectively, to 
prevent the cross-reaction of the light and heavy chains of the antibodies, which would 
make analysis of the results problematic.   
 
Figure 4.2 – Sx16 and Tlg2p both interact with yeast Vps45p when present in the cis-SNARE 
complexes. 
LCY011 (SEY5186 tlg2∆, sec18-1) cells transformed with pNB701 (empty vector), pMAZ002 
(encoding HA-Sx16) or pMAZ006 (encoding HA-Tlg2p) were grown at 25ºC for one 
generation (OD600 of 0.4-0.6) in the selective media, SD-ura-met, containing 50 M CuCl2.  
Cultures were either incubated at the non-permissive temperature (37ºC) or kept at the 
permissive temperature (25ºC) for a further 90 mins.  Immunoprecipitation of yeast cell 
lysates (prepared from equal numbers of these cells (40 OD600 equivalents)) was performed 
at 4ºC for 2 hours in the presence of 10 µl of antibody specific to the HA-tag, followed by an 
hour incubation in the presence of 50  l of settled PrA agarose.  Following extensive 
washes (see Section 2.2.18) the agarose was eluted and the proteins contained in the 
eluates anlysed using SDS-PAGE and immunoblot analysis with antibodies specific to 
Vps45p and the HA-tag. 
 
As previously observed (Bryant and James, 2003), Figure 4.2 demonstrates that incubation 
of sec18-1 cells at the restrictive temperature leads to an increased association between 
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of Vps45p with the accumulated cis-SNARE complexes (Bryant and James, 2003).  Figure 
4.2 also shows a similar increase of the association between Vps45p and Sx16 under these 
same conditions (compare lanes 5 and 6; Figure 4.2).  Since this experiment was performed 
by immunoprecipitating Tlg2p/Sx16, rather than Tlg1p (as in (Bryant and James, 2003)) it 
is important to note that the co-precipitated Vps45p also represents that bound to 
monomeric Tlg2p/Sx16.  Nevertheless, there is a marked increase in the amount of co-
precipitated Vps45p upon the accumulation of cis-SNARE complexes indicating that, like 
Tlg2p-containing cis-SNARE complexes, Sx16-containing cis-SNARE complexes bind 
Vps45p in vivo.  
4.3 Levels of Tlg2p and Sx16 are greatly reduced in yeast 
cells lacking Vps45p 
4.3.1 Levels of Tlg2p are greatly reduced in yeast cells lacking 
Vps45p 
It has previously been reported that the removal of the SM protein, Vps45p from the cell, 
results in the reduction of cellular levels of the syntaxin, Tlg2p, by greater than 90% when 
compared to wild-type cells (Bryant and James, 2001).  To confirm this I analysed the 
levels of Tlg2p in wild-type (SF838-9D) and vps45  (NOzY1; SF838-9D vps45 ) cells. 
This was achieved by preparing whole cell lysates from equal numbers (1 OD600 
equivalents) of wild-type (SF838-9D) and vps45  (NOzY1; SF838-9D vps45 ) cells 
grown to mid-log phase in the rich media, YPD.  Immunoblot analysis was used to assess 
the levels of Tlg2p, and also the other individual components of the Tlg2p-containing 
SNARE complex, present in the lysates. Marion S. Struthers, 2009    Chapter 4, 110 
 
 
Figure 4.3 – Both the t-SNARE, Tlg2p and the v-SNARE, Snc2p are greatly reduced in 
vps45∆ cells. 
Whole cell lysates prepared from equal numbers of wild-type (SF838-9D) and vps45∆ 
(NOzY1; SF838-9D vps45∆) cells (1 OD600 equivalents) grown to mid-log phase in the rich 
media, YPD, were analysed using immunoblot analysis with antibodies specific to Vps45p, 
Tlg2p, Tlg1p, Vti1p and Snc2p. 
 
Figure 4.3 confirms that endogenous levels of Tlg2p are greatly reduced in the absence of 
the SM protein, Vps45p (Bryant and James, 2001).  In contrast the levels of the t-SNAREs, 
Tlg1p and Vti1p, are unaffected.  It is interesting to note that the levels of the v-SNARE, 
Snc2p, are also reduced in cells lacking Vps45p.  As well as binding Tlg2p, Vps45p also 
binds directly to Snc2p (Carpp et al., 2006).  However no interaction between Vps45p and 
the t-SNAREs, Tlg1p or Vti1p, can be detected (Carpp et al., 2006).  These results suggest 
that the SM protein, Vps45p, plays an important role in regulating the levels of the 
syntaxin, Tlg2p, and the v-SNARE, Snc2p, within the cell.     
4.3.2 Levels of Sx16 are also greatly reduced in yeast cells 
lacking Vps45p 
Considering the results already presented in this chapter which demonstrate that Sx16 
interacts with Vps45p in vitro (Figure 4.1) and in vivo (Figure 4.2), I wondered if the levels 
of Sx16, like Tlg2p, may also be reduced in the absence of Vps45p.  In order to investigate 
this, I compared the levels of Tlg2p, Sx16 and Sx4 in wild-type and vps45  cells.  This 
was achieved by transforming wild-type (RPY10) and vps45  (NOzY2; RPY10 vps45 ) 
cells with the plasmids pNB701 (empty vector), pMAZ002 (encoding HA-Sx16), 
pMAZ006 (encoding HA-Tlg2p) or pMAZ007 (encoding HA-Sx4).  Transformants were 
grown to mid-log phase in the selective media, SD-ura-met, containing 50 µM CuCl2 to 
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these transformants (1 OD600 equivalents) were analysed using immunoblot analysis with 
an antibody specific to the HA-tag. 
 
Figure 4.4 – Sx16 and Tlg2p are both degraded in vps45∆ cells. 
Wild-type (VPS45+) and vps45∆ (VPS45∆) cells transformed with the plasmids, pNB701 
(empty vector (-)), pMAZ002 (encoding HA-Sx16), pMAZ006 (encoding HA-Tlg2p) or 
pMAZ007 (encoding HA-Sx4) were grown to mid-log phase in selective media, SD-ura-met, 
containing 50µM CuCl2.  Whole cell lysates prepared from equal numbers of these 
transformants (1 OD600 equivalents) were analysed using immunoblot analysis with an 
antibody specific to the HA-tag.  The levels of the vacuolar ATPase, Vph1p, were also 
assessed using immunoblot analysis to control for equal loading. 
 
Cells lacking endogenous Vps45p (VPS45 ) expressing either HA-Tlg2p or HA-Sx16 
have a reduced level of syntaxin when compared to wild-type cells (VPS45+) expressing 
either HA-Tlg2p or HA-Sx16 (Figure 4.4).  However cellular levels of Sx4, which does not 
bind Vps45p (Figure 4.1), remain unaffected by the presence/absence of Vps45p.  These 
results suggest that Sx16 is regulated in a manner similar to that of Tlg2p and further 
supports the hypothesis that Sx16 is a functional homologue of Tlg2p. 
4.4 A truncated version of Tlg2p/Sx16 can bypass the 
requirement for Vps45p 
It has previously been shown that, in contrast to the full-length syntaxin, a version of Tlg2p 
lacking its N-terminal 230 residues (Tlg2p∆Habc) is protected from downregulation in 
cells lacking Vps45p and is able to form SNARE complexes under these conditions 
(Bryant and James, 2001).  Expression of this mutant version of Tlg2p suppresses 
trafficking defects displayed by yeast cells lacking Vps45p (vps45 ) (Bryant and James, 
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carboxypeptidase Y (CPY) (Cowles et al., 1994, Piper et al., 1994).  In wild-type cells, 
proCPY (p2) is trafficked from the TGN to the vacuole where it is proteolytically 
processed into its active, mature form (m).  vps45  mutant cells secrete ~75-85% of their 
CPY into the extracellular media (Cowles et al., 1994, Piper et al., 1994).  The CPY which 
remains intracellular in vps45  mutant cells is in the p2 form indicating that it has been 
unable to reach the proteolytically active vacuole (Cowles et al., 1994, Piper et al., 1994).  
Expression of Tlg2p∆Habc in vps45∆ cells results in the internal CPY being processed to 
its mature form, demonstrating that the SNARE complexes formed by this mutant in the 
absence of Vps45p are functional (Bryant and James, 2001).  As a means to investigate if a 
similar version of Sx16, lacking its Habc domain, could also suppress the trafficking 
defects of vps45  mutant cells, the plasmids pSGS043 (encoding HA-Tlg2p Habc) and 
pSGS044 (encoding HA-Sx16 Habc) were generated (a detailed description of how these 
plasmids were constructed is give in Section 2.2.5).  A schematic diagram representing the 
differences between full-length and truncated version of the syntaxins is shown below. 
 
Figure 4.5 - A schematic diagram of full-length and truncated versions of syntaxins, Tlg2p 
(HA-Tlg2p∆Habc) and Sx16 (HA-Sx16∆Habc).   
The abbreviations in this diagram represent the HA-tag (HA), the Habc domain (Habc), the 
SNARE domain (SNARE) and the Transmembrane domain (TM).   
 
In order to investigate whether or not this truncated version of Sx16, like Tlg2p, could 
bypass the requirement of Vps45p, maturation of CPY was monitored in NOzY2 (RPY10 
vps45 ) cells transformed with the plasmids, pVT102u (empty vector), pSGS043 
(encoding HA-Tlg2p Habc) or pSGS044 (encoding HA-Sx16 Habc).  Equal numbers of 
these cells (1 OD600 equivalent) grown to mid-log phase were labelled with 
[
35S]cysteine/methionine for 10 mins at 30ºC prior to the addition of an excess of 
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cysteine/methionine and again after 30 mins at 30ºC.  CPY was immunoprecipitated from 
intracellular (I) and extracellular (E) fractions at the times indicated (0 and 30 mins) and 
the samples analysed using SDS-PAGE and fluorography (see Section 2.2.19).  This work 
was done in collaboration with Dr. Nia J. Bryant (University of Glasgow, UK). 
 
Figure 4.6 – Expression of either truncated HA-Tlg2p or HA-Sx16 lacking the Habc domain 
results in the maturation of CPY in vps45∆ cells. 
NOzY2 (RPY10 vps45∆) cells transformed with pVT102u (empty vector), pSGS043 (encoding 
HA-Tlg2p∆Habc) or pSGS044 (encoding HA-Sx16∆Habc) were grown to mid-log phase in the 
selective media SD-ura-met.  Equal numbers of these cells (1 OD600 equivalent) were then 
labelled with [
35S]cysteine/methionine for 10 mins at 30ºC prior to the addition of an excess 
of unlabelled cysteine/methionine.  Cells were collected immediately after the addition of 
cysteine/methionine and again after 30 mins at 30ºC.  CPY was immunoprecipitated from 
intracellular (I) and extracellular (E) fractions at the time-points indicated (0 and 30 mins).  
The resultant samples were analysed using SDS-PAGE and fluorography with the water-
soluble fluor Sodium Salicylate.   
 
As previously described CPY trafficking in vps45  cells is greatly impaired with ~75-85% 
of newly synthesised CPY being incorrectly secreted from the cell (Cowles et al., 1994, 
Piper et al., 1994), this is also reflected in these findings (Figure 4.6, compare lanes 1 and 2 
and lanes 3 and 4).  The fraction of CPY which accumulates intracellularly (I) is 
predominately in the p2 form, however upon the expression of truncated versions of the 
syntaxins Tlg2p (Tlg2p Habc) or Sx16 (Sx16 Habc) CPY successfully reaches 
maturation in the vacuole (Figure 4.6, lanes 5 and 7; 9 and 11, respectively). 
4.5 Discussion 
This chapter builds upon those findings presented in Chapter 3, which established Sx16 as 
a functional homologue of Tlg2p, by demonstrating that Sx16 utilises Vps45p when 
expressed in yeast.  This was primarily demonstrated by the ability of Vps45p to interact 
with both monomeric Tlg2p and Sx16 in vitro using Mode 2 binding (Figure 4.1).  
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in vivo (Figure 4.2).  Levels of Sx16, like Tlg2p, are also depleted in cells lacking Vps45p 
(Figure 4.4), further establishing the relationship between Sx16 and Vps45p.  Lastly it was 
demonstrated that both a truncated version of Tlg2p (Tlg2p∆Habc) and Sx16 (Sx16∆Habc) 
can bypass the requirement of the SM protein, Vps45p, and enable the vacuolar delivery of 
CPY (Figure 4.6).  This finding supports the hypothesis that one function of Vps45p is to 
activate the syntaxin for entry into SNARE complexes by facilitating a transition from a 
closed to an open conformation (Bryant and James, 2001). 
The following section further discusses the findings presented in Figure 4.6, which show 
that a truncated version of Tlg2p (HA-Tlg2p Habc) and Sx16 (HA-Sx16 Habc) can 
bypass the requirement of the SM protein, Vps45p.  Truncation of the Habc domain from 
Tlg2p and Sx16 prevents these syntaxins from adopting a closed conformation analogous 
to that of Sx1a (Dulubova et al., 1999, Misura et al., 2000).  The SM protein, Munc18a is 
required for the transition of Sx1a from a closed conformation to an open conformation 
(Dulubova et al., 1999, Misura et al., 2000).  Hence the data presented here (Figure 4.6) 
and that previously presented (Bryant and James, 2001) would support a model in which 
Vps45p is required for the transition of Tlg2p and Sx16 from a closed conformation to an 
open conformation that is compatible with SNARE complex assembly.  However this is 
contradictory to NMR data which indicates that a bacterially produced version of Tlg2p is 
unlikely to adopt a closed conformation (Dulubova et al., 2002).  It should be noted that 
the construct used in these studies only spans residues 60-283 of Tlg2p and thus lacks 24 
of the 54 residues that make up the SNARE motif (Dulubova et al., 2002).  The authors 
chose this construct as it contains sequence involved in forming a closed conformation of 
Sx1a (Dulubova et al., 1999, Misura et al., 2000) and Sso1p (Fiebig et al., 1999, Munson et 
al., 2000).  However, it is possible that this construct lacks residues required to stabilise a 
closed conformation of Tlg2p.   
In order to explain how a truncated version of Tlg2p, Tlg2p∆Habc, forms functional 
SNARE complexes in the absence of Vps45p (Bryant and James, 2001) in light of their 
conclusion that Tlg2p does not adopt a closed conformation, Dulubova and colleagues 
suggest that some inhibitory factor might bind to the N-terminal portion of Tlg2p (possibly 
the Habc domain) and prevent SNARE complex formation (Dulubova et al., 2002).  They 
postulated that Vps45p could be involved in releasing such an inhibition, and thus promote 
SNARE complex assembly.  The truncated version of Tlg2p (Tlg2p∆Habc) would not be 
able to bind this inhibitory factor and thus would not be subject to the same regulation by 
Vps45p (Dulubova et al., 2002).   Marion S. Struthers, 2009    Chapter 4, 115 
 
It is apparent that two different interpretations of the data presented in Figure 4.6 and 
(Bryant and James, 2001) exist.  Although both of these interpretations agree that Vps45p 
promotes Tlg2p SNARE complex assembly, our group suggests that this is through the 
transition of Tlg2p from a closed conformation to an open conformation (Bryant and 
James, 2001) whereas Dulubova and colleagues suggest that Vps45p acts by releasing 
some inhibitory factor bound to the N-terminal portion of Tlg2p.  In order to distinguish 
between these two different interpretations we further investigated the ability of Vps45p to 
promote SNARE complex formation by promoting the transition of Tlg2p from a closed to 
an open conformation.  The following work (published in (Struthers et al., 2009)) was 
performed by Chris MacDonald, a PhD student in the lab. 
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Figure 4.7 – Data taken from (Struthers et al., 2009) showing that SNARE-complex assembly 
is stimulated by both the deletion of the Habc domain from Tlg2p and also by Vps45p.  
(A) The ability of Tlg2p-GST, or a version lacking the Habc domain (Tlg2p∆Habc-GST), to 
form SNARE complexes in vitro was assessed by incubating the GST fusions (purified from 
E. coli and immobolised on glutathione-Sepharose) with tenfold molar excesses of His6-
tagged versions of Snc2p and Vti1p, and untagged Sx8-Tlg1p chimera.  After incubation for 
20 or 120 mins at 4ºC with continuous mixing.  Sepharose beads were harvested by 
centrifugation at 1000g for 1 minute and washed extensively with binding buffer.  
Immunoblot analysis was used to assess the amount of Snc2p bound to the Tlg2p-GST 
fusions (lower panel; a sample of the input cognate SNAREs was included in this analysis).  
Upper panel shows a Coomassie-stained gel of the Tlg2p-GST fusions that were incubated 
either with (+) or without (-) the cognate SNARE-binding proteins.  (B)  The effect of adding 
purified His6-tagged Vps45p on the ability of Tlg2p-GST and Tlg2p∆Habc-GST to form 
SNARE complexes in vitro during a 20 minute incubation was assessed by performing the 
experiments presented in A in the absence or presence of a tenfold molar excess of His6-
tagged Vps45p (over Tlg2p-GST and Tlg2p∆Habc-GST).   
 
Chris used GST pull-down experiments to investigate the ability of full-length and 
truncated versions of Tlg2p to form SNARE complexes (Struthers et al., 2009).  SNARE 
complex formation is assessed by the levels of Snc2p binding to full-length Tlg2p and 
truncated Tlg2p (Tlg2p Habc) after a 20 min and 120 min incubation in the presence of 
the SNARE components, Vti1p and the Sx8-Tlg1p chimera.  After 20 mins, it is clear that 
the truncated version of Tlg2p, Tlg2p Habc, has formed more SNARE complexes than 
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similar amounts of SNARE complexes were formed by both truncated Tlg2p 
(Tlg2p Habc) and full-length Tlg2p (Figure 4.7A).  These results indicate that Habc 
domain of Tlg2p inhibits the formation of SNARE complexes in vitro.  To investigate 
whether or not Vps45p could alleviate this inhibition, Chris added purified Vps45p to his 
pull-down experiments.  The addition of Vps45p resulted in similar amounts of Snc2p 
binding to both Tlg2p Habc and Tlg2p after a 20 min incubation (Figure 4.7B).  Hence 
Vps45p does alleviate the inhibition caused by the Habc domain of Tlg2p.   
It should be noted that these in vitro pull-down experiments used only bacterially produced 
proteins, hence the possibility of an inhibitory factor found in vivo binding to Tlg2p and 
preventing SNARE complex formation, could be ruled out.  A more likely explanation 
would be that full-length Tlg2p adopts a closed conformation which requires the action of 
Vps45p to allow its transition to an open conformation compatible with SNARE complex 
assembly.   
In addition to these findings (Figures 4.6 and 4.7; (Bryant and James, 2001)) it has recently 
been demonstrated using isothermal titration calorimetry (ITC) that fragments of Sx16 
(residues 1-302, 1-279, 1-265) greater than the N-terminal peptide (residues 1-27) can bind 
mammalian Vps45 with a higher affinity that the N-terminal peptide alone (Burkhardt et 
al., 2008).  The authors also identify an interaction between the C-terminal portion of the 
SNARE domain of Sx16 and Vps45p which is thought to be equivalent to the interaction 
between Sx1a and the central cavity of Munc18a (Burkhardt et al., 2008).  Consistent with 
the finding that Tlg2p and Sx16 are functional homologues this would suggest that the 
Tlg2p construct (60-283) used in NMR studies (Dulubova et al., 2002) was lacking 
residues required to stabilise a closed conformation of Tlg2p (Dulubova et al., 2002).   
In conclusion these results support our model that Vps45p is required for the transition of 
Tlg2p (and Sx16) from a closed conformation to an open conformation that is compatible 
with SNARE complex assembly.  
 
 
 
 
 
 
 
Chapter 5 – Regulation of Tlg2p levels in the cell 
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5.1 Introduction 
Cells lacking Vps45p (vps45 ) have reduced levels of Tlg2p (Figure 4.3 and (Bryant and 
James, 2001)).  vps45  cells synthesise Tlg2p to similar levels as wild-type cells, but the 
protein is turned over much more rapidly (t½ of Tlg2p is 20 mins in vps45  cells, compared 
to > 2 hours in wild-type cells) resulting in low cellular levels of the syntaxin (Bryant and 
James, 2001).  In order to further understand the mechanism by which Tlg2p is degraded in 
vps45  cells, I set out to investigate the regulation of steady-state levels of Tlg2p in wild-
type and vps45  cells. 
This chapter documents the vacuolar degradation of Tlg2p in wild-type cells; the 
ubiquitination and palmitoylation of Tlg2p in wild-type and vps45  cells, and also several 
attempts to identify the specific lysine(s) that is/are ubiquitinated.   
5.2 Steady-state levels of Tlg2p are mediated by the 
vacuole 
At steady-state levels, Tlg2p localises to the yeast TGN, co-localising and co-fractionating 
with the TGN markers Kex2p and DPAP A, respectively (Holthuis et al., 1998).  Proteins 
localise to the yeast TGN by continually cycling through the proteolytically active 
endosomal system (Bryant and Stevens, 1997, Kornfeld, 1992, Piper et al., 1995), and thus 
it seemed plausible that vacuolar proteases may regulate the cellular levels of Tlg2p, just as 
the ER-associated degradative pathways function to regulate cellular levels of the ER-
localised t-SNARE, Ufe1p (Braun and Jentsch, 2007).  In order to investigate this I used 
immunoblot analysis to assess the steady-state levels of Tlg2p in wild-type cells containing 
vacuolar proteases (RPY10 and SEY6210) and those harbouring the pep4-3 mutation 
(SF838-9D and RMY8).  Mutation of the PEP4 gene results in the loss of vacuolar 
activity; PEP4 encodes an aspartyl protease that is required to activate vacuolar hydrolases 
(Woolford et al., 1986).     Marion S. Struthers, 2009    Chapter 5, 120 
 
 
Figure 5.1 – Cellular levels of Tlg2p are elevated in cells lacking vacuolar activity. 
Immunoblot analysis was used to compare the steady-state levels of Tlg2p in wild-type cells 
containing active vacuolar proteases (RPY10 and SEY6210) and those lacking vacuolar 
proteases (SF838-9D and RMY8). (a)  Proteins contained within whole cell lysates, prepared 
from 1 OD600 equivalents, were separated using SDS-PAGE prior to immunoblot analysis 
with an antiserum specific to Tlg2p.  The same filter was probed for Pgk1p to control for 
equal loading. b)  The levels of Tlg2p detected by immunoblot analysis were quantified 
using the computer software, Image Processing and Analysis in Java (Image J) and 
normalised to the loading control Pgk1p.  The ratio of Tlg2p in cells lacking active vacuolar 
proteases (pep4-3) and those containing vacuolar proteases (PEP4) was then calculated 
(pep4-3/PEP4).  Error bars are ‘+’ and ‘-‘ standard deviations of the mean, n=3.      
 
Figure 5.1 shows that steady-state levels of Tlg2p in wild-type cells lacking active vacuolar 
proteases are increased approximately 2 fold when compared to their isogenic strains 
containing active vacuolar protease (2.03 ± 0.43 fold greater in SF838-9D than RPY10 and 
2.14 ± 0.18 fold greater in RMY8 than SEY6210).  These data indicate that the vacuole 
does indeed play a role in regulating the levels of Tlg2p in wild-type cells.  
To circumvent problems that arose with detecting endogenous Tlg2p using specific 
antiserum (which was in limited supply and not wholly reliable), the possibility of using 
the HA-tagged version of Tlg2p produced from pMAZ006 (described in Chapter 3) to 
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investigate if HA-Tlg2p (expressed from pMAZ006) was regulated in a similar manner to 
endogenous Tlg2p, i.e. if it would be degraded by vacuolar proteases.  Wild-type cells 
containing active vacuolar proteases (RPY10 and SEY6210) and those harbouring the 
pep4-3 mutation (SF838-9D and RMY8) were transformed with either pNB701 (empty 
vector) or pMAZ006 (encoding HA-Tlg2p).  Expression from the CUP1 promoter was 
induced by the addition of 50 µM CuCl2 to the selective media, SD-ura-met, in which the 
transformants were grown.  Proteins contained within whole cell lysates, prepared from 
equal numbers of these transformants (1 OD600 equivalents), were separated by SDS-
PAGE prior to immunoblot analysis with an antibody specific to the HA-tag. 
 
Figure 5.2 – Levels of HA-Tlg2p (expressed from pMAZ006) are elevated in wild-type cells 
lacking active vacuolar proteases. 
Two independent yeast strains RPY10 and SEY6210 (both PEP4) and their isogenic pep4-3 
strains SF838-9D and RMY8, respectively, were transformed with either pNB701 (empty 
vector) or pMAZ006 (encoding HA-Tlg2p) and grown on the selective media, SD-ura-met, 
containing 50 µM CuCl2. Levels of HA-Tlg2p present in whole cell lysates prepared from 
equal numbers of these transformants (1 OD600 equivalents) were assessed using 
immunoblot analysis with an antibody specific to the HA-tag. 
 
Figure 5.2 demonstrates that levels of HA-Tlg2p expressed from pMAZ006 are regulated 
by vacuolar proteases in a similar manner to that observed for endogenous Tlg2p (Figure 
5.1).  A HA-immunoreactive band of approximately 37 kDa (**) is present in lysates 
prepared from HA-Tlg2p expressing cells containing vacuolar activity: this is likely a 
proteolytic product of HA-Tlg2p generated by vacuolar enzymes.  It should also be noted a 
larger PEP4-independent degradation product (*) is present in lysates prepared from cells 
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lacking vacuolar activity) suggesting that (**) is generated from (*) (this is discussed in 
more detail later). 
The finding that steady-state levels of Tlg2p are regulated by the vacuole (Figures 5.1 and 
5.2) was intriguing since it has previously been reported that Tlg2p is degraded by the 
proteasome in vps45  cells (Bryant and James, 2001).  This conclusion was reached since, 
in contrast to vps45  cells containing proteasomal activity, vps45  cells in which 
proteasomal activity has been abolished (through mutation of either the catalytic subunits, 
Pre1p and Pre2p (pre1-1, pre2-2) or the regulatory domain, Cim3p (cim3-1) (Heinemeyer 
et al., 1993, Heinemeyer et al., 1991, Ghislain et al., 1993)) contain levels of Tlg2p that 
can easily be detected through immunoblot analysis (Bryant and James, 2001).  
Inactivation of vacuolar proteases through the pep4-3 mutation, on the other hand, did not 
restore Tlg2p levels in vps45  cells (Bryant and James, 2001).   
Considering the data presented in Figures 5.1 and 5.2 and that from (Bryant and James, 
2001), it would appear that both the proteasome and the vacuole are involved in mediating 
the levels of Tlg2p within the cell.  One possibility is that more Tlg2p becomes exposed to 
vacuolar proteases in wild-type cells compared to vps45  cells, as Vps45p is required to 
allow the efficient delivery of proteins to the proteolytically active endosomal 
compartment (Bryant and Stevens, 1998, Cowles et al., 1994, Piper et al., 1994).  Hence, 
the degradation of Tlg2p in wild-type cells would be dependent on both the vacuole and 
the proteasome, whereas the proteasome would be responsible for the degradation of Tlg2p 
in cells lacking Vps45p.  This model would explain why levels of Tlg2p are not rescued in 
vps45  pep4-3 cells (Bryant and James, 2001).  
In order to investigate the possibility that Tlg2p does not enter the proteolytically active 
endosomal system in the absence of Vps45p, I decided to increase the production of HA-
Tlg2p from pMAZ006 to a level at which it was still detectable in vps45  cells. As 
described in Chapter 3, expression of HA-Tlg2p from pMAZ006 is under the control of the 
regulatable CUP1 promoter, and so by increasing the concentration of Cu
2+ ions in the 
growth media it is possible to increase the production of HA-Tlg2p from pMAZ006.  A 
copper concentration of 100 µM (twice that used in the complementation experiments 
discussed in Chapter 3) was selected.  Increasing the production of HA-Tlg2p in vps45  
cells would enabled me to investigate whether or not HA-Tlg2p is subject to vacuolar 
degradation in the absence of Vps45p, as it is in the presence of the SM protein (Figures 
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product is detectable in wild-type cells containing active vacuolar proteases, expressing 
HA-Tlg2p (** in Figure 5.2).  If Tlg2p does not enter the proteolytically active endosomal 
system in the absence of Vps45p this PEP4-dependent Tlg2p degradation product should 
be absent or at least reduced.  Two independent strains containing active vacuolar 
proteases (RPY10 and SEY6210) and their isogenic vps45  derivatives (NOzY2 and 
LCY007, respectively) were transformed with either pNB701 (empty vector) or pMAZ006 
(encoding HA-Tlg2p).  Expression from the CUP1 promoter was induced by the addition 
of 100 µM CuCl2 to the selective media in which the transformants were grown.  Proteins 
contained within lysates, prepared from equal numbers of these cells (1 OD600 equivalents), 
were separated using SDS-PAGE prior to performing immunoblot analysis with an 
antibody specific to the HA-tag. 
 
Figure 5.3 – A comparison of steady-state levels of HA-Tlg2p in wild-type (WT) and vps45∆ 
cells containing active vacuolar proteases. 
Two independent yeast strains A) RPY10 and B) SEY6210 (both PEP4) and their isogenic 
vps45∆ derivatives NOzY2 and LCY007, respectively, were transformed with either pNB701 
(empty vector) or pMAZ006 (encoding HA-Tlg2p).  Transformants were grown on the 
selective media, SD-ura-met containing 100  M CuCl2.  Proteins contained within whole cell 
lysates, prepared from equal numbers of these transformants (1 OD600 equivalents), were 
separated by SDS-PAGE prior to immunoblot analysis with an antibody specific to the HA-
tag (and the SNARE protein, Vti1p, to control for equal loading).   
 
It is evident from Figure 5.3 that a smaller fraction of HA-Tlg2p is processed by vacuolar 
proteases in cells lacking Vps45p.  This is represented by the decreased levels of the        
37 kDa (**) HA-immunoreactive reactive band detectable in lysates prepared from vps45  
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detected by the anti-HA antibody (also detected in Figure 5.2) which appears to be at 
elevated levels in lysates prepared from vps45  cells expressing HA-Tlg2p when 
compared to those from wild-type cells also expressing HA-Tlg2p (Figure 5.3).  This 
larger degradative product (*) is also detected at elevated levels in lysates prepared from 
wild-type cells lacking active vacuolar proteases, expressing HA-Tlg2p (Figure 5.2).  
These results suggest that the levels of Tlg2p in vps45  cells are regulated in a manner 
independent of the vacuole and that this larger degradative product (*) is the substrate for 
the degradative process that generates the PEP4-dependent product (**).  These 
observations are consistent with the hypothesis outlined above, which states that in the 
absence of Vps45p, Tlg2p does not enter the proteolytically active endosomal system. 
The vacuolar dependent cleavage event(s) detected in Figures 5.2 and 5.3, must occur 
towards the C-terminus of the protein, as the product can be detected by HA antibodies and 
the HA-tag is at the extreme N-terminus of the protein (A in Figure 5.4).  Thus product is 
lacking sequence from the C-terminus, the lumenal portion of Tlg2p.  A schematic diagram 
of the proposed topology of Tlg2p is shown below. 
 
Figure 5.4 – A schematic diagram showing the proposed topology of Tlg2p. 
Residues 1-316 of the syntaxin, Tlg2p, represent the cytosolic domain which harbours the 
SNARE motif (SNARE) and the Habc domain (Habc). Residues 317-334 represent the 
Transmembrane domain which is buried within the phospholipid bilayer.  Unlike other 
syntaxins, Tlg2p also contains an additional lumenal domain (residues 335-396) at its C-
terminus.  This diagram was constructed using the data provided in (Dulubova et al., 2002).  
A and B represent N- and C-terminally HA-tagged versions of Tlg2p, respectively.   
 
In order to test this assumption, i.e. that the PEP4-dependent cleavage event(s) generating 
the HA-immunoreactive band of 37 kDa (** in Figures 5.2 and 5.3) is/are occurring Marion S. Struthers, 2009    Chapter 5, 125 
 
towards the C-terminus of the protein, I used immunoblot analysis to investigate whether 
or not I could detect any degradative products in cells expressing a C-terminally HA-
tagged version of Tlg2p (Tlg2p-HA) (B in Figure 5.4).  NOzY2 (RPY10 vps45 ; PEP4) 
cells were transformed with the plasmids pNB701 (empty vector) pMAZ006 (encoding 
HA-Tlg2p) or pCOG039 (encoding Tlg2p-HA).  Expression of these constructs (HA-Tlg2p 
and Tlg2p-HA) was under the control of the CUP1 promoter and hence expression was 
driven by the addition of 100 µM CuCl2 to the selective media, SD-ura-met, in which the 
transformants were grown.  Proteins contained within whole cell lysates prepared from 
equal numbers of these transformants (1 OD600 equivalents) were separated using        
SDS-PAGE prior to immunoblot analysis with an antibody specific to the HA-tag. 
 
Figure 5.5 - N- and C-terminally HA-tagged versions of Tlg2p display different patterns of 
degradation products in vps45∆ cells (containing active vacuolar proteases). 
Whole cell lysates prepared from NOzY2 (RPY10 vps45∆; PEP4) cells transformed with the 
plasmids pNB701 (empty vector), pMAZ006 (encoding N-terminally tagged HA-Tlg2p) or 
pCOG039 (encoding C-terminally tagged Tlg2p-HA) were analysed using immunoblot 
analysis with an antibody specific to the HA-tag.  Expression of the N- and C-terminally HA-
tagged versions of Tlg2p from the CUP1 promoter was induced by the addition of 100 µM 
CuCl2 to the media in which the transformants were grown.  Levels of Vti1p were also 
assessed using immunoblot analysis to control for equal loading. 
 
In contrast to N-terminally HA-tagged Tlg2p (HA-Tlg2p), no HA-immunoreactive 
degradative products ((*) or (**)) are detectable in lysates prepared from vps45  cells 
containing active vacuolar proteases expressing C-terminally HA-tagged Tlg2p (Tlg2p-
HA) (Figure 5.5).  These data support the contention that the PEP4-dependent product of 
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It has been reported that Tlg2p expression in bacteria can be improved by removal of the 
lumenal domain (Paumet et al., 2005).  Considering this and the data already provided in 
this chapter, it seemed plausible that the lumenal domain could also be involved in 
regulating the levels of Tlg2p in vivo.   In order to investigate this I used SDM to introduce 
two stop codons immediately after the TM domain of the coding sequence for HA-Tlg2p 
(in pMAZ006) generating the plasmid pMAZ038 (encoding HA-Tlg2p(1-336)) (details of 
how this plasmid was generated are described in Section 2.2.5).  A schematic diagram of 
full-length HA-tagged Tlg2p (HA-Tlg2p) and truncated HA-tagged Tlg2p (HA-Tlg2p(1-
336)) is shown below. 
 
Figure 5.6 – A schematic diagram of full-length HA-tagged Tlg2p (HA-Tlg2p) and truncated 
HA-tagged Tlg2p (HA-Tlg2p(1-336)). 
The truncated version of HA-tagged Tlg2p was generated by introducing two stop codons 
immediately after the TM domain of the coding sequence for HA-Tlg2p (in pMAZ006).  The 
abbreviations in this diagram represent the HA-tag (HA), the Habc domain (Habc) and the 
SNARE domain (SNARE).  The TM domain is embedded in the phospholipid bilayer. 
 
The newly generated plasmid, pMAZ038 (encoding HA-Tlg2p(1-336)), the parental 
plasmid pMAZ006 (encoding HA-Tlg2p) and the empty vector, pNB701 were used to 
transform wild-type cells with (RPY10) and without (SF838-9D) active vacuolar proteases.  
Expression of these constructs (HA-Tlg2p(1-336) and HA-Tlg2p) was under the control of 
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the selective media, SD-ura-met, in which the transformants were grown.  Whole cell 
lysates prepared from equal numbers of these transformants (1 OD600 equivalents) were 
subject to immunoblot analysis with an antibody specific to the HA-tag. 
 
Figure 5.7 – Removal of the lumenal domain from Tlg2p does not increase the steady-state 
levels of Tlg2p, nor does it prevent the PEP4-dependent degradation of Tlg2p. 
Whole cell lysates prepared from 1 OD600 equivalents of PEP4 (RPY10) cells and pep4-3 
(SF838-9D) cells transformed with the plasmids pNB701 (empty vector), pMAZ006 (encoding 
HA-Tlg2p) or pMAZ038 (encoding HA-Tlg2p(1-336)) were analysed using immunoblot 
analysis with an antibody specific to the HA-tag.  Expression from the CUP1 promoter was 
induced by the addition of 100 µM CuCl2 to the media in which the transformants were 
grown. 
 
No obvious difference in the levels of Tlg2p is detectable after the removal of the lumenal 
domain (Figure 5.7).  It is however apparent that the truncated version of Tlg2p (HA-
Tlg2p(1-336)) encoded by the plasmid pMAZ038 undergoes PEP4-dependent degradation, 
as a HA-immunoreactive band of ~37 kDa (**) is still detectable in wild-type cells 
containing active vacuolar proteases (PEP4) expressing HA-Tlg2p(1-336).  These results 
suggest that the processing event(s) that result in the generation of the 37 kDa (**) product 
occur in the cytosolic portion of Tlg2p. 
5.3 Tlg2p is ubiquitinated in wild-type and vps45∆ cells 
Ubiquitination is the process by which the small protein moiety, ubiquitin, becomes 
covalently attached to a protein (Hicke and Dunn, 2003).  Ubiquitin is linked to its target 
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residue of ubiquitin to the ε-amino group of a lysine residue in the target protein or less 
commonly to the amino group at the N-terminus of the target protein (Hicke and Dunn, 
2003).  Ubiquitination is most commonly known as the signal for degradation of a protein 
by the proteasome; however ubiquitination can also have a variety of different effects 
within the cell, for example ubiquitin can also signal for the entry of proteins into MVBs 
for degradation by the vacuole (Hicke and Dunn, 2003) (see Section 1.4.1.1).   
As discussed previously in this chapter, Tlg2p is degraded by the proteasome in vps45  
cells (Bryant and James, 2001).  Taking this finding into consideration along with those 
presented earlier in this chapter (Section 5.2), which demonstrate that the steady-state 
levels of Tlg2p are, in part, regulated by the vacuole, it seemed possible that Tlg2p may be 
a target for ubiquitination in both wild-type and vps45  cells.   
In order to investigate this, I used a GST fusion protein harbouring the ubiquitin binding 
(UBA) domain of the yeast protein, Dsk2p (Funakoshi et al., 2002).  Dsk2p is an adaptor 
protein involved in the delivery of polyubiquitinated proteins to the proteasome for 
degradation (Funakoshi et al., 2002).  Dsk2p has two key domains which are critical for 
this process: an N-terminal ubiquitin-like (Ubl) domain and a C-terminal ubiquitin-
associated (UBA) domain (Funakoshi et al., 2002).  The Ubl domain facilitates association 
with the proteasome, whilst the UBA domain (residues 328-373) binds ubiquitin chains 
(Funakoshi et al., 2002).   
Structural studies indicate that the interaction between the UBA domain of Dsk2p and 
ubiquitin is facilitated through the main chain amide group of Gly47 of ubiquitin (Ohno et 
al., 2005).  Two residues within the UBA domain of Dsk2p were identified as being 
important for its interaction with ubiquitin: a methionine residue at position 342 (Met342) 
and a phenylalanine residue at 344 (Phe344) which make hydrophobic contacts with Ile44 
and Gly47 of ubiquitin respectively (Ohno et al., 2005).  Mutation of these residues within 
Dsk2p, were predicted to abolish any interaction with ubiquitin (Ohno et al., 2005).   
Although the UBA domain of Dsk2p has preference for binding K48-linked polyubiquitin 
chains, it can also associate with K63-linked chains as well as monoubiquitin (Funakoshi et 
al., 2002).  This feature makes this domain ideal to investigate whether a protein is 
modified by ubiquitination, as a GST-fusion protein harbouring the UBA domain of Dsk2p 
(GST-UBA encoded by the plasmid pGEX-DSKUBA) (Funakoshi et al., 2002) would serve 
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protein.  Hence, I utilised this to look at the ubiquitination status of Tlg2p.  As a negative 
control for these studies, I took advantage of a mutated version of the GST-UBA fusion 
protein (encoded by the plasmid pCAL1; constructed by Christopher Lamb, PhD student, 
University of Glasgow, UK).  GST-mutUBA is identical to GST-UBA except the two 
residues critical for ubiquitin binding, Met342 and Phe344 have been mutated to an 
arginine and alanine, respectively (described in Section 2.2.5). 
pGEX-DSKUBA and pCAL1 (encoding GST-UBA and GST-mutUBA respectively), were 
transformed into BL21 Star™ (DE3) cells (Invitrogen).  The resultant transformants were 
grown to mid-log phase in 500 ml Terrific Broth containing ampicillin (at a final 
concentration of 100  g/ml) at 37°C before protein expression was induced by the addition 
of IPTG to a final concentration of 1 mM.  The cultures were returned to 37°C for 4 hours 
with continuous shaking, after which time cells were harvested by centrifugation.        
GST-UBA and GST-mutUBA were purified on glutathione-Sepharose (as described in 
Section 2.2.20.2).  The purity and amount of GST-UBA and GST-mutUBA bound to 
glutathione-Sepharose beads was assessed using SDS-PAGE followed by Coomassie 
staining (Figure 5.8). 
 
Figure 5.8 – SDS-PAGE quantification of the purified GST-fusion proteins 
GST-UBA and GST-mutUBA fusion proteins were expressed in bacteria and purified 
glutathione-Sepharose beads.  Proteins eluted from the beads were separated by SDS-
PAGE (15% (v/v) polyacrylamide gel) and visualised using Coomassie Blue staining.  In 
order to estimate the quantity of protein bound to the beads a series of protein standards (2 
µg, 4 µg, 10 µg and 20 µg BSA standards) were also included.  A sample of purified GST was 
also included to ensure that the proteins had not substantially degraded. 
 
From Figure 5.8, I estimate that a 1 in 10 dilution of glutathione-Sepharose suspension (of 
which 5 µl was loaded on the gel) has approximately 20  g GST-UBA or GST-mutUBA 
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GST-fusion).  Therefore the concentration of GST-UBA or GST-mutUBA purified on the 
glutathione-Sepharose is approximately 40 µg/µl.  Importantly, this gel shows that by 
using equal volumes of the GST-UBA and GST-mutUBA bound glutathione-Sepharose, I 
will be using comparable amounts of the two fusion proteins in my pull-down experiments.  
Initial pull-down experiments were performed by incubating the Sepharose-bound proteins 
(GST-UBA and GST-mUBA) with yeast lysates prepared from SF838-9D (“wild-type”; 
i.e. VPS45, TLG2, but lacking active vacuolar proteases) and its isogenic vps45   and 
tlg2  derivatives NOzY1 and NOzY3, transformed with the vector p2313 (Scott et al., 
2004b).  p2313 encodes a GFP-tagged version of the yeast amino acid permease, Gap1p.   
This was included as a positive control for a protein known to be ubiquitinated under the 
growth conditions used (Hein and Andre, 1997, Helliwell et al., 2001, Springael and 
Andre, 1998, Springael et al., 1999).  Following incubation with lysates prepared from 
equal numbers (16 OD600 equivalents) of the indicated strains for 2 hours at 4°C with 
continual mixing the amount of Tlg2p and Gap1p bound to the immobilised fusion proteins 
was assessed using immunoblot analysis with an antibodies specific to Tlg2p and the GFP-
tag.  
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Figure 5.9 – No ubiquitinated Tlg2p is detected in wild-type or vps45∆ cells. 
Lysates prepared from SF838-9D (WT), NOzY1 (SF838-9D vps45∆) and NOzY3 (SF838-9D 
tlg2∆) cells expressing Gap1p-GFP (from p2313) were incubated with GST-UBA and       
GST-mutUBA prebound to glutathione-Sepharose for 2 hours at 4°C with continuous 
mixing.  Following extensive washing (described in Section 2.2.21.2) proteins bound to GST-
UBA and GST-mutUBA were eluted and separated using SDS-PAGE prior to immunoblot 
analysis with antiserum specific to Tlg2p (top panel).  The same filter was then probed with 
an antibody specific for GFP-tag (to detect Gap1p-GFP; bottom panel).  5% of lysate (input) 
was also included in this analysis.    
 
This approach did not detect any ubiquitinated Tlg2p.  It may be that only a small fraction 
of endogenous Tlg2p is ubiquitinated at any particular moment.  One approach that I 
considered turning to, was to, utilise cells that are deficient in proteasomal activity (pre1-1, 
pre2-2, cim3-1) with the rationale that these would accumulate any ubiquitinated Tlg2p 
(especially in cells lacking VPS45).  However, these cells are notoriously ‘sick’ and may 
not accumulate ubiquitinated Tlg2p, as there is only a limited pool of ubiquitin that is 
normally recycled (following the proteasomal degradation of ubiquitinated proteins). 
As an alternative approach, I chose to use HA-tagged Tlg2p expressed from pMAZ006.  
My rationale was to slightly elevate the levels of Tlg2p in the hope that this would elevate 
the levels of ubiquitinated Tlg2p so that they would be detectable in the pull-down assay.  
As previously demonstrated (Figure 5.3) a copper concentration of 100 µM elevates the 
levels of Tlg2p to a level at which it is not fully degraded in the absence of Vps45p.   Marion S. Struthers, 2009    Chapter 5, 132 
 
Wild-type (SF838-9D) and vps45  (NOzY1; SF838-9D vps45 ) cells transformed with 
pNB701 (empty vector), pMAZ006 (encoding HA-Tlg2p) or p2313 (encoding Gap1p-
GFP) were grown to mid-log phase in the selective media, SD-ura-met, containing 100 µM 
CuCl2.  100 µl of lysate prepared from equal numbers of transformants (16 OD600 
equivalents) was incubated with the Sepharose-bound proteins (either GST-UBA or GST-
mutUBA) for 2 hours at 4ºC.  The Sepharose was washed and eluted (as described in the 
Section 2.2.21.2).  Proteins contained in the eluates were separated by SDS-PAGE prior to 
immunoblot analysis with antibodies specific to the HA- and GFP-tags. 
 
Figure 5.10 – HA-tagged Tlg2p is ubiquitinated in wild-type and vps45∆ cells. 
Wild-type (WT, SF838-9D) and vps45∆ (NOzY1; SF838-9D vps45∆) transformed with empty 
vector (pNB701), pMAZ006 (encoding HA-Tlg2p) or p2313 (encoding Gap1p-GFP) were 
grown to mid-log phase in SD-ura-met containing 100 µM CuCl2.  100  l of whole cell lysates 
prepared from equal numbers of transformants (16 OD600 equivalents) were incubated with 
either GST-UBA or GST-mutUBA prebound to glutathione-Sepharose for 2 hours at 4ºC with 
continuous mixing.  Following extensive washes (described in Section 2.2.21.2) the 
Sepharose was eluted and the proteins bound to the GST-fusions analysed using           
SDS-PAGE and immunoblot analysis with antibodies specific for the HA- (left panel) and 
GFP-tags (right panel).  2.5% of the lysate (input) was also included in this analysis. 
 
The elevated expression of HA-Tlg2p was enough to provide a pool of ubiquitinated Tlg2p 
detectable by the pull-down assay in both wild-type and vps45  cells (Figure 5.10).  Both 
HA-Tlg2p and the positive control Gap1p-GFP are present in the GST-UBA pull-down, 
but not in the control (GST-mutUBA) (Figure 5.10).  It should also be noted that there is a 
“ladder” of HA-immunoreactive bands (Ub-HA-Tlg2p in Figure 5.10) pulled-down by 
GST-UBA from wild-type cells expressing HA-Tlg2p which is not detectable in the empty 
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(monoubiquitinated on multiple sites).  This is less evident in the sample prepared from 
vps45  cells, possibly because levels of Tlg2p are downregulated in the absence of Vps45p 
(Bryant and James, 2001). 
5.4 Mapping the ubiquitination sites of Tlg2p 
It is evident from Figure 5.10 that a fraction of HA-Tlg2p expressed from pMAZ006 in the 
presence of 100  M CuCl2 is ubiquitinated in both wild-type and vps45  cells.  However 
HA-Tlg2p expressed at this level is not completely degraded in the absence of Vps45p 
(Figure 5.3 and 5.10).  In order to map possible sites of ubiquitination involved in targeting 
Tlg2p for degradation in cells lacking Vps45p, I decided to express Tlg2p at levels slightly 
higher than endogenous Tlg2p, but low enough to be degraded in the absence of Vps45p.  
Hoping that, the difference in the levels of Tlg2p between wild-type and vps45  cells 
would be easily scorable using immunoblot analysis.  This was important as it would allow 
me to knockout specific lysines in the cytosolic domain of Tlg2p and use immunoblot 
analysis to look for its recovery in vps45  cells.   For this purpose I used the plasmid 
pMAZ001.  This was constructed by subcloning the TLG2 ORF along with 500 bp of 
upstream and 300 bp of downstream sequence into the plasmid, pRS416 (Sikorski and 
Hieter, 1989).  This strategy was designed to put TLG2 under the control of its own 
promoter and 3’ UTR in a centromeric plasmid.  By virtue of their centromere, centromeric 
(CEN) plasmids are faithfully inherited upon cell division and are maintained at a low copy 
number (generally 1-3 copies per cell) (Blackburn, 1984, Clarke and Carbon, 1980, 
Resnick et al., 1990).  
In order to investigate whether or not Tlg2p expressed from the CEN plasmid, pMAZ001, 
was fully degraded in vps45  cells, I compared the level of Tlg2p expressed from the 
genomic TLG2 locus to that of Tlg2p expressed from pMAZ001 in vps45  cells.  For this 
purpose wild-type cells (RPY10) and vps45  cells (NOzY2; RPY10 vps45 ) were 
transformed with the plasmids pRS416 (empty vector) or pMAZ001 (encoding Tlg2p).  
Whole cell lysates prepared from equal numbers of these transformants (1 OD600 
equivalents) were then analysed using immunoblot analysis with an antibody specific to 
Tlg2p. 
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Figure 5.11 – Tlg2p expressed from pMAZ001 is fully degraded in vps45∆ cells. 
Wild-type (RPY10) were transformed with pRS416 (empty vector) and vps45∆ (NOzY2; 
RPY10 vps45∆) cells were transformed with either pRS416 (empty vector) or pMAZ001 
(encoding Tlg2p).  Proteins contained within whole cell lysates prepared from equal 
numbers of these transformants (1 OD600 equivalents) were separated by SDS-PAGE prior to 
immunoblot analysis with an antiserum specific to Tlg2p.  Levels of Vti1p were also 
assessed using immunoblot analysis to control for equal loading. 
 
Figure 5.11 shows vps45  cells expressing Tlg2p both from their chromosomal copy of the 
gene and from pMAZ001, down-regulate Tlg2p to an extent that the difference between 
those cells and wild-type cells are easily detected by immunoblot analysis.  Thus 
pMAZ001 is a good tool for investigating the degradation of Tlg2p in vps45  cells.  
As mentioned previously in this chapter (Section 5.2) there were problems that arose with 
detecting Tlg2p using specific antiserum (which was in limited supply and not wholly 
reliable), hence as a complementary approach to detecting Tlg2p degradation by 
immunoblot analysis I also set out to develop a functional assay which could also be used 
to map possible sites of ubiquitination.  
My approach was to utilise the enzyme imidazoleglycerol-phosphate dehydratase, His3p 
(Struhl and Davis, 1977).  His3p catalyzes the sixth step in histidine biosynthesis; 
mutations cause histidine auxotrophy and sensitivity to Cu, Co, and Ni salts (Struhl and 
Davis, 1977).  The rationale behind this functional assay was to produce a fusion protein 
made up of Tlg2p and His3p.  I hypothesised that in wild-type cells (lacking endogenous 
His3p) this would support growth on media lacking histidine, but in cells lacking Vps45p 
this fusion protein would be degraded (by virtue of its Tlg2p sequences) and would no 
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then be introduced in the context of the fusion proteins to look for those that allow the 
fusion protein to support growth of vps45  cells on media lacking histidine. 
 
Figure 5.12 – Schematic diagram of the strategy used to develop a functional assay to 
monitor the degradation of Tlg2p in cells lacking endogenous Vps45p. 
If the fusion protein is regulated in a similar manner to that of Tlg2p, a) wild-type cells 
lacking endogenous His3p (his3∆) expressing the fusion protein Tlg2p-His3p should be able 
to grow on media lacking histidine (SD-his) where as b) vps45∆ cells lacking endogenous 
His3p (his3∆, vps45∆) expressing the fusion protein Tlg2p-His3p should not be able to grow 
on media lacking histidine.  Introduction of mutations within the coding sequence of TLG2 
of the fusion protein, which disrupt degradation of Tlg2p in vps45∆ cells should c) promote 
the growth of his3∆, vps45∆ on histidine deficient media.  
 
Construction of the fusion protein for the assay was based around pMAZ001, as levels of 
Tlg2p expression are similar to that of endogenous Tlg2p, and importantly, degradation of 
Tlg2p is marked when Tlg2p is produced at this level (Figure 5.11).  The fusion protein 
that was used in the assay outlined above was encoded by pMAZ017 (details of the 
construction of the plasmid encoding this can be found in Section 2.2.5).  The first 33 
residues of Tlg2p are necessary for Mode 2 binding by Vps45p (Dulubova et al., 2002, 
Carpp et al., 2006).  This information was taken into consideration during the design of the 
fusion protein and this is why the HIS3 coding sequence was fused in-frame after codon 33 
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Figure 5.13 – Schematic diagram of the fusion protein encoded by pMAZ017. 
This diagram is a modification of one presented by Dulubova and colleagues (Dulubova et 
al., 2002).  The HIS3 coding sequence was introduced in-frame after the first 33 codons of 
TLG2.  The first 33 residues (Vps45p Binding Motif) of Tlg2p are necessary for Mode 2 
binding (Dulubova et al., 2002).  Residues 70-102, 109-143 and 152-187 represent the Habc 
domain (Dulubova et al., 2002).  Residues 253-307 represent the SNARE domain and 
residues 317-334 represent the transmembrane domain (TM) (Dulubova et al., 2002).   
 
It was important to ensure that the Tlg2p-His3p fusion protein was regulated in a similar 
manner to that of Tlg2p.  In order to do this I monitored expression of the fusion protein 
from pMAZ017 in the his3 auxotrophic strain SEY6210 and its isogenic derivatives; 
LCY007 (vps45 ) and MSY001 (tlg2 ).  Wild-type (SEY6210), tlg2  (MSY001) and 
vps45  (LCY007) cells were transformed with either the plasmid pMAZ017 (encoding the 
Tlg2p-His3p fusion protein) or pRS416 (empty vector).  Proteins contained within whole 
cell lysates, prepared from equal numbers of these transformants (1 OD600 equivalents), 
were separated by SDS-PAGE prior to immunoblot analysis with an antibody specific to 
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Figure 5.14 – Expression of the Tlg2p-His3p fusion protein 
Wild-type (SEY6210), tlg2∆ (MSY001) and vps45∆ (LCY007) were transformed with the 
plasmid, pMAZ017 (encoding the Tlg2p-His3p fusion protein) or pRS416 (empty vector).  
Proteins contained within whole cell lysates, prepared from equal numbers of these 
transformants (1 OD600 equivalents), were separated using SDS-PAGE, after which 
immunoblot analysis was performed using an antiserum specific for Tlg2p.  Similarly levels 
of Vti1p were assessed to control for equal loading. 
 
Figure 5.14 shows that the Tlg2p-His3p fusion protein runs on SDS-PAGE as a ~70 kDa 
Tlg2p immunoreactive band (present in wild-type cells carrying pMAZ017 (lane 2), but 
not in those carrying the parent vector pRS416 (lane 1)).  Interestingly, the fusion protein 
is present at higher levels in cells lacking endogenous Tlg2p (tlg2 ) (compare lanes 2 and 
4).  This likely reflects the mechanisms employed by the cell to regulate Tlg2p levels.  If, 
under the growth conditions used, the cell maintains Tlg2p at, say 50000 copies per cell 
this would be made up of, for example, 35000 copies produced from the endogenous gene, 
and 15000 molecules of the fusion protein in wild-type cells.  In contrast, in tlg2  cells, the 
fusion protein would account for all 50000 copies, hence the more intense band.  This 
provides some evidence that the fusion protein is folded properly in the cell and is 
recognised by cellular machinery as Tlg2p.  Further evidence for this comes from the 
observation that no fusion protein is detected in vps45  cells carrying pMAZ017 (lane 6), 
presumably as it is subject to the same down-regulation as wild-type Tlg2p.  No 
endogenous Tlg2p is detected in these cells (lanes 5 and 6), consistent with the finding that 
Vps45p is required for the stability of Tlg2p (Bryant and James, 2001).   Marion S. Struthers, 2009    Chapter 5, 138 
 
SEY6210 is a histidine auxotroph (it carries the his3- 200 mutation) and is therefore 
incapable of growing on histidine deficient media.  In order to investigate whether or not 
His3p was functional within the context of the fusion protein, I monitored the growth of 
wild-type (SEY6210), tlg2  (MSY001; SEY6210 tlg2 ) and vps45  (LCY007; SEY6210 
vps45 ) cells on media lacking histidine.  Wild-type (SEY6210), tlg2  (MSY001) and 
vps45  (LCY007) cells transformed with either pMAZ017 (encoding Tlg2p-His3p) or 
pRS416 (empty vector) were grown in the selective media, SD-ura-met, to mid-log phase.  
Cells were harvested and resuspended in sterile dH20 at an OD600 of 0.8.  Subsequent serial 
dilutions were performed, generating cultures with an OD600 of 0.8, 0.08, 0.008, 0.0008.  5 
 l from each of these cultures was spotted on to SD-ura-met and SD-his plates.  Growth 
was monitored for 2-3 days at 30ºC. 
 
Figure 5.15 – A Tlg2p-His3p fusion protein supports growth of ‘wild-type’ and tlg2∆ but not 
vps45∆ histidine auxotrophic cells on media lacking histidine.  
Wild-type (SEY6210), tlg2∆ (pMSY001; SEY6210 tlg2∆) and vps45∆ (LCY007; SEY6210 
vps45∆) cells transformed with the plasmids, pMAZ017 (which drives the expression of the 
Tlg2p-His3p fusion protein) or pRS416 (empty vector) were grown in the selective media, 
SD-ura-met, to mid-log phase (OD600=0.8).  Cells were harvested by centrifugation and 
resuspended in sterile dH2O at an OD600 of 0.8.  Subsequent dilutions were performed 
generating cultures with an OD600 of 0.8, 0.08, 0.008 and 0.0008.  5 µl from each of these 
cultures was then spotted on to SD-ura-met or SD-his plates.  Growth was monitored at 30ºC 
for 2-3 days. 
 
The expression of the Tlg2p-His3p fusion protein in either SEY6210 (wild-type) or the 
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the same cells carrying the empty vector (pRS416) cannot grow on this media (Figure 
5.15).  It is noteworthy that pMAZ017 supports growth in cells lacking endogenous Tlg2p 
to a greater extent than it does wild-type cells.  This likely reflects the higher steady-state 
levels of the Tlg2p-His3p fusion protein in these cells (Figure 5.14).  Consistent with the 
data presented in Figure 5.14 showing substantially lower levels of the Tlg2p-His3p fusion 
protein in vps45  cells carrying pMAZ017 (compared to wild-type or tlg2  cells), 
pMAZ017 does not support growth of  his3-200 vps45  cells on media lacking histidine 
(Figure 5.15).  
I went on to employ the assay described above to screen through lysine residues in Tlg2p 
to identify those whose ubiquitination may target Tlg2p for degradation.  This was 
achieved using SDM to mutate the sequence encoding selected lysine residues to arginine 
residues in the background of the fusion protein.  The lysine residues selected for mutation 
were based on published and unpublished data (Chapter 3 and 4) and the reasoning for 
their selection is discussed in detail below. 
The first lysine residue selected resides in the N-terminal peptide of Tlg2p, Lys26.  As 
mentioned previously, Vps45p binds to monomeric Tlg2p via Mode 2 binding (Carpp et 
al., 2006, Dulubova et al., 2002).  One possibility is that the association of Vps45p with 
Tlg2p through this mode of binding could mask this lysine residue, thus preventing its 
ubiquitination and subsequent targeting to the proteasome for degradation.  
Other lysine residues targeted include 5 lysine residues (Lys189, 193, 198, 218, 229) 
present in the linker region between the Habc domain and the SNARE domain of Tlg2p.  
These were targeted based on the assumption that Tlg2p adopts a closed conformation in 
the absence of Vps45p and hence exposes these residues in the linker region for the 
attachment of ubiquitin.  It should be noted that although NMR studies performed on 
isolated sections of Tlg2p suggest that it does not exist in a closed confirmation (Dulubova 
et al., 2002), data provided in this thesis (Figures 4.6 and 4.7s) and also in (Bryant and 
James, 2001) contradicts these findings and as of yet no structural evidence exists to 
confirm that full-length Tlg2p does not adopt a closed conformation.  Hence these lysine 
residues remain a good target for ubiquitination. 
I also targeted 3 lysine residues present in the region between the SNARE domain and TM 
domain (Lys305, 311, 315).  These lysine residues were selected as they are conserved 
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homologue of Tlg2p, Sx16 is also degraded in vps45  cells (Figure 4.4) hence these 
lysines also represent good targets.   
Those lysine residues selected for mutation are highlighted in the following diagram. 
 
Figure 5.16 – Sequence alignment of Sx16 and Tlg2p 
Vector NTI (Invitrogen) was used to align the amino acid sequence of the functional 
homologues Sx16 and Tlg2p in order to identify regions in which lysine residues may be 
conserved. Those lysine residues of Tlg2p that were mutated to arginine residues are 
shown in blue (K26R), red (5KR) and green (3KR).  The SNARE domain is underlined and the 
transmembrane domain is shown in bold (the residues included in the SNARE and 
transmembrane domain are taken from (Dulubova et al., 2002)).  Other potential lysine 
residues conserved between Sx16 and Tlg2p are shown in pink.  There are a total of 25 
lysine residues present in the cytosolic domain of Tlg2p.   
 
Sequence encoding the lysine residues described above were mutated to sequence 
encoding arginine residues in the plasmid, pMAZ017 (encoding the Tlg2p-His3p fusion 
protein) using SDM (details of how these plasmids were generated is described in Section 
2.2.5).  LCY007 (SEY6210 vps45 ) were transformed with the resultant plasmids, 
pMAZ028 (Tlg2p-His3p(K26R)), pMAZ030 (Tlg2p-His3p(5KR)), pMAZ033 (Tlg2p-Marion S. Struthers, 2009    Chapter 5, 141 
 
His3p(3KR)), the parent plasmid pMAZ017 (Tlg2p-His3p) or empty vector (pRS416).  As 
a positive control for this experiment I constructed a plasmid, pMAZ027, which would 
represent the maximal growth achievable by those cells expressing the fusion protein.  This 
plasmid (pMAZ027) expresses His3p under the control of the TLG2 promoter and 3’ UTR 
and was constructed by firstly removing the sequence encoding the first 33 codons of 
TLG2 from pMAZ017 (Tlg2p-His3p) and secondly by using SDM to introduce two stop 
codons at the end of the HIS3 coding sequence (this is described in detail in Section 2.2.5).  
LCY007 (SEY6210 vps45 ) cells were also transformed with the plasmid pMAZ027.  
Transformants were grown to mid-log phase in the selective media SD-ura-met.  Cells 
were harvested and resuspended in sterile dH2O at an OD600 of 0.8.  Serial dilutions were 
subsequently performed generating cultures with an OD600 of 0.8, 0.08, 0.008, 0.0008.  5  l 
from each of these cultures was spotted on to SD-ura-met and SD-his plates.  Growth was 
monitored for 2-3 days at 30ºC. 
 
Figure 5.17 – Analysis of lysine residues in Tlg2p. 
SEY6210 vps45∆ (LCY007) cells transformed with pRS416 (empty vector), pMAZ027 (His3p), 
pMAZ017 (Tlg2p-His3p), pMAZ028 (Tlg2p-His3p(K26R)), pMAZ030 (Tlg2p-His3p(5KR)) or 
pMAZ033 (Tlg2p-His3p(3KR)) were grown to mid-log phase in the selective media SD-ura-
met, before harvesting by centrifugation.  The resultant cell pellets were resuspended in 
sterile dH2O at an OD600 of 0.8.  Serial dilutions were subsequently performed generating 
cultures with an OD600 of 0.8, 0.08, 0.008, 0.0008.  5  l from each of these cultures was then 
spotted onto plates containing the selective media SD-ura-met and SD-his.  Growth was 
monitored for 2-3days at 30ºC. 
 
None of the lysine mutants screened prevented the degradation of the fusion protein in 
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It should be noted that not all of lysine residues present in the cytosolic domain were 
screened (there are a total of 25) and this may be essential to prevent the ubiquitination and 
subsequent degradation of Tlg2p in the absence of Vps45p.  Mutation of lysine residues is 
a complicated means to investigate ubiquitination, as ubiquitin ligases seem to select other 
lysine residues for modification if their favoured residue is not available (Hou et al., 1994, 
Lawson et al., 1999).  Hence a more definitive way of mapping which residues of Tlg2p 
are targeted for ubiquitination would be to utilise another technique such a mass 
spectrometry characterisation of immunoprecipitated protein.  This technique works by 
detecting the presence of glycine-glycine motifs present on the ubiquitinated lysine 
residues of the target protein after trypsin digestion (Peng et al., 2003).   
5.5 Cellular levels of Tlg2p are regulated by Mode 2 
binding 
Vps45p interacts with its cognate syntaxin, Tlg2p, at two independent stages of the 
SNARE assembly/disassembly cycle, using two distinct modes of binding, Mode 2 and 
Mode 3 (Bryant and James, 2003, Carpp et al., 2006).  In order to further understand how 
Vps45p functions to regulate the cellular levels of Tlg2p, Dr. Lindsay N. Carpp (University 
of Glasgow, UK) set out to investigate whether or not Mode 2 binding is required for the 
stabilisation of Tlg2p.  In order to do this, she used immunoblot analysis to assess the 
cellular levels of Tlg2p present in vps45  cells expressing either wild-type or the ‘pocket-
filled’ mutant version of Vps45p (Vps45pL117R); abrogated for Mode 2 binding.  Her 
results (published in (Carpp et al., 2007)) demonstrate that there is a significant decrease in 
the cellular levels of Tlg2p present in those vps45  cells expressing the ‘pocket-filled’ 
mutant version of Vps45p (Vps45pL117R) compared to those expressing wild-type 
Vps45p.  These results were intriguing as vps45  cells expressing Vps45pL117R as their 
only source of Vps45p correctly sort CPY (Carpp et al., 2006, Carpp et al., 2007), which 
suggests that these cells contain enough Tlg2p to facilitate trafficking.  In order to quantify 
the levels of Tlg2p present in vps45  cells expressing Vps45pL117R, whole cell lysates 
prepared from equal numbers (1 OD600 equivalents) of NOzY1 (SF838-9D vps45 ) cells 
expressing either the ‘pocket-filled’ mutant version of Vps45p (Vps45pL117R) or wild-
type Vps45p (from the centromeric plasmids, pNB706 or pNB708 respectively) were 
assessed using immunoblot analysis with an antiserum specific to Tlg2p. Marion S. Struthers, 2009    Chapter 5, 143 
 
 
Figure 5.18 - vps45∆ cells expressing Vps45L117R contain ~15% of Tlg2p that is found in wild-
type cells. 
Levels of Tlg2p present in whole cell lysates prepared from equal numbers (1 OD600 
equivalents) of NOzY1 (SF838-9D vps45∆) cells expressing either the pocket-filled mutant of 
Vps45p (Vps45pL117R) from pNB706 were assessed using immunoblot analysis with an 
antiserum specific to Tlg2p.  Different dilutions of wild-type lysates (NOzY1; SF838-9D 
vps45∆ cells expressing wild-type Vps45p from pNB708) were incorporated as a means of 
roughly estimating the levels of endogenous Tlg2p in those vps45∆ cells expressing 
Vps45pL117R.   
 
Figure 5.18 (published in (Carpp et al., 2007)) demonstrates that vps45  cells expressing 
Vps45pL117R contain ~15% of the Tlg2p present in wild-type lysates.  These results 
further support Lindsay’s findings that the cellular levels of Tlg2p are reduced in vps45  
cells expressing the ‘pocket-filled’ mutant version of Vps45p, which is unable to bind to 
Tlg2p via Mode 2 binding.   
In order to determine whether or not Vps45p also regulates cellular levels of Tlg2p via 
Mode 3 binding, Lindsay also assessed the levels of Tlg2p present in vps45  cells 
expressing a double mutant version of Vps45p (Vps45pW244R/L117R) which can only 
bind Tlg2p via Mode 3 binding (Carpp et al., 2006).  Her results demonstrate that cellular 
levels of Tlg2p in cells expressing the double mutant version of Vps45p 
(Vps45pW244R/L117R) are not similar to that of vps45  cells expressing wild-type 
Vps45p (Carpp et al., 2007).  Hence Vps45p regulates the cellular levels of Tlg2p via 
Mode 2 binding. 
Considering these findings, that Vps45p regulates the cellular levels of Tlg2p via Mode 2 
binding (Carpp et al., 2007), I wondered if the N-terminal peptide of Tlg2p, required for 
this mode of binding, is the sole determinant that regulates the degradation of Tlg2p in 
vps45  cells.  In order to investigate this, I used SDM to introduce two stop codons at the 
end of the HIS3 coding sequence in the plasmid pMAZ017 (see Section 2.2.5).  The newly 
synthesised plasmid, pMAZ029, encodes the first 33aa of Tlg2p fused to full-length His3p 
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Figure 5.19– Schematic diagram of the truncated fusion protein encoded by pMAZ029. 
The first 33 residues (Vps45p Binding Motif) of Tlg2p, necessary for Mode 2 binding 
(Dulubova et al., 2002) fused to full-length His3p. 
   
The ability of LCY007 (SEY6210 vps45 ) transformed with pMAZ029 to grow in the 
absence of histidine was monitored on SD-his plates, using the technique described 
previously in this chapter (see Figure 5.15 and 5.17). 
 
Figure 5.20 – Expression of the N-terminal peptide of Tlg2p (1-33aa) fused to full-length 
His3p allows the growth of vps45∆ histidine auxotrophic cells on media lacking histidine. 
LCY007 (SEY6210 vps45∆) cells transformed with the plasmids pRS416 (empty vector) 
pMAZ017 (encoding Tlg2p-His3p), pMAZ027 (encoding His3p) or pMAZ029 (encoding 
Tlg2p(1-33)-His3p) were grown to mid-log phase in the selective media SD-ura-met, before 
harvesting by centrifugation.  Cell pellets were resuspended in sterile dH2O at an OD600 of 
0.8.  Serial dilutions were subsequently performed generating cultures with an OD600 of 0.8, 
0.08, 0.008, 0.0008.  5  l from each of these cultures was spotted onto plates containing the 
selective media SD-ura-met and SD-his.  Growth was monitored for 2-3 days at 30ºC.   
 
vps45  histidine auxotrophic cells expressing a truncated version of Tlg2p (residues 1-33) 
fused to full-length His3p (Tlg2p(1-33)-His3p) grow well on histidine deficient media 
(SD-his) when compared to vps45  histidine auxotrophic cells containing empty vector 
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terminal peptide of Tlg2p alone does not contain all the sequences required to target Tlg2p 
for degradation in the absence of Vps45p. 
5.6 Other factors that may be involved in regulating 
levels of Tlg2p in the cell 
5.6.1 Palmitoylation of Tlg2p 
Considering that both of the SNARE partners of Tlg2p, the t-SNARE Tlg1p and the v-
SNARE Snc2p, are modified by palmitoylation (Valdez-Taubas and Pelham, 2005) 
(discussed in Section 1.4.1.2), it appeared plausible that Tlg2p may also be palmitoylated.  
In fact, two potential sites of palmitoylation have already been identified (Valdez-Taubas 
and Pelham, 2005).   
As a means to detect whether HA-Tlg2p is subject to palmitoylation, yeast lysate 
containing 100  g of protein (estimated using the Bradford protein assay) prepared from 
either wild-type (SF838-9D) or vps45  (NOzY1; SF838-9D vps45 ) cells transformed 
with pNB701 (empty vector) or pMAZ006 (encoding HA-Tlg2p) grown in media 
containing 100  M CuCl2, were treated with hydroxylamine, which selectively removes 
thioester-linked palmitates (Chamberlain and Burgoyne, 1998).  As a control for the 
specificity of the chemistry of hydroxylamine treatment, an equivalent amount of yeast 
lysate (100  g) was also treated with the weak nucleophile Tris-HCl (as described in 
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Figure 5.21 – Levels of HA-Tlg2p are reduced in wild-type and vps45∆ lysates treated with 
the compound, hydroxylamine. 
Yeast lysate containing 100  g of protein (estimated using the Bradford protein assay) 
prepared from either wild-type (SF838-9D) or vps45∆ (NOzY1; SF838-9D vps45∆) cells 
transformed with the plasmids pNB701 (empty vector) or pMAZ006 (encoding HA-Tlg2p) 
grown in media containing 100  M CuCl2, were treated with either Hydroxylamine-HCl pH7.4 
(H) or Tris-HCl pH7.4 (T) for 1 hour at room temperature. The lipids and associated 
components were separated from non-lipid contaminants using a mixture of chloroform and 
methanol. The proteins present in the interphase were precipitated by the addition of 
methanol and the resultant pellets resuspended in loading sample buffer lacking any 
reducing agents.  The presence of HA-tagged Tlg2p was assessed in Tris (T) and 
Hydroxylamine (H) treated samples using immunoblot analysis with an antibody specific to 
the HA-tag (similarly the levels of Pgk1p were assessed to show that equal loading amounts 
of lysate were used in each treatment).  Snc2p was also included as a positive control for a 
protein known to be palmitoylated (Valdez-Taubas and Pelham, 2005). 
 
Treatment of lysates with hydroxylamine results in a reduction of the levels of HA-Tlg2p 
compared to those treated with Tris-HCl (Figure 5.21).  It is important to note that, 
although levels of Pgk1p vary between transformants they are equal between different 
treatments (T and H).  It is also clear to see that levels of Snc2p also decrease upon 
hydroxylamine treatment; Snc2p is known to be palmitoylated (Couve and Gerst, 1994, 
Valdez-Taubas and Pelham, 2005).  Note that there are two Snc2p-immunoreactive bands 
in the hydroxylamine-HCl treated samples compared to the single band present in the Tris-
HCl treated samples, this represent both the palmitoylated and depalmitoylated form of the 
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It is not apparent why the levels of HA-Tlg2p are greatly reduced in those lysates treated 
with hydroxylamine, although it is noteworthy that the same phenomenon is seen for 
Snc2p which is known to be palmitoylated (Couve and Gerst, 1994, Valdez-Taubas and 
Pelham, 2005).  I was, however, concerned that hydroxylamine treatment of HA-Tlg2p 
may alter the protein in such a way, that the protein would be separated into the upper 
phase rather than the interphase or lower phase following chloroform:methanol treatment.  
As only the lower phase and interphase were analysed, this seemed a possible explanation 
for the absence of HA-Tlg2p in the hydroxylamine treated samples.  To investigate this, I 
decided to omit the chloroform:methanol separation step and perform direct methanol 
precipitation of the proteins following treatment with either Tris-HCl or hydroxylamine for 
1 hour at room temperature.   
 
Figure 5.22 - Levels of HA-Tlg2p are reduced in wild-type and vps45∆ lysates treated with 
the compound, hydroxylamine. 
Yeast lysate containing 100  g of protein (estimated using the Bradford protein assay) 
prepared from either wild-type (SF838-9D) or vps45∆ (NOzY1; SF838-9D vps45∆) cells 
transformed with the plasmids pNB701 (empty vector) or pMAZ006 (encoding HA-Tlg2p) 
grown in media containing 100  M CuCl2, were treated with either Hydroxylamine-HCl pH7.4 
(H) or Tris-HCl pH7.4 (T) for 1 hour at room temperature. The proteins were precipitated by 
the addition of an equal volume of 100% (v/v) methanol and the resultant pellets 
resuspended in loading sample buffer lacking any reducing agents.  The presence of       
HA-tagged Tlg2p was assessed in Tris (T) and Hydroxylamine (H) treated samples using 
immunoblot analysis with an antibody specific to the HA-tag (similarly the levels of Pgk1p 
were assessed to show that equal loading amounts of lysate were used in each treatment).   
  
These results clearly indicate that the hydroxylamine treated HA-Tlg2p was not separated 
into the upper phase following chloroform:methanol treatment in the experiment presented 
in Figure 5.21 and confirms that the levels of HA-Tlg2p are greatly reduced following 
hydroxylamine treatment.  Further work is required in order to understand the effects that 
hydroxylamine treatment has on HA-Tlg2p.  It would be important to investigate whether 
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with radiolabelled palmitate.  If this work confirms that Tlg2p is subject to palmitoylation 
an important additional step would be to investigate how this palmitoylation functions to 
regulate the levels of Tlg2p in vivo.  Interestingly, palmitoylated Tlg1p is not recognised 
by the ubiquitin ligase, Tul1p and hence palmitoylation appears to protect Tlg1p from 
degradation by the vacuole (Valdez-Taubas and Pelham, 2005).  It would be interesting to 
investigate whether or not this is also the case for Tlg2p, particularly in wild-type cells, 
where the vacuole appears to play a significant role in regulating the steady-state levels of 
Tlg2p (Section 5.2).  
5.7 Discussion 
This chapter describes several attempts to further investigate those findings presented in 
Chapter 4 and (Bryant and James, 2001), which document the degradation of Tlg2p in the 
absence of Vps45p.   
The information provided in this chapter demonstrates that the vacuole is, in some part, 
involved in regulating the steady-state levels of Tlg2p (Figure 5.1 and 5.2).  Vacuolar 
degradation is more significant in wild-type than vps45  cells (Figure 5.3), suggesting that 
the levels of Tlg2p are primarily regulated by a different degradative pathway in vps45  
cells.  This is consistent with previous findings that document the proteasomal degradation 
of Tlg2p in vps45  cells (Braun and Jentsch, 2007, Bryant and James, 2001).  The 
expression of a truncated version of Tlg2p, lacking its lumenal domain (HA-Tlg2p(1-
336)), previously reported to increase the expression of Tlg2p in bacterial cells (Paumet et 
al., 2005), did not alter the levels of Tlg2p in vivo nor did it prevent the PEP4-dependent 
degradation of Tlg2p (Figure 5.7).  These results suggest that the processing event(s) that 
result in the generation of the PEP4-dependent product occurs in the cytosolic portion of 
Tlg2p. 
Also documented in this chapter is the ubiquitination of Tlg2p in both wild-type and 
vps45  cells (Figure 5.10).  However, it is unclear whether this is mono- or poly-
ubiquitination or perhaps both depending on which degradative pathway Tlg2p is targeted 
to; the proteasome or the vacuole.  This could be further determined using antibodies 
specific to the different types of ubiquitination (mono- or poly-) and also antibodies 
specific to the different linkages (e.g. Anti-Ubiquitin, Lys63-Specifc, clone HWA4C4 from 
Millipore).  This information might provide clues as to the role of the ubiquitination of 
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For example the attachment of four ubiquitin moieties via Lys48 signals a protein for 
degradation by the proteasome, whereas the attachment of a single ubiquitin moiety plays 
and role in the intracellular transport of proteins through the late secretory and endocytic 
pathways (Hicke and Dunn, 2003). 
Focusing solely on the degradation of Tlg2p in vps45  cells, I set out to identify those 
lysine residues which may undergo ubiquitination and hence target Tlg2p for degradation.  
This involved the development of a functional assay, which used a fusion protein made up 
of Tlg2p and His3p.  This fusion protein was degraded in his3- 200, vps45  cells (by 
virtue of its Tlg2p sequences) and in theory would only allow the growth of this strain on 
media lacking histidine when I had successfully prevented the ubiquitination of Tlg2p.  
This was, however, unsuccessful as none of the lysine mutants screened prevented the 
degradation of the fusion protein in his3- 200, vps45  cells as assessed by the ability of 
these cells to grow on media lacking histidine (Figure 5.17).  It should be noted that not all 
of the lysine residues present in the cytosolic domain of Tlg2p were screened and this may 
be essential to prevent the degradation of the fusion protein in the absence of Vps45p.  It 
has also recently been suggested that the levels of Tlg2p present in vps45  cells are, in 
part, mediated by (Ub)-proteasome-dependent ER-associated degradation (ERAD) (Braun 
and Jentsch, 2007).  This conclusion was reached since, in contrast to vps45  cells with a 
fully functional ERAD pathway, vps45  cells in which ERAD has been abolished (through 
deletion of the Ub-conjugating enzymes Ubc6p and Ubc7p (ubc6 , ubc7 ) or through the 
expression of a temperature sensitive mutant of Ufd1p (Ufd1-2) which is the substrate-
recruiting cofactor of the chaperone-like enzyme, Cdc48p) contain higher levels of Tlg2p 
detectable through immunoblot analysis (Braun and Jentsch, 2007).  Hence it is possible 
that lysine residues not contained in the cytosolic domain of Tlg2p are also subject to 
ubiquitination.  It is also possible that the ubiquitin moiety may become attached to a 
serine or threonine residue (Wang et al., 2007).  Hence, a more definitive way of mapping 
which residue(s) are targeted for ubiquitination would be to utilise mass spectrometry 
characterisation (Peng et al., 2003), however immunoprecipitation of proteins can be 
problematic, resulting in low yields and high contamination. 
It has been demonstrated that Vps45p regulates cellular levels of Tlg2p via Mode 2 binding 
(Carpp et al., 2007).  In this chapter I further demonstrate that vps45  cells expressing the 
‘pocket-filled’ mutant version of Vps45p (Vps45pL117R) contain ~15% of the Tlg2p that 
is present in wild-type cells (Figure 5.18).  These results would suggest that the N-terminal 
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However expression of the first 33 amino acids of Tlg2p fused to full-length His3p, did not 
prevent the growth of  his3-200,  vps45 cells in media lacking Histidine (Figure 5.20), 
suggesting that the N-terminal peptide of Tlg2p alone does not contain all of the sequences 
required to target Tlg2p for degradation in the absence of Vps45p.  Neither is the N-
terminal peptide targeted for ubiquitination, as mutation of the only lysine residue present 
in this region (K26R) did not prevent the degradation of Tlg2p in the absence of Vps45p 
(Figure 5.17).  Hence further work is required to understand how Vps45p stabilises Tlg2p 
through Mode 2 binding. 
Treatment of Tlg2p with the compound, hydroxylamine resulted in a reduction of the 
levels of HA-Tlg2p compared to those treated with Tris-HCl (Figure 5.21 and 5.22).  It is 
not apparent why the levels of HA-Tlg2p are so greatly reduced in those lysates treated 
with hydroxylamine-HCl, although a similar effect is seen for Snc2p which is known to be 
palmitoylated (Valdez-Taubas and Pelham, 2005).  These results are preliminary and 
further work is required to investigate whether Tlg2p is palmitoylated in vivo.  This could 
be performed using metabolic labelling with radiolabelled palmitate.  If this work confirms 
that Tlg2p is palmitoylated an important additional step would be to investigate how this 
palmitoylation functions to regulate the levels of Tlg2p in vivo.  For example, it would be 
of interest to identify which palmitoyltransferase is involved in this process.  A good target 
would be the palmitoyltransferase, Swf1p, as a swf1 null mutant shows synthetic sick 
interactions with tlg2 mutant cells (Tong et al., 2004).  Data published by (Valdez-Taubas 
and Pelham, 2005), indicates that Swf1p-dependent palmitoylation protects Tlg1p from 
ubiquitination and degradation by the vacuole.  The authors demonstrate that palmitoylated 
Tlg1p is protected from ubiquitination by the ubiquitin ligase, Tul1p, which subsequently 
prevents the entry of Tlg1p into MVBs and its degradation by the vacuole (Valdez-Taubas 
and Pelham, 2005).  It has previously been discussed, in this chapter (Figure 5.7), that a 
fragment greater than the lumenal domain of Tlg2p is subject to vacuolar degradation, 
which suggests that the cytosolic domain is also exposed to vacuolar proteases.  
Considering this alongside the possibility that Tlg2p may be monoubiquitinated (Figure 
5.10) and also its sensitivity to hydroxylamine treatment (Figures 5.21 and 5.22), it would 
seem sensible to further investigate whether or not Tlg2p is degraded by the vacuole in a 
manner similar to that of Tlg1p (Valdez-Taubas and Pelham, 2005).   
In summary, the information provided in this chapter would suggest that the vacuole is, in 
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the proteasome are also involved in the degradation of Tlg2p as well as deciphering the 
significance of palmitoylation makes this an interesting avenue of research.  
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Type 2 diabetes is characterised by insulin resistance caused by a deregulation of insulin 
action (Saltiel and Kahn, 2001, Zimmet et al., 2001).  One of the major consequences of 
insulin binding to its receptor is the translocation of GLUT4 from its intracellular location 
to the plasma membrane (Bryant et al., 2002).  In order to understand how insulin alters the 
trafficking itinerary of GLUT4 to bring about its delivery to the cell surface, it is important 
to understand how membrane traffic is regulated in eukaryotic cells.  However, due to the 
experimental intractability of terminally differentiated insulin-sensitive cells, it has proven 
hard to gain molecular insight into this regulation.  As with many areas of cell biology a lot 
of our knowledge about the molecular mechanism that regulates membrane traffic has 
come from model systems such as yeast, worms and flies (Calakos and Scheller, 1996).  
The overall aim of the work described in this thesis was to investigate the possibility of 
using the experimentally tractable yeast strain, S. cerevisiae, as a model organism to 
further investigate the molecular mechanism of insulin-regulated GLUT4 trafficking. 
6.1 Sx16 is a functional homologue of the yeast t-SNARE, 
Tlg2p 
Sx16, the syntaxin of interest in this study, and its binding partner, Sx6 (Kreykenbohm et 
al., 2002, Mallard et al., 2002, Perera et al., 2003) have been implicated as playing an 
important role in insulin-regulated GLUT4 trafficking (Perera et al., 2003, Proctor et al., 
2006, Shewan et al., 2003).  In silico analysis has demonstrated that the mammalian 
syntaxin, Sx16 is homologous to the yeast t-SNARE, Tlg2p (Simonsen et al., 1998).  The 
first aim of my work was to investigate whether or not Sx16 is also a functional homologue 
of the yeast t-SNARE, Tlg2p.  
Cells lacking Tlg2p (tlg2 ) are viable, however they display a variety of different 
phenotypes representative of defects in endocytosis (Abeliovich et al., 1998, Holthuis et 
al., 1998, Seron et al., 1998).  These include delayed turnover of the phermone receptors, 
Ste2p and Ste3p by the vacuole (Abeliovich et al., 1998, Holthuis et al., 1998, Seron et al., 
1998); defects in sorting of vacuolar proteases, such as CPY, with approximately 15-20% 
of total CPY secreted in the late Golgi (p2) form (Abeliovich et al., 1998) and defects in 
the retrieval of TGN resident proteins such as Kex2p (Abeliovich et al., 1998, Holthuis et 
al., 1998) and less significantly DPAP A (Holthuis et al., 1998).  Tlg2p is also required for 
recycling of the SNARE protein, Snc1p, through early endosomes (Lewis et al., 2000); the 
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pathway (Abeliovich et al., 1999) and TGN homotypic fusion (Brickner et al., 2001).  
tlg2  cells are also sensitive to osmotic stress (Abeliovich et al., 1998) and have a 
fragmented vacuolar morphology (Abeliovich et al., 1998, Seron et al., 1998).   
In Chapter 3, I described the construction of three different expression vectors which drive 
the expression of Tlg2p, Sx16 and the unrelated mammalian syntaxin, Sx4.  Furthermore I 
demonstrated that the heterologous expression of Sx16, but not Sx4 complements for the 
loss of Tlg2p, by correcting the trafficking defects displayed in tlg2  mutant cells.  These 
include osmotic sensitivity (Figure 3.15), incorrect trafficking of vacuolar proteases such 
as CPY (Figure 3.16), impaired endocytosis (Figure 3.17 and 3.18) and vacuolar 
morphology (Figure 3.18).   
Further to these findings which demonstrate that heterologous expression of Sx16 in yeast 
complements for the loss of Tlg2p, I performed preliminary experiments to investigate 
whether or not Sx16 co-localises to the same region as Tlg2p when expressed in yeast.  
Confocal immunofluorescence microscopy demonstrated that these syntaxins do co-
localise to the same intracellular structures (Figure 3.19), however further work is required 
to confirm this.   
6.2 Sx16 is regulated by the Tlg2p-binding SM protein, 
Vps45p 
A family of proteins essential for SNARE-mediated membrane fusion in vivo are the SM 
proteins.  Loss of function mutations in SM genes results in a block in membrane fusion as 
demonstrated in the organisms S. cerevisiae (Cowles et al., 1994, Novick and Schekman, 
1979, Ossig et al., 1991, Robinson et al., 1988, Wada et al., 1990), D. melanogaster 
(Harrison et al., 1994) and C. elegans (Hosono et al., 1992).  SM proteins are arched-
shaped peripheral membrane proteins of approximately 60-70 kDa (Bracher and 
Weissenhorn, 2002, Jahn, 2000, Misura et al., 2000).  Most SM proteins bind to the 
syntaxin that is involved in the same transport step (Jahn, 2000). 
Consistent with its identification as a functional homologue of Tlg2p (which binds to the 
SM protein, Vps45p (Bryant and James, 2001)), Sx16 has previously been shown to bind 
to the mammalian homologue of Vps45p (mVps45) and also to yeast Vps45p in vitro 
(Dulubova et al., 2002).  However it has yet to be determined whether or not Sx16 can 
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whether or not Sx16 interacts with Vps45p in vivo.  This was important as it would provide 
further confirmation that Sx16 is a functional homologue of Tlg2p by establishing whether 
it utilises the same molecular machinery as Tlg2p when expressed in yeast. 
Vps45p uses two different modes of binding to interact with its cognate syntaxin, Tlg2p, at 
two different stages in the SNARE complex assembly/disassembly cycle (Bryant and 
James, 2003, Carpp et al., 2006).  Vps45p binds to monomeric Tlg2p (Bryant and James, 
2003, Carpp et al., 2006, Dulubova et al., 2002) using Mode 2 binding (Carpp et al., 2006, 
Dulubova et al., 2002) and also to Tlg2p containing cis-SNARE complexes (Bryant and 
James, 2003) using Mode 3 binding (Carpp et al., 2006).  In Chapter 4, I demonstrated that 
Vps45p can interact with monomeric Sx16 in vitro using Mode 2 binding (Figure 4.1) and 
also Sx16-containing cis-SNARE complexes in vivo (Figure 4.2).  I also demonstrated that 
levels of Sx16, like Tlg2p, are depleted in those cells lacking Vps45p (Figure 4.4).   
In Chapter 4, I further demonstrated the functional homology between Tlg2p and Sx16, by 
demonstrating that truncated Tlg2p (Tlg2p Habc) and Sx16 (Sx16  Habc) can bypass the 
requirement of the SM protein, Vps45p, and enable the vacuolar delivery of CPY (Figure 
4.6).  These findings are consistent the hypothesis that one function of Vps45p is to 
activate Tlg2p for entry into SNARE complexes.  This would suggest that Vps45p interacts 
with Tlg2p in a mode analogous to that of Munc18a binding to Sx1a; Mode 1 binding 
(Bryant and James, 2001), which would require Tlg2p to adopt a closed conformation akin 
to that of Sx1a (Bryant and James, 2001).  However evidence for and against a closed 
conformation of Tlg2p exists (Bryant and James, 2001, Dulubova et al., 2002).  Evidence 
that Tlg2p can form a closed conformation is provided by the ability of a truncated version 
of Tlg2p, lacking its Habc domain (Tlg2 Habc) to partially complement the CPY 
trafficking defects observed in vps45  cells (Figure 4.6 and (Bryant and James, 2001)).  
Evidence against a closed conformation of Tlg2p comes from NMR data which suggests 
that a bacterially produced construct of Tlg2p (residues 60-283) is unlikely to form a 
closed conformation (Dulubova et al., 2002).  However, it should be noted that the 
construct used in these NMR studies lacked residues present in the SNARE domain that 
may be required to form a closed conformation of Tlg2p.   
In order to explain how a truncated version of Tlg2p, Tlg2p∆Habc, forms functional 
SNARE complexes in the absence of Vps45p (Bryant and James, 2001) with respect to 
their conclusion that Tlg2p does not adopt a closed conformation, Dulubova and 
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Tlg2p (possibly the Habc domain) and hence prevent SNARE complex formation 
(Dulubova et al., 2002).  They postulated that Vps45p could be involved in releasing such 
an inhibition and thus promote SNARE complex assembly.  Tlg2p∆Habc would not be 
able to bind this inhibitory factor and thus would not be subject to the same regulation by 
Vps45p (Dulubova et al., 2002).   
In order to distinguish between these two different interpretations (1) Vps45p is required 
for the transition of Tlg2p from a closed to an open conformation compatible with SNARE 
complex assembly or 2) Vps45p is required to release some inhibitory factor bound to the 
N-terminal portion of Tlg2p that is preventing SNARE complex assembly) we further 
investigated the ability of Vps45p to promote SNARE complex formation by promoting a 
transition of Tlg2p from a closed to an open conformation.  Chris Macdonald (University 
of Glasgow, UK) performed GST pull-down experiments using full-length and truncated 
Tlg2p.  He demonstrated that the truncated version of Tlg2p (Tlg2p∆Habc) was capable of 
forming complexes at a rate much faster than full-length Tlg2p (Figure 4.7a), suggesting 
that the Habc domain of Tlg2p inhibits SNARE complex formation, consistent with the 
hypothesis that Tlg2p forms a closed conformation.  Addition of Vps45p to the GST pull-
down assay (again performed by Chris Macdonald) allowed full-length Tlg2p to form 
SNARE complexes at a rate comparable to that of truncated Tlg2p (Figure 4.7b).  These 
results support our hypothesis that Vps45p is required for the transition of Tlg2p from a 
closed to an open conformation compatible for SNARE complex assembly.   
In support of our findings, it has been demonstrated using isothermal titration calorimetry 
(ITC) that an interaction exists between the C-terminal portion of the SNARE domain of 
Sx16 and Vps45, which is analogous to the interaction between Sx1a and the central cavity 
of Munc18a (Burkhardt et al., 2008).  Consistent with the finding that Tlg2p and Sx16 are 
functional homologues this would suggest that the Tlg2p construct (60-283) used in NMR 
studies (Dulubova et al., 2002) was lacking residues required to stabilise a closed 
conformation of Tlg2p (Dulubova et al., 2002).   
More recently, in the last couple of weeks, further evidence that Vps45p interacts with a 
closed conformation of Tlg2p via Mode 1 binding, has been provided using a fluorescent 
electrophoretic mobility shift assay (EMSA) (Furgason et al., 2009).  Initially it was 
demonstrated that this mode of binding between Vps45p and Tlg2p is separate from Mode 
2 binding, as a Tlg2p construct (residues 37-318) lacking its first 36 residues, which are 
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(Furgason et al., 2009).  In the reciprocal experiment the ‘pocket-filled’ mutant version of 
Vps45p (Vps45pL117R) is also capable of associating with the truncated version of Tlg2p, 
demonstrating that the interaction is not via Mode 2 binding (Furgason et al., 2009).  This 
mode of binding is analogous to that shared between Munc18a and Sx1a (Mode 1 binding) 
as it requires sites in the Habc and SNARE domain of Tlg2p.  Mutation of an isoleucine 
residue, present in the SNARE domain of Tlg2p, to an alanine residue generated a 
construct (Tlg2p(37-318)-I285A) that is no longer capable of competing with Tlg2p(37-
318) for binding to Vps45p (Furgason et al., 2009).  Similarly mutation of three lysine 
residues in the Habc domain of the Tlg2p construct (37-318)-K134A, K137A, K163A that 
are required for Tlg2p to adopt a closed conformation, generated a construct that is also 
unable to compete with Tlg2p(37-318) for binding to Vps45p (Furgason et al., 2009).  
These three lysine residues, important in forming a closed conformation of Tlg2p, are 
predicted to pack tightly against residues in the C-terminal section of the SNARE domain 
(Furgason et al., 2009).  Those C-terminal residues important for packing tightly against 
K134, K137 and K163 as well as the isoleucine residue at position 285 were not included 
in the Tlg2p construct (residues 60-283) used by Dulubova and colleagues in their NMR 
studies and this may explain why their structural studies did not observe a closed 
conformation of Tlg2p (Dulubova et al., 2002, Furgason et al., 2009).  These results further 
support the hypothesis that Tlg2p does form a closed conformation akin to that of Sx1a and 
supports our model that Vps45p is required for the transition of Tlg2p from a closed to an 
open conformation compatible with SNARE complex assembly.  
Further to their findings that Tlg2p can adopt a closed conformation, Furgason and 
colleagues also demonstrated that unlike Munc18a and mammalian Vps45 (Burkhardt et 
al., 2008), binding of Tlg2p to Vps45p via Mode 2 does not positively influence Mode 1 
binding (Furgason et al., 2009).  In fact Vps45p binding to Tlg2p via Mode 2 decreases the 
affinity of Vps45p for the closed conformation of Tlg2p (Furgason et al., 2009).  This was 
demonstrated by the ability of the N-peptide of Tlg2p (1-33) to compete with Tlg2p (37-
318) for binding to Vps45p (Furgason et al., 2009).  This competition is specific to the 
binding of Vps45p as opposed to an intramolecular binding of the N-terminal peptide to 
the Tlg2p construct (37-318) as no competition was detected using the ‘pocket-filled’ 
mutant of Vps45p (Furgason et al., 2009).   
SM proteins may also regulate membrane fusion via an indirect mechanism, acting as 
chaperone-like molecules (Toonen et al., 2005).  Deletion of VPS45 results in a decrease in 
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2001).  In Chapter 4, I also detected a reduction in the cellular levels of the v-SNARE, 
Snc2p, in cells lacking Vps45p (Figure 4.3).  As well as binding Tlg2p, Vps45p also binds 
directly to Snc2p (Carpp et al., 2006).  However no interaction between Vps45p and the t-
SNAREs, Tlg1p or Vti1p, can be detected (Carpp et al., 2006).  These results suggest that 
the SM protein, Vps45p may play an important role in regulating the cellular levels of the 
syntaxin, Tlg2p and the v-SNARE, Snc2p.  This may be important to control the overall 
trafficking of molecules in vivo as Snc2p is also involved in other trafficking events, such 
as exocytosis.  For example, if levels of Tlg2p are depleted in vps45  cells this may lead to 
an increase in the availability of the v-SNARE, Snc2p, to participate in other fusion events.  
One caveat of this model is that I would have imagined it to predict that the levels of the 
other SNARE proteins, Vti1p and Tlg1p, should also be depleted in the absence of 
Vps45p, but they are not (Figure 4.3 and (Bryant and James, 2001)).  One possible 
explanation for the unregulated levels of Vti1p and Tlg1p compared to that of Snc2p, 
would be the tighter regulation involved in exocytosis, which requires Snc2p, compared to 
that of endosomal trafficking, which requires Tlg1p and Vti1p. 
6.3 Regulation of Tlg2p levels in the cell 
Cells lacking Vps45p (vps45 ) have reduced levels of Tlg2p (Figure 4.3 and (Bryant and 
James, 2001).  In order to further understand the mechanism by which Vps45p stabilises 
this syntaxin, I set out to investigate the regulation of steady-state levels of Tlg2p in both 
wild-type and vps45  cells.  
Considering the results provided in Chapter 5, it would appear that levels of Tlg2p are 
regulated by two different degradative pathways. 
1)  In the absence of Vps45p, levels of Tlg2p are regulated by proteasomal activity 
(Bryant and James, 2001), possibly via the ERAD pathway as demonstrated by 
Braun and colleagues (Braun and Jentsch, 2007).   
2)  In the presence of Vps45p, steady-state levels of Tlg2p are primarily regulated by 
vacuolar degradation (Figure 5.1, 5.2, 5.3 and 5.7).   
Findings provided by Braun and colleagues which demonstrate that the levels of Tlg2p are 
restored in vps45  cells in which ERAD has been abolished (through deletion of the      
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temperature sensitive mutant of Ufd1p (Ufd1-2) which is the substrate-recruiting cofactor 
of  the chaperone-like enzyme, Cdc48p) (Braun and Jentsch, 2007), suggest that the SM 
protein, Vps45p, stabilises Tlg2p shortly after synthesis.  However, stabilised Tlg2p is 
capable of reaching the appropriate intracellular location in vps45  mutant cells in which 
proteasomal degradation has been abolished (Bryant and James, 2001) arguing that Tlg2p 
is trafficked out of the ER in the absence of it SM protein. 
Vps45p stabilises cellular levels of Tlg2p via Mode 2 binding (Carpp et al., 2007); 
demonstrated by the decreased levels of Tlg2p present in vps45  cells expressing the 
‘pocket-filled’ mutant version of Vps45p (Vps45pL117R) (Figure 5.18 and (Carpp et al., 
2007)).  However the expression of the first 33 amino acids of Tlg2p fused to full-length 
His3p did not prevent the growth of  his3-200,  vps45 cells in media lacking Histidine 
(Figure 5.20), which suggests that the N-terminal peptide of Tlg2p alone does not contain 
all of the sequences required to target Tlg2p for degradation in the absence of Vps45p.  
Neither is the N-terminal peptide targeted for ubiquitination, as mutation of the only lysine 
residue present in this region (K26R) did not prevent the degradation of Tlg2p in the 
absence of Vps45p (Figure 5.17); demonstrating that Vps45p binding is not masking a 
possible ubiquitination site.  
Interestingly abrogation of Mode 2 binding through mutation of the phenylalanine and 
leucine residue at position nine and ten of Tlg2p to alanine residues, results in increased 
levels of the syntaxin when expressed in tlg2  cells (Furgason et al., 2009).  This is in 
contrast to those results presented in this thesis which demonstrate that abrogation of Mode 
2 binding through mutation of Vps45p leads to the destabilisation of Tlg2p (Figure 5.18) as 
well as those results presented in a study involving the syntaxin Ufe1p, and its cognate SM 
protein, Sly1p, which demonstrate that abrogation of Mode 2 binding through mutation of 
Ufe1p results in decreased levels of the syntaxin (Braun and Jentsch, 2007).  One possible 
explanation for these contrasting results could be that mutation of the N-terminal peptide 
of Tlg2p results in a conformation of Tlg2p that is no longer compatible with targeting 
Tlg2p for degradation by the proteasome.  This could also be further investigated by 
assessing the levels of ‘wild-type’ and the mutant (F9A/L10A) version of Tlg2p in vps45  
cells containing proteasomal activity compared to those vps45  cells in which proteasomal 
activity has been abolished (through mutation of either the catalytic subunits, Pre1p and 
Pre2p (pre1-1, pre2-2) or the regulatory domain, Cim3p (cim3-1) (Heinemeyer et al., 1993, 
Heinemeyer et al., 1991, Ghislain et al., 1993)).  This would address whether or not this Marion S. Struthers, 2009    Chapter 6, 160 
 
mutant version of Tlg2p (Tlg2pF9A/L10A) is subject to the same regulation as ‘wild-type’ 
Tlg2p in vps45  cells.      
The results presented in Chapter 5 also support a model in which Vps45p utilises different 
modes of binding to carry out its functions within the cell; regulating the cellular levels of 
Tlg2p and regulating membrane fusion.  Vps45p binding to Tlg2p via Mode 2 binding is 
required for stabilisation of Tlg2p (Carpp et al., 2007) whereas Vps45p binding to Tlg2p 
via Mode 1 binding is involved in regulating the entry of Tlg2p into SNARE complexes 
(Figures 4.6 and 4.7 and (Bryant and James, 2001, Furgason et al., 2009)) and Mode 3 
binding is involved in the recycling of Tlg2p following membrane fusion (Bryant and 
James, 2003, Carpp et al., 2006).  This model is also supported by the recent finding that 
Mode 1 and Mode 2 binding of Vps45p to Tlg2p is non-cooperative (Furgason et al., 
2009), suggesting that these modes of binding also function independently.  However this 
model does not explain those findings which demonstrate that the introduction of the 
‘pocket-filling’ mutation to the dominant negative version of Vps45p 
(Vps45pW244R/L117R) prevents the dominant negative version of Vps45p from blocking 
membrane fusion (Carpp et al., 2006), which would suggest that Vps45p binding to Tlg2p 
via Mode 2 binding is required for membrane fusion.  Nor does it explain the recent 
findings which demonstrate that abrogation of Mode 1 and 2 binding is required to disrupt 
membrane fusion (Furgason et al., 2009).  However it should be noted, that this later 
finding was demonstrated using a mutant version of Tlg2p (Tlg2pF9A/L10A) that is 
unable to bind to Vps45p via Mode 2 binding (Dulubova et al., 2002) as opposed to a 
mutant version of Vps45p (Vps45pL117R) that is unable to bind to Tlg2p via Mode 2 
binding (Carpp et al., 2006).  However, as discussed previously, this mutant version of 
Tlg2p (Tlg2pF9A/L10A) also results in elevated levels of Tlg2p rather than decreased 
levels of Tlg2p as detected when Mode 2 binding is disrupted through mutation of Vps45p 
(Vps45pL117R).  
In Chapter 5, I also provided preliminary data to suggest that Tlg2p is palmitoylated 
(Figure 5.21 and 5.22).  Palmitoylation has been proposed to increase the stability of 
proteins in vivo; this has been reported for the v-SNARE, Snc1p (Couve et al., 1995) and 
the t-SNARE, Tlg1p (Valdez-Taubas and Pelham, 2005).  Interestingly, palmitoylated 
Tlg1p is thought to be protected from ubiquitination by the E3 ligase, Tul1p, which 
subsequently prevents its entry in MVBs and hence prevents its degradation by the vacuole 
(Valdez-Taubas and Pelham, 2005).  In Chapter 5 (Figure 5.7), I demonstrated that in the 
presence of Vps45p a fragment greater than the lumenal domain of Tlg2p is subject to Marion S. Struthers, 2009    Chapter 6, 161 
 
vacuolar degradation, which suggests that the cytosolic domain is also exposed to vacuolar 
proteases.  Considering this alongside the possibility that Tlg2p may be monoubiquitinated 
(Figure 5.10) and also its sensitivity to hydroxylamine treatment (Figures 5.21 and 5.22), it 
would seem sensible to further investigate whether or not Tlg2p is regulated in a manner 
similar to that of Tlg1p.  This would primarily require investigating whether or not Tlg2p 
is palmitoylated in vivo.  This could be performed using metabolic labelling with 
radiolabeled palmitate.  If this work confirms that Tlg2p is palmitoylated an important 
additional step would be to investigate how this palmitoylation functions to regulate the 
levels of Tlg2p in vivo.  For example, it would be of interest to identify which 
palmitoyltransferase is involved in this process.  A good target would be the DHHC-CRD 
palmitoyltransferase, Swf1p, as a swf1 null mutant shows synthetic sick interactions with 
tlg2 mutant cells (Tong et al., 2004). 
6.4 Future Work 
This study has provided strong evidence to suggest that Sx16 is a functional homologue of 
the yeast t-SNARE Tlg2p.  This opens up the possibility of using the model organism,      
S. cerevisiae to further investigated the role that Sx16 plays in the regulation of insulin-
regulated GLUT4 trafficking.  It has been demonstrated that Sx16 is dephosphorylated 
upon insulin binding to its receptor (Perera et al., 2003) making Sx16 an extremely 
attractive candidate as a regulatory node of insulin-regulated GLUT4 trafficking as 
phosphorylation is thought to play an important role in regulating membrane fusion 
(Gurunathan et al., 2002).  Tlg2p is phosphorylated on Serine 90, which prevents its entry 
into SNARE complexes (Gurunathan et al., 2002).  Sequence alignment of Tlg2p and 
Sx16, performed by Dr Kirsty Proctor (University of Glasgow, UK), has identified two 
potential sites of phosphorylation in Sx16, Serine 94 and 95.  In order to further determine 
which of these sites is/are targeted for phosphorylation and hence is/are involved in 
regulating the entry of Sx16 into SNARE complexes, the complementation experiments 
discussed in Chapter 3 could be used.  Initially mutation of both of the serine residues 
present in Sx16 to aspartate residues (which carry a negative charge and are mimetic of 
residues which have undergone phosphorylation) would allow us to determine if either of 
these residues are involved in regulating SNARE complex assembly by preventing this 
mutant version of Sx16 from correcting the trafficking defects displayed in tlg2  mutant 
cells.  Subsequent to this mutation of each of the individual serine residues to aspartate 
residues would allow us to determine which, if not both of these residue(s), is/are involved 
in regulating SNARE complex assembly.  As a control for these experiments the serine Marion S. Struthers, 2009    Chapter 6, 162 
 
residues should also be mutated to asparagine residues, which are equivalent in size to 
aspartate residue(s) but are uncharged, this would rule out the possibility that the aspartate 
residue(s) is/are altering the conformation of Sx16 and that the effect is specific to the 
negative charge of the aspartate rather than the size.  A further control for this experiment 
would be to include phosphoresistant versions of Sx16 in which the serine residue(s) of 
interest is/are mutated to alanine residues and hence are unable to undergo 
phosphorylation, if these residue(s) is/are involved in regulating membrane fusion this 
mutant version of Sx16 should be capable of correcting the trafficking defects displayed in 
tlg2  mutant cells.  One possible problem with this investigation could be the close 
proximity of the two serine residues, which may make it difficult to tease apart whether 
both of these residues are involved in regulating SNARE complex assembly or just one.  
Following the identification of possible phosphorylation site in Sx16 using yeast, it would 
be of great importance to further investigate the phosphorylation of Sx16 in mammalian 
cells. 
With respect to the regulation of steady-state levels of Tlg2p in the presence and absence 
of Vps45p, a substantial amount of work is required in order to understand how Vps45p, 
the proteasome and/or vacuole, palmitoylation and/or ubiquitination are all involved in 
regulating the cellular levels of Tlg2p.  This would involve identifying whether or not 
Tlg2p is mono and/or polyubiquitinated; which residue(s) is/are subject to ubiquitination 
and which E3 ligase is responsible.  As well as identifying whether or not Tlg2p is 
palmitoylated in vivo; if so which palmitoyltransferase is involved in this process and also 
which residues are subject to palmitoylation. 
The work presented in this thesis has established Tlg2p-mediated trafficking in                  
S. cerevisiae as a model system for investigating Sx16 function in insulin-sensitive cells 
and also uncovered some of the molecular mechanisms by which these syntaxins are 
regulated within the cell. 163 
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